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This thesis was written by myself based on work
carried out over the past five years. I was a member
of the team involved in the treatment of advanced
cancer by whole body hyperthermia. I was responsible
for investigation of the physiological background
necessary to enable a safe method of whole body
hyperthermia to be established, and for evaluating the
response of patients to this form of therapy.
The second part of this thesis is based on a new
method of hyperthermia perfusion of the urinary
bladder for the treatment of transitional cell carcinoma.
I devised the apparatus and carried out all the treatments
in this section. I assessed all the bladders before and
after treatment and took most of the biopsies.
In any new treatment of patients, one person can
only be part of a team concerned with the best possible
treatment for each patient. I would like to thank all




















































1.1 Fever therapy in the treatment of cancer is
reviewed. Biochemical'mechanisms of heat induced
cellular damage are discussed with ways of
potentiating the selective lethal effect. Conditions
inducing heat resistance are stated.
1.2 Relationship of temperature to time above
the 'critical temperature' for cell death is
described. A clinical unit of heat stress, the
centigrade degree minute is defined and used in
subsequent studies.
1.3 Animal work involving treatment by temperatures
in excess of 40°C. (hyperthermia), is reviewed.
Methods of inducing controlled whole body hyper¬
thermia are described, and the difficulties
discussed. Dr. Pettigrew's method is described.
1.4 Physiological studies during hyperthermic
therapy of disseminated human cancer investigating
the haemodynamic response, fluid and electrolyte
losses, and modifications of replacements required
to produce a stable, safe treatment are described.
1.5 Liver sensitivity limited the maximum
therapeutic temperature. Increasing stress and a
leucocytosis was observed during treatment.
Prolonged treatment in sensitive tumours induced
disseminated intravascular co-agulation
necessitating fractionation of therapy.
1.6 Tumour response to treatment is assessed and
complications noted. Whole body hyperthermia
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alone was not curative but caused good short term
palliation of sensitive tumours.
1.7 Methods of inducing local hyperthermia are
evaluated.
1.8 A new method involving hyperthermic perfusion
of the distended urinary bladder for transitional
cell carcinoma is described. Advantages including
tumour exposure, heat gradient and reproduceable
effects are discussed.
1.9 Following perfusion under epidural anaesthesia
the damage to tumour and normal bladder was
proportional to the treatment given; that necessary
for deep tumour necrosis produced unacceptable
damage to the normal bladder. Therapy was limited
by vascular thrombosis in the bladder wall.
1.10 Treatment given by smaller daily fractions
did not summate. Treatment without epidural
anaesthesia was ineffective and the reasons for
this are discussed. Vascular damage was of use
in arresting gross haematuria.
1.11 Hyperthermia alone was palliative but
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A. INTRODUCTION
2.1. Surgical excision of localised cancer is
curative. Cancer therapy for extensive or
inoperable disease relies on the narrow margin of
difference shown in respect of recovery from
stress of the normal and the cancer cell. Such
stress may be applied by selective poisons,
localised ischaemia, X-ray therapy of a combination
of these agents. Recently there has been
considerable interest in the response of cancer
cells to heat stress.
2.2. In this thesis the background of cancer therapy
by heat stress using temperatures in excess of 40°C.
(hyperthermia) is reviewed, together with in vitro
and animal studies which illustrate the mechanism
of action of hyperthermia and its selective effect
on some cancer cells. Two clinical studies were
carried out to assess the effect of hyperthermia
in the treatment of human cancer. The first using
whole body hyperthermia for disseminated disease
and the second, hyperthermic perfusion of the urinary
bladder in the treatment of localised transitional
cell carcinoma. The results of these studies are
tabulated and show that hyperthermia alone can offer
a degree of palliation in some advanced cancers but
is not curative. Future management using hyperthermia
as a potentiating agent to conventional therapy,
in selective tumour types, has a great promise. The
effect of hyperthermia alone, its fractionation,
dosage and the safety margins in man are important
9.
building blocks with which to plan this combined
therapy.
B. A HISTORICAL REVIEW OF FEVER THERAPY
2.3 In 1866 Busch described the complete
disappearance of a sarcoma from the face following
recurrent attacks of erysipelas. The patient
remained well and disease free when reviewed two
years later. Bruns (1887) observed a terminally
ill patient with a metastatic malignant melanoma
who developed intercurrent erysipelas and
associated pyrexia of 40°C. for several days. All
the tumours disappeared and the patient was alive,
well and free from disease eight years later.
2.4 The work of W. B. Coley in the New York
Hospital has been described by his daughter (Nauts,
Fowler and Bogatko, 1953). After losing one of
his first patients with a sarcoma he reviewed all
such cases treated in that hospital and found the
only survivor had a severe post operative wound
infection with erysipelas causing a prolonged high
fever. In May 1891 Coley attempted to transfer
erysipelas to a patient with a recurrent and
inoperable myosarcoma of the neck. After repeated
trials he succeeded and the resulting severe
erysipelas was associated with complete regression
of the tumour. In attempting to induce erysipelas
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in 9 other patients Coley recognised the
difficulties that either the patient might prove
immune to infection or the infection might prove
so severe as to be fatal. He reported this
group of 10 patients in 1893 together with 28
who had accidently developed intercurrent
infection with erysipelas. All patients had
histologically diagnosed advanced cancer. In 12
the tumours completely regressed and 19 patients
showed some improvement. Of the 10 patients
that Coley had deliberately infected the two
patients with the highest fevers survived for 7
and 27 years respectively. Realising the dangers
of live vaccines Coley then tried injecting
streptococci sterilised by heating to 100°C. or
by filtration. These proved entirely ineffective.
2.5 In December 1892 Coley combined toxins from
bacillus prodigiosus with those of the strept¬
ococci in an attempt to produce a more effective
product. The first Coley mixed toxins were
sterilised by filtration and the first case treated
by this preparation was a bed ridden young man
with a sarcoma of the abdominal wall extending
to the pelvis and involving the bladder. He was
given repeated injection of toxin into the
tumour over a 4 month period. Each injection
produced a pyrexia with a rise of temperature
between 0.5 and 0.6°F. His extensive growth
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regressed completely and he eventually died free
from disease, 2 6 years later (Nauts, Fowler and
Bogatko, 195 3).
2.6 From that time until his death in '.19 36 Coley
tried a variety of toxins and in 1946 when Nauts
reviewed 600 case histories from different
clinics in America at least 15 varieties of the
toxin had been used. The methods of treatment
varied with different dosages, injection sites
and duration of treatment, but the greatest
response rate was noted with patients showing a
marked response to toxin therapy associated with
a temperature rise above 39.4°C. In a study
reviewing 86 patients with lymphosarcoma treated
by Coley's toxins Nauts and Fowler (1969), found
that no patient survived who had little or
no febrile reaction to the toxin, 11% with a
moderate reaction and 48% of those with a marked
reaction (averaging 38°C. to 40°C.) survived.
The highest cure rate being in patients treated
over a period of 4 - 6 months.
2.7 Coley's toxins were rarely, if ever,
standardised biologically and consequently the
effects were inconsistent and unpredictable,
successful treatment often leading to haemorrhage
and necrosis. In 1940 Shear and Perrault attempted
to isolate the pyogenic and tumour necrotising
substance and devise a method of bio-assay to
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standardise its potency. The toxin was found to
be a high molecular weight polysaccharide but its
effect in transplantable sarcoma in mice was
unpredictable. Further purified extracts of
bacterial polysaccharides capable of producing
pyrexia and tumour necrosis were obtained by
Creech, Hamilton et al, in 1948 but the high
toxicity of such extracts discouraged clinical
studies (Rieman and Nishimura, 1949). The use
of toxins fell into disrepute, partly because of
the effects were unpredictable and had a
considerable mortality when given to seriously
ill patients with disseminated cancer, and partly
because of the development of X-rays and radium,
with their use in the treatment of neoplasms.
8 In 1918, Rhodenburg reviewed 166 cases of
well documented spontaneous regression of human
tumours and found 72 cases had intercurrent high
fevers, heat applications or severe infections.
Of 26 spontaneously regressing sarcomas, 19 had
fever, heat treatment or infection. Everson and
Cole, (1956) reviewed 1,000 cases of spontaneous
regression reported in the world literature and
mentions fever or infection as a possible factor
of regression in 130 cases which he considered
adequately documented.
9 In the early part of this century there was
general agreement that in some cases infection
or toxins might have a beneficial effect in the
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treatment of cancer. It was not known if the
effect due to hyperpyrexia, to a direct action
of bacterial products, or to stimulation of the
immune response. Vidal in 1910 observed that
pyrexia had been associated with a large number
of treatments causing cancer regression. He
believed that leucocytosis and other symptoms of
fever produced a profound constitutional reaction
of the whole organism to the tumour. Recently
there has been renewed interest in stimulating
cell mediated immunity against tumours by
activating thymus dependant lymphocytes with
B.C.G. or corynebacterim parvum (Klein 1973,
MacGregor and Falk, 19 75).
2.10 In this thesis the effects of hyperthermia
on physiology and the function of the normal and
cancer cell are compared. The immunological
response is at present under study but it is most
probably that the overall effects are contributed,
as suggested by Crile in 1963, by a combination of
both direct damage with decrease in tumour bulk,
and a subsequent stimulation of the immune response.
C. BIOCHEMICAL MECHANISMS OF ACTION OF HYPERTHERMIA
2.11 Lambert 1912 using hanging drop plasma
cultures, found that mouse sarcoma cells survived
for three hours at 43°C. whereas connective tissue
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cells derived from mouse aorta, survived for six
hours. Vollmar (1941) found that explants of
normal chick and rodant tissue survived treatment
at 42°C. while ascites and sarcoma explants did
not. More recently Bender and Schramm (1966),
estimated the temperature of a 30 minute exposure
which produced irreversible damage in 46 tumours
of animal and human origin and compared these
with a variety of normal tissues. There was a
tendency for the tumour cells to be more sensitive
than normal with the difference being of the order
of 1 - 2°C. In some instances there was no
difference between tumour and normal sensitivities.
Since that time numerous works have confirmed
these studies(Levine and Robbins, 1970).
INHIBITION OF OXYGEN UPTAKE
Variation of thermal tolerance of normal tissue
12 In 1915 Fuhrman and Field found that the rate
of oxygen uptake of rat liver slices increased
with temperature up to 45°C./ whereas rat heart
reached a maximum uptake of 38°C. then declined to
half that value to 42.5°C. In a further study
by Burger and Fuhrman in 1964, the rate of oxygen
consumption was measured at 38°C. after exposure
of various rat organs to hyperthermia for varying
time intervals. In the liver there was a reduction
of 20% after one hour at 45°C. Cerebral cortical
tissue showed the same reduction after one hour at
15.
43°C. and for kidney cortical tissue the same
effect was elicited after one hour at 44°C.
2.13 Conversely when the whole animals were heated
to between 43 - 44°C. until they became anoxict
the oxygen uptake of tissue slices showed no
impairment in the cerebral cortex, whereas liver
oxygen uptake was reduced by 40%. This resistance
of cerebral cortex was confirmed and studies by
Ten Carte (1949) by electro-encephalographic
studies which demonstrated that the disappearance
of the normal pattern only occured at between 44
and 45°C. Mossa (192 7) found that chick neurones
maintained in culture survived up to temperatures
of 49°C. As judged by inhibition of oxygen uptake,
normal tissues vary in their resistance to damage
produced by elevated temperature, but are in
general, quite tolerant - the rat brain being
remarkably resistant to thermal damage (Burger and
Fuhrman , 19 6 4) .
Variation of oxygen uptake of tumour during A;;
hype rthe rmia.
2.14 Some tumour cells show a greater reduction
in aerobic and anaerobic glycolysis with a moderate
increase in temperature than normal cells. This
was first clearly demonstrated by Westermark in
1927 who compared Flexner Jobling carcinoma and
Jensen sarcoma cells with normal rat liver.
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Cavaliere, Ciocato et al (1967) repeated these
experiments using Novikhoff hepatoma and Ehrlich
ascites cells as compared with normal rat liver
cells and found that the oxygen uptake of the
tumour cells was considerably less than 42°C.
than at 38°C. There was little difference in
respiration at these two temperatures in normal
or regenerating liver cells. The inhibition of
respiration of the Novikhoff hepatoma cells was
irreversible after 90 minutes. Anaerobic glycolysis
was not inhibited in either groups of tissue until
temperatures of between 42 - 43°C. were used.
2.15 Muckle and Dickson (1971) confirmed these
results in the rabbit working with a VX2 carcinoma
at 42°C. Following incubation at this temperature
the tumour showed a decrease in viability and
growth potential as measured by its ability to
produce tumours when subsequently innoculated into
healthyrabbits. They found respiration and
anaerobic glycolysis of normal rabbit liver, kidney
and red boood cells were unaffected by incubation
at 42°C. Dickson and Muckle (1972) found that
whereas the oxygen uptake of the VX2 carcinoma was
inhibited by two hours at 42°C. cells from the
metastases of the VX2 carcinoma showed some decrease
but no inhibition of oxygen uptake at 42°C.
2.16 Dickson and Shah (1972) showed that there was
depression of respiration in rat breast adeno¬
carcinoma at temperatures over 40°C. with irreversible
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damage to the cells after four hours as indicated
by a low oxygen uptake,"loss of viability and
failure of the cells to proliferate.
INHIBITION OF NUCLEIC ACID SYNTHESIS
Normal Cells
2.17 The rate of synthesis of nucleic acids is
usually measured by incubating cells with radio-
actively labelled precursor such as thymidine or
uridine. The cells are then fixed and covered
with a layer of photographic emulsion for a period
of one month. When developed such autoradiographs
show grains of silver which can be counted over a
standard area of nuclei and converted to relative
rates by comparison with the grains per unit area
of the controls.
2.18 In 1965 Sisken, Morsca et al, exposed human
amnion cells to various elevated temperatures for
five hours and then measured the uptake of Tritium
labelled thymidine. He found that the greatest
rate of incorporation was in the range of 37 to
39°C. At temperatures above 40°C. there was a
rapid fall in the rate of DNA production and at
temperatures between 41 and 43°C. there was an
arrest of production with extensive irrepairable
cellular damage. Simard and Bernhard, (1967),
working with hamster fibroblasts and using high
resolution autoradiography was able to demonstrate
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a profound disturbance of RNA synthesis with little
incorporation of tritated thymidine following a
hyperthermia episode. The nucleolus, which is
the main site of RNA synthesis, was particularly
sensitive being selectively destroyed after 15
minutes at 42°C.
Tumour Cells
2.19 Mondovi, Agro et al, (1969) working with
Novikhoff hepatoma cells found a 50% reduction
3
_ of incorporation of H thymidine into DNA after
one hour at 43°C. though inhibition was evident
at temperatures over 40°C. In comparison an
increased incorporation of precursors was found
in regenerating rat liver cells after incubation
at 4 3°C.
2.20 Warocquier and Scherrer, (1969) studied Hela
cells which were less sensitive to heat and showed
a different pattern. During incubation at 42°C.
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the rate of C uridine uptake fell uniformly
reaching a plateau at six hours. This was confirmed
by Love, Soriano and Walsh, (1970) who also found
that the net RNA synthesis was impaired though
not completely blocked by this degree of hyper¬
thermia but at 46°C. there was complete inhibition
of nucleic acid synthesis.
2.21 Mondovi, Agro et al (1969) related the heat
sensitivity to the 'malignancy' of the tumour,
Novikhoff cells being more metabolicaliy active,
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were more easily inhibited than minimal deviation
hepatoma 512 3 cells. A~~critical temperature for
Novikhoff hepatoma cells was 41°C. by increasing
the temperature above this no additional effect
was achieved. Wlist, Norpoth, et al (1973) found
that there was inhibition of uptake of labelled
precursors of nucleic acid synthesis in all
proliferating tissue incubated at 41°C. They
found no difference in sensitivity between Jensen's
sarcoma, G.W.39 tumour, embryo tissue and
regenerating liver cells. The degree of inhibition
was proportional to the extent and duration of
the hyperthermia. There were no corresponding
influences of hyperthermia on non-proliferating
tissues, the sensitivity to temperature appeared
to be. limited to proliferating cell systems.
2.22 These findings would correspond to Poswillo,
and Nunnerly's (1974) finding that hyperthermia
is a teratogenic agent in marmosets and is of
clinical interest as a factor linking prenatal
influenza with central nervous system defects in
children (Edwards 19 72).
CHANGES IN THE NUCLEOLUS AND KNA SYNTHESIS
Changes in the structure and function
2.23 Ribosomal RNA is synthesised mainly in the
nucleolus, by transcription of nucleolar DNA,
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forming a large precursor molecule of about
45s, which is then cleared through a series of
intermediate steps to active 28s and 18s
ribosomal RNAs. These combine with protein and
move into the cytoplasm constituting the ribosomal
sub-units. The active granular ribonuclear
protein of the nucleolus is concerned with protein
synthesis.
2.24 Following incubation of BHK cells derived
from Syrian hamsters, at 42°C. Simard and Bernhard,
(1967), found a loss of granular ribcnuclear
protein, intranuclear chromatin and nucleolar
structure. The nucleolus became round and some¬
times had wide open meshes and the fibrillar
reticulin completely disappeared. After recovery
from heat stress the cells built up their lost
nucleolar structure in an exaggerated manner,
the nucleolus becoming larger than previously
with granular ribonuclear protein in greater amount.
These findings were confirmed by Dickson and Shah
(1972) in the VX2 rabbit carcinoma.
2.25 Love, Soriano and Walsh, (1970) working with
BHK 21 cells, three lines of H.ela cells and two
lines of human diploid cells,found that the
nucleolar DNA and granular DNA disappeared following
exposure of exponentially growing cells to temp¬
eratures of 45 to 46°C. for periods of 15 to 16
minutes. Diffusion of the nucleolinar material
was demonstrated by specific stains to be
throughout the nucleus. All such cells developed
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cytoplasmic inclusion consisting of aggregations
of ribosome like granules and no cytoplasmic
inclusions were observed in cells that did not
have nucleoli. At temperatures of 41 - 44°C.
the changes occurred but were less marked than
at 46°C.
2.26 Simard and Bernhard, (1967) noticed a
critical temperature at 42°C. in BHK cells, the
nucleoli rather suddenly becoming heat sensitive
after 15 minutes at 42°C., though a more
pronounced effect was noticeable after one hour.
EFFECTS OF RIBOSOMAL FUNCTION AND
PROTEIN SYNTHESIS.
2.27 McCormick and Penman (1969) found that the
incubation of Hela cells at 42°C. caused a rapid
disaggregation of polysomes and a corresponding
reduction in the rate of amino acid synthesis.
This was maximal after 9 minutes at 42°C. after
which time there was a slow recovery of protein
synthesising capacity in Hela cells. The
protein produced at elevated temperatures was not
normal and seemed to be produced by a thermally
stable group of small ribosomes. Further more
this recovery of synthetic power was dependant on
the production of a species of RNA which promotes
the association of ribosomes with messenger RNA.
This species of RNA is produced by cells under
22.
prolonged heat stress.
2.28 The process of ribosomal disaggregation caused
by heat stress was reversible by subsequent
incubation at 37°C., recovery being complete
within 24 hours. Reversibility of the disaggregation
of polysomes was confirmed by Love et al (1970) in
Hela cells at 46°C. and Heine (1971) who observed
complete recovery by 24 hours.
2.29 Mondovi, Agro et al (1969) found that in
Novikhoff hepatoma 5123 cells there was a
progressive inhibition and final arrest of protein
synthesis at 40°C. whereas the rate of protein
synthesis in regenerating liver cells was higher
at 43°C. than at 38°C.
EFFECTS ON CHROMOSOMES AND CELL CYCLE
In Vitro Observations
2.30 Rao and Engelberg, (1965) working with Hela
cells showed that exponential growth could be
maintained between 33 - 40°C. The growth rate
was maximal at 38°C. and fell rapidly above 40°C.
There was no cell division at 41°C. but an
increase in the mitotic index was observed.
Sisken, Morasca and Kibby, (1965) found that the
optimum temperature for human amnion cells was
between 37 - 39°C. Some human tumour lines
showed an arrest of growth occurring between 39
23.
and 40°C. with a delay in mitosis with cells being
arrested in metaphase. --Above 40°C. irrepairable
damage to some tumour lines occurred while other
lines showed thermal stability (Selawry, Goldstein
and McCormick, 1957).
2.31 Westra and Dewey, (1971) found that heat
stress has a differential effect on the various
parts of the mitotic cycle. Synchronous
populations of Chinese hamster ovary cells were
heated in different phases of their cycle for
6, 10 or 15 minutes at 45.5°C. There was a
dramatic decrease in survival as cells moved into
the 'S' phase followed by an increased survival
in G2 with an increased sensitivity in metaphase.
Cells heated in mitosis induced tetraploidy in
90% of the cells scored in the next mitosis and
5% diplochromosomes were observed. There was a
long mitotic delay of up to 11 hours induced by
heat regardless of the phase heated, and it was
possible to induce mitotic synchrony by phased
heating, (Martin, 1964).
2.32 The 'S' phase was very sensitive for cell
killing and cells heated in this phase sustained
a very high frequency of chromosomal aberrations,
which increased with the time of treatment
(Dewey and Westra, 1971). Abnormalities produced
included deletions of chromosomal material,
chromatid deletions and chromatid interchanges.
Half of the aberrations in the mitotic and G1
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cells occurred at the position of the secondary
constriction of the X chromosome. The high
frequency of aberrations agreed qualitatively
with the high sensitivity of cell killing in the
'S' phase.
2.33 The effect of inhibiting the synthesis
of DNA or protein by cyclohexamide in Hela cells
protected the cells from heat damage (Palzer and
Heidelberger, 1973) . Further protection was
afforded when both DNA and protein synthesis
were suppressed. Contrasting effects were
obtained when RNA synthesis was blocked which
produced an increase in cell killing during
hyperthermia. Giovenella, Lohman and Heidelberger,
(1970) found this same effect to be true in
L.1210 cells.
EFFECTS ON CELL MEMBRANES
In Vitro Observations
2.34 Belehradek (1957) suggested that the cause
of 'heat death' in cells was due to melting of
cellular lipids. This lipoid liberation theory
was originally proposed by Heilbrunn in 1924 and
was based on the relationship between the degree
of saturation of the lipids in the tissues of a
poikilotherm and environmental temperature. Low
25.
environmental temperatures leads to the formation
of unsaturated fatty acids with a low melting
point, whereas at higher environmental temp¬
eratures a greater proportion of saturated fatty
acids of higher melting point are laid down.
The 'melting' point of the lipids varies with
the degree of saturation but is critical to
maintain the specific liquid crystalline state
of cellular membranes. Experiments with goldfish
have confirmed that a relationship exists
between the acclimitised state of the fish and
______ the degree of saturation of brain phospholipids
(Johnston and Roots, 1964).
2.35 The permiability of cell membranes change
during hyperthermia with an increase in
permiability of the cytoplasmic membrane and the
consequent passive leakage of solutes. This has
been shown to be an exponential relationship
with temperature as measured by efflux of flour-
excein from dye loaded Erlich and Yoshida ascites
cells (Strom, Santoro et al, 1973) , labelled
uridine from pig kidney cells (Reeves 1971) ,
loss of intracellular ions in the crayfish
(Bowler, 1973), or reflux of Lanthanum across the
damaged membrane (Fahimi and Contan, 1971).
EFFECTS ON LYSOSOMES
2 . 36 Overgaard and Overgaard (1972) working with
26.
mouse mammary carcinoma cells, found an increase
in the number and activity of lysosomes following
incubation at 41 - 43.5°C. The cellular changes
were similar to those following X-ray therapy
and consisted of pronounced autophagy with
destruction of cytoplasmic elements such as mito¬
chondria, the golgi apparatus and in extreme cases,
the nucleus. Turano, Ferraro et al, (1970) found
that Novikhoff hepatoma and Erlich ascites cells
have very labile lysosomes, being markedly more
fragile at elevated temperatures than were
lysosomes from normal regenerating liver cells.
Overgaard and Overgaard, (1975) proposed that
autodigesion was one method of action of hyper¬
thermia. Heat alone increased lysosomal activity
and by inhibiting aerobic glycolysis which
together with increased anaerobic glycolysis
caused an increase in lactic acid production by
the cell. This resulted in a decrease in the
intracellular P.H. which also stimulates lysosomal
activity (Eigner, 1961) .
2.37 As leakage of lysosomal enzymes due to
membrane damage might cause an inhibition of
oxygen uptake in the affected mitochondria, Turano
et al (1970), incubated cells with trypan blup,
which inhibits lysosomal enzymes, and showed no
change in the inhibition of oxygen uptake at
elevated temperatures. He therefore concluded
27.
that the lysosome was not the primary site of
action of hyperthermia though there were effects
on the lysosomal membrane. Heat activation of
lysosomes may be important in cell killing
though autophagocytosis is a common response to
many sublethal agents, and is an effective means
of disposal of damaged cytoplasmic organelles
without the death of the cell (Ericsson 1969) .
INHIBITION OF REPAIR
2-38 Mammalian cells have the capacity to repair
sublethal damage from noxious stimulae (Elkind
and Sutton, 1960). This property has been
extensively studied following X irradiation,
following which there is a characteristic shoulder
in the survival of cells to a gradually increasing
dose of X-rays prior to a region of exponential
response in which dose and cell death rates are
directly proportional (Puck and Marcus, 1955).
The shoulder is due to the capacity of the cells
to accumulate sublethal damage before a lethal
effect is registered (Elkind and Sutton, 1960).
2.39 Repair enzymes, such as DNA polymerase,
depend on protein stability for maintenance of
a functional quaternary structure. In vitro
work on thermal stability of complex enzymes
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necessary for cellular repair have shown that
they are only functional between narrow
temperature limits and are readily denatured by
temperatures of 42°C. or above (Horowitz and
Leopold, 1951). The more complex molecules
being more thermolabile (Brandts, 1967). DNA
polymerase has been found to be reversibly
temperature sensitive; it is inactive above
42°C. but becomes functional again when the
temperature is lowered (Karam and Speyer, 1970).
The heat inactivation energy causing denaturaticn
of several cellular enzymes and proteins has
been found to be between 110 and 198 K Cals/
mole (Johnson, Eyring and Polissar, 1954),
compared with an inactivation energy for the
cell between 125 - 140 K Cals/mole (Westra and
Dewey, 1971). This suggests that the
denaturation of critical protein plays an
important part in the heat inactivation of
mammalian cells.
2.40 That the proteins inactivated are those
normally involved in repair of sublethal
damages is suggested by the loss of the shoulder
on the survival curve when cultures are treated
by hyperthermia combined with radiotherapy
(Harisiadis, Hall et al, 1975), Ben-Hur, Elkind
and Bronk, (1975) found complete inhibition of
repair or radiotherapeutically induced lesions
29.
by incubation at 42°C. for 1.5 hours. This
inhibition of repair of cellular damage induced
by X-rays has been shown in many tissues
(Gillette and Thrall, 1974, Robinson, Wizenberg
and McCreadie, 1974, Gerner, Connor et al, 1975),
each tissue showing a differing thermosensitivity.
The same pattern has been shown after exposure
to chemotherapeutic agents (Palzer and Heidelberger,
1973, Hahn, 1974).
Factors Affecting Repair
2.41 Repair has been shown to be dependant on
nutritional status, those cells cultured and
starved during hyperthermia being less able to
repair sublethal damage. This would account for
the increased sensitivity of hypoxic tumour
cells to heat (Kim, Kim and Hahn, 1976) . Chinese
hamster ovary cells treated by incubation at 45.5°C.
for 7-9 minutes prior to irradiation showed
complete inhibition of repair. The half
value time for recovery from heat damage as
measured by the return of the shoulder of the
X-ray survival curve was 9 hours for cells in
Gl, or 16 hours in cells in 'S' phase. This
recovery of repair capacity occurred in the absence
of cell cycle progression which was delayed by
approximately 17 hours (Gerwick and Dewey, 1974).
30.
SUMMARY OF THE BIOCHEMICAL MECHANISM
OF ACTION.
2.42 Hyperthermic stress is a general effect on
the cell and there are changes in the function of
most cellular activities. By an increase in
temperature there is an increase in entropy and,
hence, an increase in the rate of chemical reactions
up to a critical value when the spatial
arrangement of the complex substances taking part
are changed. Each system has a different critical
temperature whereas the survival of the whole cell
is dependant not only on the damage incurred
but its capacity to repair sublethal damage. The
longer the cell is stressed the more damage is
done, this taken together with some inhibition
of the repair mechanism,results in a temperature
time survival curve characteristic for that cell
in a particular environment. Figure 1. summarises
the reported effects of hyperthermia stress and
emphasises the fact that cellular enzyme systems
are intimately linked with reticulo endothelium
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Summary diagram of the biochemical mechanisms of action
of hyperthermic stress.
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D. FACTORS AFFECTING HEAT SENSITIVITY
Exponential Growth
2.43 The growth rate of exponentially growing
Hela cells was found to be greatest at 37.5°C.
falling off steeply with increasing temperature,
and being completely inhibited at 41°C. Lag
phase cultures, being metabolically active, but
not actively dividing, were more resistant than
exponentially growing cells (Dickson and Shah,
1972). This was not true for the V79 Chinese
hamster cells which showed no difference in
sensitivity between cells in either phase
(Schulman and Hall, 1974) .
Nutritional Status
2.44 Chronically hypoxic or nutritionally
deprived cells have been shown to be more
sensitive to hyperthermia. That this effect is
due to nutritional deprivation rather than
anoxia has been suggested by Hahn (1976).
Contract Inhibition
2.45 Serially propagated growing heteroploid
human cancer cells and growing diploid human
skin fibroblasts do not survive incubation at
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42°C. for 24 hours. Contact inhibited monolayers
are still viable and show an increase in thymidine
and uridine uptake at 42°C. (Bender and Schramn,
1966). This finding may explain the differential
sensitivity of some tumour cells which are rarely
contact inhibited. It is probably that the minimal
level of DNA synthesis in contact inhibited cells
endows them with this measure of protection
against elevated temperature (Cavaliere et al, 1967,
Levine and Robbins, 1970, Kase and Hahn, 1974).
Method of Transformation
2.47 Cells transformed in vitro by methyl
cholanthrene or X irradiation were more heat
sensitive than cells transformed in vitro by
viral particles (Ossovaski and Sacks, 1967).
In contrast tumours produced in vivo by viral
transformation were more sensitive to hyperthermia
than those induced by physical agents (Kachini
and Sabin, 1969).
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E. ACQUIRED RESISTANCE OF CELLS TO
HYPERTHERMIA
2.48 As a biological phenomenon, thermal
tolerance is usually associated with cells that
are genetically endowed for existence at high
temperature levels. Thermophilic bacteria either
have protein enzymes of ionusual heat stability or
the rate of heat denaturation of proteins may be
counter balanced by an increased rate of
synthesis (Adye, Koffler and Mallett, 1957).
2.49 Harris (1967 A.), however, found thermal
resistant cells in a seemingly homogeneous
clonal line of pig kidney cells following
exposure at 47°C. for 90 minutes. The surviving
fraction, after recovery at 37°C. showed a
decrease rate of heat induced mortality, as
compared with the original parental population,
when subsequently incubated at 46°C. The clone
of heat resistant cells produced were able to
pass on this property to daughter cells for
several generations without further heat stim¬
ulation being required (Harris, 196 7 B.). There
was no apparent change in the genetic material of
such cells but following further exposure to
heat they did exhibit a small colony phenomenon,
the size of recovering colonies being inversely
proportional to the temperature of heat stress.
35.
The Rate of Cell Death Related to Temperature
and Time.
2.50 The death rate of cells undergoing hyper¬
thermic stress is related to the degree of stress
to which they are subjected. Figure 2 shows a
typica1 sigmoidal survival curve for Hela cells
(After Palzer and Heidelberger, 1973). Each
tissue has its own survival curve for set
conditions, which is dependant on its heat
sensitivity. This was extensively studied in
various tissues of the frog by Orr (1955), a
summary of his results is shown in Figure 3.
This variation of heat sensitivity is also true




A typical cell survival curve for Hela cells
incubated at 42 C. for various times.




Thermal death rate related to temperature and time









F. RATE OF CELL DEATH RELATED TO
TEMPERATURE AND TIME.
2.51 In 1971 Westra and Dewey studied the
quantitive relationship between rate of cell
death at a fixed incubation temperature and the
duration that the cells were kept at that
temperature. This again shows a sigmoid curve
mimicking that of an X-ray dose related survival
curve. These results are in good agreement with
the formula of Arrhenius for the change in rate
of a chemical reaction with temperature.
2.52 Arrhenius in 1889 studied the quantitive
effect of temperature on the rate of hydrolysis
of sucrose and found that it was too great to
be accounted for in terms of the effect of
temperature on the kinetic energy of the molecule
alone. He found that the relationship between
the velocity of reaction Kt at one temperature
To and the velocity Kt at a different temperature
T1 is described by the equation:





In which U is a constant called the inactivation
energy, e is the base of the natural logarithms,
To and Tl the absolute temperatures corresponding
to To and Tl respectively.
40.
MINUTES OF HEAT TREATMENT
FIGURE 5.
Survival curves for Asynchronous hamster cells
incubated at different temperatures as shown.
(After Westra and Dewey, 1971).
41.
2.53 The rate of heat inactivation increases by
about 12% per degree in an exponential proportion
as opposed to the increase in kinetic energy which
amounts to only 1/6% per degree rise (Johnson,
Eyring and Polissar, 1954) . The kinetics of
heat inactivation were determined by Westra and
Dewey (1971) working with Chinese hamster
ovary cells subjecting asynchronous cell
populations for different time intervals to
temperatures varying between 43.5 and 46.5°C.
The resulting survival curves, Figure 5indicate
that the inactivation was sigmoidal in response,
i.e. a shoulder followed by a straight line
exponential portion.
2.54 The slopes of the exponential portions
of the curve gave values for inactivation rates.
The inactivation rate is equal to 1/D37 where
D37 is defined as the treatment time required
to reduce the survival on the exponential part
of the curve to 37% of the initial value.
Comparing D37 values for different temperatures
showed that for each 1° rise in temperature the
inactivation rate was approximately doubled.
2.55 In order to assess the rate of change in
heat sensitivity an Arrhenius type plot was used.
In this logarithms of the inactivation rates
(1/D37) are related to the absolute temperature.
This produced a straigh line graph (Figure 6.)
the slope of which, /J is the inactiVation energy.
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The slope of the graph was approximately the same for
Chinese hamster ovary cells and pig kidney cells,
with a slope or inactivation energy of 141 K Cals/
mole though the sensitivity of the hamster cells
was ten times greater. This was reflected by a
smaller shoulder on the survival curve with cell
death starting at a lower temperature, the rate of
change of death rate with increasing temperature
was however the same (Suit, 1974),
2.56 Some cells, such as Hela cells have a
resistant 'tail' at lower temperatures but the
overall shape of the survival curve was found to
be the same (Palzer and Heidelberger, 1973).
Relative values of the slope of the survival curves
have been calculated in temperature range for
43 - 46.5°C., they are as follows
Jensen Sarcoma in vitro
Flexner Joblins Carcinoma in vitro
Crocker Mouse Sarcoma in vitro
Chinese hamster Cells in vitro
Pig kidney cells in vitro
Mouse Feet in vitro
Sarcoma 180 in vivo
Below 43°C. there is a varying sensitivity of
differing tumours due to the appearance of resistant


































An Arrhenius plot for heat inactivation of Chinese
hamster ovary cells. On the ordinate the reciprocal
of the D37 values (inactivation rates) are plotted
against temperature in C. The energy of
inactivation equals the slope of the graph and is
equivalent to 141 K Cals/mole.
(After Westra and Dewey, 1971).
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G. ANIMAL STUDIES IN VIVO
Localised Heating
57 In 1927 Westermark set out to answer the
question, "is it possible to affect a tumour in
tissues by heat alone in such a way that there
is only tumour damage with sparing of surrounding
normal tissue?" He treated rats who had Flexner-
Joblings' carcinoma or Jensens sarcoma, by means
of high frequency diathermy currents, applied
locally and measured tissue temperatures with a
thermocouple. He found that the tumour would
disappear with 20 minutes at 48°C., 30 minutes
at 47°C., 50 minutes at 46°C., 90 minutes at
45°C. or 120 minutes at 4 4°C., which is in good
agreement with the Arrhenius plot for a constant
energy of activation. He found that at 48°C.
there was no appreciable difference between the
time required to kill the tumour and normal tissues
but at 44°C. the tumour was damaged more quickly
by heat than was the surrounding normal tissue.
58 Overgaard and Okkels, (1940) treated Woods
sarcoma implated subcutaneously in the tails of
mice by means of diathermy so raising the tumour
to various temperatures and showed tumour
regression in a significant number of cases. In
1961 Crile found that T241 sarcomas implanted into
the foot pads of C57BL6 mice could be cured by
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immersing the paw in a waterbath at various
temperatures for differing periods of time.
The majority being cured at 43°C. for 70
minutes, but by varying the temperature and
time of exposure he was able to confirm the in
vitro studies that at temperatures above 42°C.
the exposure required to obtain the same
biological effect can be halved for each 1°C.
rise in temperature (Crile, 1962).
2.59 In these studies various single fractions
were given using differing temperature time
equivalents. There were no cures without loss
of the foot in the T241 sarcoma series. Heating
paws of DBA/1 mice with similarly implanted S91
melanomas,or implanted sarcoma 180 in SWR mice,
to 44°C. for 30 to 40 minutes destroyed a high
proportion of tumours without damage to the feet
in which the tumours were implanted (Crile, 1963).
The differential heat sensitivity of tumour
over the surrounding normal tissue to localised
heating has also been found by Overgaard and
Overgaard, (1972), in mouse mammary carcinoma.
In general mouse and rat tumours are very sensitive
to heat, hamster tumours being relatively
resistant and chicken rous sarcoma tumours are
more resistant than the surrounding normal tissue
(Gerike, Chandra et al, 1971).
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Animal Studies by Whole Body Heating
2.60 The thermal sensitivity of animals to
elevated temperature varies considerably (Adolf,
1947) Figure 7, 90% of rats heated to 42°C. for
one hour die (Dickson, 1975), whereas rabbits
can tolerate this degree of hyperthermia
(Dickson and Muckle, 1972). Figure 7 shows the
survival curves of various animals subjected
to hyperthermia.
2.61 Dickson and Ellis, (1974) worked with
—transplanted Yoshida tumours in rats have
indicated that there may be an increased
incidence of metastases following whole body
hyperthermia. However, only 12 of 250 animals
survived hyperthermia and in this small
survival group there was an increased incidence
of metastases. In the rabbit there was also an
increased rate of metastatic disease following
hyperthermia but due to technical difficulties
it was not possible to maintain a central body
temperature of 42°C. in these animals (Dickson
and Muckle, 1972).
2.62 In these two studies the state of the
survivors and the technical diffj.culties encountered
indicate the need for further studies in heat
resistant animals before the results can be
accepted. There has been no increase in metastases
47.




Relative thermal death rates in different species.
(After Adolf, 1947).
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A. METHODS OF INDUCING WHOLE BODY
HYPERTHERMIA IN MAN.
3.1. Methods of inducing whole body hyperthermia
have been numerous indicating the technical
difficulties involved. All methods depend on
preventing the physiologcal process of heat loss
from the body and generating an increase in
temperature by either increasing the patient's
own metabolic rate or applying an external heat
source. At temperatures over 40°C. there is a
collapse of the normal thermoregulatory systems
of the body and it is then necessary to provide
an external control system (Stolwijk, 1975).
3.2. The importance of a safe, easily controlled
method is stressed by the report from the United
States Council of Physical Therapy (1934) which
reported 29 deaths in 2,408 patients treated with
a lesser degree hyperthermia for venereal disease.
Patients with disseminated cancer already seriously
ill and any temperature control system must be
simple, easy to control, have a high degree of
accuracy and allow full access to the patient at
all times.
Increase of Internal Heat Production
3.3. The injection of toxins, like Coley's fluid,
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or hormones such as Thyroxine, produce a slow rise
to 40°C. The effects are unpredictable,especially
when given to already very ill patients,and there
may be a stimulatory effect on the spread and
growth of metastases at temperatures below 40°C.
(Dickson and Ellis, 1974). Toxins however, are
easy to administer and repeated injections have
cured patients with advanced cancer (Nauts, 1946).
External Radiant Heat Sources
3_. 4 Microwave and ultrasonic sources of energy
are the most difficult to control and cannot at
present be used for whole body treatment.
External sources otherwise rely on the skin
conduction. For efficient heat exchange the
maximum area exposed for heat uptake is critical
as a skin temperature of 45°C. or above for any
length of time causes burns (Moritz, 1947).
Infrared heating lamps are normally only exposed
to 50% of the available area as the couch is not
usually heated. These methods also cause a poor
exchange rate as the evaporation of sweat cools
the skin surface. Patients are enclosed and
access is therefore limited. Stafford Warren,
(1935) used a box incorporating diathermy in the
couch surface, on which the patient lay, with lights
in the lid of the box. He treated numerous tumour
cases at 41.5°C. for periods of time ranging
between four and twenty four hours. He was
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treating tumour recurrence following conventional
therapy and reported numerous regressions but no
cures.
External Heating by Hot Air Currents
3.5 Air heating involves enclosing the patient
in a constant stream of heated air. The patient
must be insulated to prevent evaporation of
sweat otherwise excessive skin temperatures are
required to cause a net influx of heat energy.
The method requires a closed system and the
accessability of the patient is therefore reduced.
The air temperature can however be rapidly
changed and is easily controlled. The method is
being used by Stirling Edwards (1976) to treat
patients with advanced cancer. The rate of heating
was not as great as immersion techniques but the
temperature was easy to control.
External Heating by Immersion in Heated
Water.
3.6. The immersion of the patient in hot water
requires a complicated system for accurate
temperature control. As the patient is unable
to evaporate sweat due to the surrounding humidity
the body core temperature is wholly dependant
on the surrounding water temperature. A constant
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flow technique is required whereby the temperature
of the water can be changed quickly. Circulation of
water is also required to avoid conduction difficulties
due to local areas of stagnant hot or cold water.
Water has the advantages that because of buoyancy
there are few pressure areas and the patient is
exposed providing easy access during treatment.
Water baths have been used by Suryanarayan (1966)
to elevate body core temperature for 30 - 40
minutes at 42°C., or by Von Ardenne (1969)
using a more sophisticated apparatus for longer
periods of time at 40°C.
3.7 In both series cytotoxic drugs were used
along with elevation of body temperature for the
treatment of disseminated cancer. The results
of Von Ardenne's work using a multistep treatment
regime, whose 'optimisation' has changed several
times during his series are particularly difficult
to assess. No cures are claimed in either series
though numerous worthwhile remissions have been
induced. One disadvantage of this method is the
long time, almost two hours, required to elevate
the body temperature to 40°C.
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E. SELECTION OF PATIENTS
3.8' Patients in the terminal stages of
disseminated cancer were considered for hyper¬
thermic treatment after failure of conventional
therapy to control the disease. Treatments
considered, including surgery, radiotherapy or
cytoxic chemotherapy, and it was only when no
other method of treatment had any likelihood
of improving the quality of life or causing
tumour regresaon was hyperthermic therapy offered
to the patient. Patients were only treated if
they had symptoms such as severe pain and if
their life expectancy could be assessed in days
or weeks rather than months. No patient referred
who fulfilled these criteria was refused treatment.
3.9. No attempt was made to treat any one group
of tumours but it was hoped by palliative treat¬
ment in this extremely ill group of patients that
we would be able to identify the sensitive
tumours. We might then be able, at a later date,
to offer a curative treatment to fitter patients
earlier in the disease.
3.10 . All patients knew the nature of their disease,
that the treatment was experimental, and that we
were not able to say that the treatment would be
effective in their case. We did not offer curative
treatment but hoped to relieve pain, to improve
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the quality of life, and to cause some degree of
tumour regression. Before treatment the nature
of the treatment and its possible side effects
were discussed with the patient and their
relatives and fully informed consent to treatment
was given by all patients in this study.
3.11. Patients were admitted to various wards
in the Western General Hospital and treated the
following day. They were looked after overnight
in the intensive care unit at the Western General
Hospital and then returned to their wards. Some
patients early in the series, who received the
same dosage fraction each week were able to come
in on the day of treatment and return home the
following day. Later with treatment by increasing
dosage fractions, patients had to be kept in
hospital between treatment fractions.
C. DR. PETTIGREW'S METHOD OF INDUCING
WHOLE BODY HYPERTHERMIA.
3.12. The patient was premeditated with
Promethazine Hydrochloride, induced with
Thiopentone Sodium and curarised. An epidural
catheter is introduced at the L4 - 5 level and
taped securely in place. The patient is placed
in a double envelope of polythene in a specially
construced bath (Figure 8.) Ventilation is
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maintained through an insulated endotracheal tube
using an oxygen/air/nitrous oxide mixture heated
to 80°C. by passage through a steam driven heat
exchanger. Using dry air this imparts 6 calories
per 500 ml. breath (Moritz, 1945), which offsets
the loss of 13 calories per breath due to the
latent heat of evaporation of the 23 Grams of
water required to saturate 500 mis. of dry air
(Moritz, 1945). A urinary catheter and naso¬
gastric tube were inserted and left on continuous
free drainage during treatment.
3.13 Three osophageal and three rectal thermometers
are placed at 3 cm. intervals to ensure good
mucosal contact of at least one thermometer in
each group. The highest reading thermometer is
taken as the correct reading. A tracheal therm¬
ometer and more recently a tympanic probe were
also inserted giving a total of eight thermometers
which record continuously on two different systems
in case of failure of one.
3.14 After heat sealing the polythene envelope
surrounding the patient low melting point paraffin
wax (melting point 43 - 46°C. heated to 50°C. is
pumped into the bath surrounding the patient.
(Figure 9.) The normal physiological process of
heat loss is reversed and energy is introduced into
the body at a rate of approximately 3,000 calories





















A diagram of the specially constructed bath showing
the monitoring devices used during therapy.















The normal physiological process of heat loss is
reversed and energy is absorbed from the sources
as shown at a rate of approximately 3,000 calories
per minute.
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metabolism provides between 1,000 - 1,500
calories per minute increasing by 15% for each
1°C. rise in temperature to 40°C. (Selawry,
Carlson and Moore, 1958). Approximately 2,000
calories per minute are absorbed from the wax
so raising the body core temperature through
5°C. over a period of approximately one hour.
3.15 When the temperature reaches 41°C. all but
a thin layer of solid wax is removed, (Figure 11).
There follows a slow rise in temperature to
41.8°C. Constant temperatures are then maintained
by opening the envelope which encloses the patient
and varying the area of skin exposed for the
evaporation of sweat (Figure 12.). Narcosis is
maintained by intermittent opiates together with
a continuous epidural blockade. At the end of the
hyperthermia period the patient is removed from
the bath and cooling is rapid, (Figure 13.). Care
is taken that the cooling does not over-shoot in
that the normal thermo-regulatory system takes
time to recover and hypothermia could easily occur.
The epidural line is left in situ for 24 hours and
topped up intermittently for sedation and pain
relief.
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At a temperature of approximately 41 C. (dependant
on body weight), the molten wax is syphoned off,
leaving a thin pellicle of solid wax.
62.
FIGURE 12.
Constant temperature is maintained by opening the
envelope which enclosed the patient and varying




OESOPHAGEAL AND RECTAL TEMPERATURE DURING HYPERTHERMIA
FIGURE 13.
There is a rapid rise to 3. controlled, temperature
of 41.8°C. At the end of treatment the patient
is removed from the bath and cooling is rapid.
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D. MATERIALS AND METHODS
The Haemodynamic Response
3.16 Prior to treatment an 18 guage catheter was
introduced into the superior vena cava via the
left median cubital vein and was used for
measurement of central venous pressure. A
second routine intravenous infusion heated to 45^C.
by passage through a heating coil, was used for
fluid replacement. E.C.G. electrodes were
attached in the standard position and a
sphygmomanometer cuff attached to the right upper
arm. A stethoscope was strapped over the
termination of the brachial artery, and a pulse
meter working on capillary light transmission
attached to the right thumb. Blood pressure
was estimated by the use of an arm cuff in the
usual way, the pulse meter acting as a check for
systolic pressure. Heart rate was measured from
the E.C.G. trace which was continuous during
treatment. All measurements were taken at 15
minute intervals during treatment.
Plasma, Electrolyte and Enzyme Balance
2.17 Fluid and electrolyte losses were great
during hyperthermia and serum electrolyte
concentrations, and packed cell volumes were
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were measured at half hourly intervals throughout
treatment. Results were obtained within 20
minutes of sampling, initially fluids were infused
at a rate according to the level of the central
venous pressure and its electrolyte constitutents
varied according to the serum electrolyte
concentrations. The packed cell volume was used
as a measure of dilution. From these results the
intravenous regime recorded in Figure 19 -• was
developed and was used in all subsequent patients.
As a check on the accuracy of fluid and salt
replacement, losses during hyperthermia were
estimated from urinary losses and sweat collection
data.
3.18 Sweat was assessed by enclosing one limb
of each patient in a polythene bag and multipling
the volume of sweat collected in the bag during
treatment on the assumption that sweat loss from
the limbs and trunk are proportional to their
relative surface areas. Data given by Allan,
Armstrong and Roddie, (1973) indicates that 60%
of the sweat is from the arms and legs, including
hands and feet, which together represents 59% of
the total body surface area. Half hourly sweat
samples were also collected from the trunk on
weighed pads of filter paper to measure sweat
electrolyte concentrations and variations in sweat
rate.
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Liver Function; A Limiting Factor in Maximal
Temperature. —•
3.19 The serum activities of lactate dehydrogenase,
aspartate aminotransferase and alanine aminotrans¬
ferase, have been shown to be stable at the temp¬
erature involved (42°C.) (Burger, 1970). These
were monitored regularly before treatment, and at
daily intervals following 64 treatments in 10
patients. A further 10 patients and three controls
were studied in depth. In the latter group
Bromosulphaphthalein (B.S.P.) tests were carried out
prior to induction to anaesthesia, at the end of
the hyperthermic period and at between one and seven
days post hyperthermia. The three control volunteers
were undergoing prolonged anaesthesia for varicose
vein operations. Anaesthesia was induced as for the
hyperthermia patients though the ventilating gasses
were not heated nor was their body core temperature
elevated. In this group the B.S.P. tests were
carried out before induction of anaesthesia, at the
end of the operation and between one and four days
later.
3.20 The method was used for the B.S.P. test was that
an indwelling venous catheter, was inserted and a
dose of 3 mg/Kg body weight of B.S.P. for patients
undergoing hyperthermia, or 4 mg/Kg body weight for
the controls, was injected intravenously into the
opposite arm.
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Samples of blood were taken immediately prior to
injection of B.S.P.yat 45 seconds,and
subsequently at 2, 7, 10, 15, 20, 25, 35, 45, and
55 minutes.
Plasma Cortisol and ACTH Levels
3.21 Serial plasma Cortisol levels were
estimated in 8 patients during 15 treatment
sessions, and serum adrenocorticotrophic hormone
(ACTH) in 4 Of these patients during 5
treatment sessions. In these patients narcosis
was induced prior to hyperthermia by intravenous
thiopentone administration (300 - 400 mgs. )#
Operidine was given intermittently (1 mg. per
injection) over a period of 4-5 hours. In
some instances, Valium and/or propranolol were
administered, and in one case inotropic drugs
were given during a one hour interval, in order
to improve cardiovascular function.
3.22 Blood samples were taken at regular intervals
from the catheter as before, and placed in
lithian heparin tubes. These were analysed for
plasma Cortisol^using a modification of Mattingly
(1962) method^within 24 hours of sampling.
Similar samples for ACTH estimation were taken
and separated promptly, they were then frozen
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until the assays were carried out. Plasma ACTH
levels were measured by radio immuno assay.
Initially, samples were taken at 20
minute intervals during treatment. In later
treatments samples were taken at each centigrade
degree rise in the body core temperature and
hourly thereafter during treatment. Post treat¬
ment samples were taken at 6, 12 and 24 hours.
During treatment the haematocrit was
estimated at the same time as the plasma
Cortisol ACTH concentrations to ensure that no
dilution effect occurred.
Marrow Studies and Changes in Haemoglobin
Concentration
3.23 Sternal marrow punctures were carried out
before, immediately after treatment and at one
week post treatment. Haemoglobin estimations
on blood taken at regular intervals during treat¬
ment and daily after treatment and measured by
coulter counter. In five patients the osmotic
fragility of red blood cells was measured at
half hourly intervals during treatment.
White Blood Count and the Immune Response
3.24 Blood samples were taken at regular
intervals before, during and at daily intervals
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following treatment from an indwelling intravenous
catheter, as before. White counts were carried
out using a coulter counter and a differential
count was then done visually.
Serum immunoglobulin levels were measured,
before, immediately after, and at ten days
post treatment. Blood samples were also taken
prior to therapy and at fourteen days for
viral studies which consisted of antibody titres
to myxovirus influenze B, mycoplasma pneumonia
and cystomegalo virus.
Intravascular Co-agulation Studies
3.25 Prior to treatment an intravenous cannula
was inserted into the superior vena cava as
before. Blood was taken at regular intervals
from this cannula before, during and after
treatment and estimations carried out for
haemoglobin, platelets, prothrombin time,fibrinogen^
and fibrinogen degradation products. Three
patients received controlled low dose heparin
throughout hyperthermia period. In order to
standardise the treatment fractions for different
temperature time equivalents, the degree minute,
41°C. standard, was taken as the unit of hyper¬
thermic therapy. This was calculated by the temp¬
erature in degrees centigrade multiplied by the
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time in minutes that the body core temperature
was above 40°C. Most patients were treated by
serially increasing fractions at weekly
intervals though some early cases were not
managed in this way. The fraction of treatment
received was then plotted against the subsequent
changes in platelet count for patients showing
a clinical response to therapy as compared with
those who did not.
E. METHOD OF ASSESSMENT OF CLINICAL
RESPONSE TO HYPERTHERMIA.
3.26 Patients were assessed prior to treatment
at a special clinic which was set up for this
purpose. ^ All available information concerning
weight loss, tumour size and previous
investigations were entered oh the specially
constructed assessment sheet (Figure 14).
Routine X-rays of chest and pelvis were taken and
in later cases, liver and spleen scans were
routinely carried out. Other X-rays were arranged
as indicated. All patients had an E.C.G. prior
to treatment. Routine blood was taken for the
tests as shown on the review sheet. All
documents relating to the patient were examined
and the histological slides reviewed by
Dr. N. McLean. Coagulation studies were also
performed on all patients prior to therapy.
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Review was repeated at one week post treatment
and monthly subsequent to completion of the
prescribed course of hyperthermic fractions.
3.27 The response to treatment was judged
favourable if there was weight gain, increased
mobility, or pain relief together with
objective evidence of regression in tumour size
on direct measurement, pathological evidence
of necrosis and serial biopsy specimens, or
radiological evidence of regression. Further
evidence of heat induced tumour necrosis was
obtained at necropsy in five of the six patients
who died soon after hyperthermia.
3.28 Initially all patients were treated for
approximately four hours above 41°C. at
weekly intervals. Later patients were






















































Hyperthermia review sheet which was completed prior
to each treatment, and at montly intervals post
treatment.
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A. THE HAEMODYNAMIC RESPONSE
Heart Rate
4.1. In patients treated without epidural
blockade the heart rate increases rapidly with
temperature (Figure 15). The increase is
linear and averages with 8.5 beats/min./
Centigrade degree rise in temperature, with a
range of 5-15 beats/min./Centigrade degree.
In the same patient heated on different
occasions the rate of increase in heart rate
depends on the rate of heating (Figure 16).
Fast heating intially increases the heart rate
less per degree rise in temperature. However,
at the end of active heating heart rate continues
to rise for sometime reaching a typical maximum
for each patient at 41.8°C. which is independent
of the rate of heating. The final heart rate at
stable temperature corresponds to a rise of 11
beats/min./Centigrade degree rise.
4.2 Stable narcosis was required to maintain
this constant heart rate and an increase in
heart rate was found to be one of the first
indications of decreasing depth of narcosis. With
the high level epidural anaesthesia now used
there is a blockade of the sympathetic outflow
and the rise in heart rate is less averaging with
a range of 7-8,.5, beats/min ./'Centigrade degree
rise in temperature (Figure 17). An increase in
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heart rate in those patients is indicative of
a decrease in the effect of the epidural blockade.
Blood and Central Venous Pressures
4.3 Drugs used in the induction of anaesthesia
induce an initial mild degree of hypotension
(Figure IS). Thereafter during active heating
the systolic blood pressure rises by 20 - 50 mas.
of mercury with little change in the diastolic
pressure. During active heating there is also
a rise in the central venous pressure averaging
5 - 10 centimetres of water. At stable
temperatures, these values return to the initial
values and tend to fall further unless a plasma
expander is infused. For this reason, plasma is
given once 41.8°C. is reached (Figure 19) . The
blood and central venous pressures are thus
maintained at the pretreatment value throughout
treatment.
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Haemodynamic response to hyperthermia
Hours
FIGURE 15.
The heart rate increases rapidly with temperature
without epidural anaesthesia, stable narcosis was
required for control of heart rate. With epidural
anaesthesia, the rise in heart rate is less and
the variations in rate more easily controlled.
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Variation of heart rate with oesophageal temp¬
erature during active heating without epidural
anaesthesia
36 37 38 39 40 41 42
Oesophageal temp (°C)
FIGURE 16.
Without epidural blockade there was considerable
variations in the heart rate, dependant on the
rate of heating and the depth of anaesthesia.
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FIGURE 17.
With epidural blockade the heartrate rose linearly
with temperature and did not vary wxth dxfferen
rates of heating.



























A summary chart relating heart rate, blood pressure
and central venous pressure to temperature over the
treatment session. After an initial rise in blood
and central venous pressure there is a fall at




saline dextrose dextrose Hartmann'
plasma
Hartmanns 5% Hartmann's Hartmanns solution c
0-9% 5% 4 3% solution solution laevulose solution 4 hourly <
HEATING STABLE TEMPERATURE 41 8 °C COOLING
hours
FIGURE 19.
The fluid replacement regime necessary to maintain
plasma electrolyte concentrations within the
normal range was worked out empirically. Plasma
is given at stable temperature to prevent a fall
in blood pressure.
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B. FLUID AND ELECTROLYTE BALANCE
4.4 With the present infusion regime there was
no significant change in the serum sodium or
chloride concentrations of the ten patients
studied in depth, (Figure 20.). There is a slight
early decrease in the serum sodium concentration
averaging 4 m.mol/1 which coincides with, and
has been attributed to premedication(Stevenson,
1960). In 50 treatments on 8 patients the
serum sodium and chloride measured 24 hours
after treatment showed no significant change from
the pre-treatment value. The serum potassium
rises by 0.5 m. eq/1. during the first ninety
minutes of treatment. This increase is not
maintained beyond three hours when a slow fall
in potassium concentration starts, and 24 hours
after treatment the serum potassium concentration
is on average 0.5 m.mol/1 lower than the pre-
treatment values. This lower level continues
for three to four days and occasionally potassium
supplements were given.
Sweat and Urinary Losses
4.5 Sweating was profuse during hyperthermia
averaging 500 mls/hr, (Figure 21.). The sweat
rate increases rapidly with temperature. At
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PLASMA ELECTROLYTES DURING HYPERTHERMIA
Premed Anaesthetic TIME (HOURS)
FIGURE 20.
Using the replacement regime there were no changes
in the plasma electrolyte concentrations
outwrth normal limits.
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Infusion 570 52 10 43 - - - -
*mean of 40 measurements
**mean of 60 measurements
FIGURE 21.
Fluid and electrolyte losses were great during
hyperthermia but were well balanced by the
infusion regime.
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stable temperature flucuations of over 10% occur
in the sweat rate; no further increase with
continued exposure to high temperatures has been
determined. In general patients with a high
sweat loss had a low urinary output and vice
versa but it was not possible to correlate these
differences with any measureable parameter.
C. LIVER FUNCTION; A LIMITING FACTOR
IN MAXIMAL TEMPERATURE.
4.6. In 47 treatments conducted in 10 patients
during which neither the rectal nor the
oesphogeal temperatures rose above 41.8°C.
there was no significant increase in the serum
enzyme activities and the serum bilirubin
concentration rose from an average of 8.0 u mol/1
to an average of 10.6 u mol/1. No values
lying outside the reference range (Figure 22.).
However, during 17 patients within the same
group when the temperature was held at between
41.8 and 42.2°C. for periods of between 10 and
40 minutes the average activity of amino¬
transferase increased by a factor of 25, that of
the alanine aminotransferase by a factor of 8 and
the serum bilirubin to 26.7 u mol/1. These
changes were greatest at 48 hours post treat¬
ment, most returning to the pre treatment values
within five days.
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SERUM ENZYME AND BILIRUBIN CONCENTRATIONS BEFORE AND AFTER









ABOVE 41 -8 °C
LACTATE
DEHYDROGENASE 72-395 270 266 815
ASPARTATE
AMINOTRANSFERASE
9-43 29 32 678
ALANINE
AMINOTRANSFERASE
5-41 21 25 166
BILIRUBIN 3-14
fjmol/l
80 10 6 26-7
FIGURE 22.
At body core temperature below 41.8 C. there was no
significant changes in serum enzymes or bilirubin
concentrations.
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13 Patients were studied in depth and
had serum enzymes and B.S.P. tests carried out
(Figure 23). These patients were divided
into four groups. The anaesthetic controls,
those in whom the temperature did not rise above
41.8°C., those whose temperature rose above
42°C.,and the patients with hepatic metastases.
Each group was small containing three patients
with four patients in the group treated with
hepatic metastases. The control group showed no
significant changes in liver function or B.S.P.
clearance due to the anaesthesia used (Figure 23).
All patients treated by hyperthermia had an
increased B.S.P. retention at the end of the
hyperthermic period, this was greatest in patients
treated at over 42°C. and in one of these cases,
and two of the patients with hepatic metastases,
the B.S.P. excretion did not return to the pre-
treatment value within 7 days. In all other
cases liver function had returned to pre treatment
value within 7 days
86.





























BILIRUBIN 3-Upmol/l 120 103 103 5-2 52 6-8 68 37-6 171 38 5 47-9 47 9
ALKALINE
PHOSPHATASE
20-28 iu/l 50 6 40-3 480 120 116 135 83 87 68-5 323 275 285
ASPARTATE AMINO¬
TRANSFERASE
9-43 u/l 227 22-0 244 34-2 28 5 342 185 868 18 3 44-6 715 854
BROMSULPHTHALEIN
RETENTION AT 45 mins <5% 1-3 36 10 46 193 75 103 26-7 15 14 8 26-5 18 6
FIGURE 23
Patients studied in depth showed that although there
was no rise in serum enzymes following hyperthermia
at less than 41.8 C. there was delay in
Bromsulphthalein excretion. This was greatest in
patients treated at ever 41.8°C. and those with
liver metastases.
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D. THE STRESS RESPONSE; PLASMA
CORTISOL AND ACTH LEVELS.
4.8 The plasma Cortisol response to hyperthermia
is divided into three phases. Initially,
during active heating there is a fall followed
by a second phase during which there is a sharp
rise returning to the previous values. If heat
stress continues over two hours at 41.8°C. there
is a further rise. Figure 24 shows the typical
response in one patient treated over an extended
period and the relationship of body core temp¬
erature to plasma ACTH and Cortisol levels is
shown. During the induction of anaesthesia there
is a slight rise in plasma Cortisol which then
begins to fall as active heating commences.
This fall is most marked at temperatures over
38°C. and continues for approximately 1 hour.
Figure 25 shows the relationship of plasma ACTH
to plasma Cortisol during active heating. At a
temperature of approximately 38°C. there is a
sudden fall in the ACTH level, which then begins
to rise sharply reaching the pre treatment
level at approximately 39.5°C. at which time the
plasma Cortisol level is at its lowest. A
further rise in ACTH precedes the subsequent rise
in Cortisol level. A subsequent fall in ACTH
is reflected by stabilisation of the Cortisol
but with increase in temperature there is a further
rise in both plasma ACTH and Cortisol levels.
88.
BODY CORE TEMPERATURE RELATED TO ACTH AND CORTISOL LEVELS
DURING A SINGLE TREATMENT
TREATMENT TIME IN MINUTES
FIGURE 24.
This is a representative figure taken from one
patient and shows the initial fall in plasma
Cortisol followed by a sharp rise in both plasma
ACTH and Cortisol levels. After prolonged hyper¬
thermia there is a further sharp rise in both
levels indicative of continuing thermal stress.
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Average ACTH and Cortisol levels during active
heating shows a fall in both ACTH and cortisol
levels followed by a sharp rise.
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4.9 To study further the effects of continuing
heat stress on adrenocortisoi function the mean
levels of plasma ACTH and Cortisol were plotted
Q
against the degree minutes 39 C. standard of
heat stress, (Figure 26). This unit was chosen
as ACTH inhibition occurred above 38°C. and
because in other heat sensitive systems the
degree of heat stress is related to temperature
and the time that tissue is exposed to that
temperature. For each centigrade degree rise
in temperature the time taken to achieve the
same degree of stress is halved. The centigrade
degree minute, 39°C. standard, is equivalent
to the time in minutes spent at 39°C. and
represents the area under the temperature graph
shown in Figure 24. above 38°C.
4.10 There is a rise in plasma Cortisol from
Q
the lowest point occurring at 25 C minutes,
39°C. standard to pre treatment values. At above
150 C° minutes there is a further rapid rise in
the ACTH and Cortisol levels, (Figure 26),
which is independent of the rate of heating. If
heat stress is continued beyond 450 C° minutes,
39°C. standard, there is a further increase in
plasma Cortisol and ACTH levels. If the treat-
o o
ment fraction was less than 450 C minutes, 39 C.
standard, approximately equivalent to two hours
at 41.8°C., the plasma Cortisol returned to the
pre treatment value within 8 hours. If the
CORTISOL AND ACTH LEVELS PLOTTED AGAINST DEGREE MINUTES
CORTISOL
FIGURE 26
The response of plasma ACTH and Cortisol was not
related directly to temperature but to the
quantity of thermal stress plgtted here in
centigrade degree minutes, 39 C. standard.
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treatment was extended beyond 45C0°minutes,
39°C. standard, the plasma Cortisol did
not return to the pre treatment value within
24 hours. In none of the patients was there
a significant change in haemotocrit levels
during treatment.
E. MARROW STUDIES AND CHANGES IN
HAEMOGLOBIN CONCENTRATION.
4.11 Sternal marrow histology before,
immediately after treatment and at seven days
post treatment in 14 patients showed no change
with no evidence of marrow depression. The
haemoglobin level fell by an average of 10%
following the first treatment though the
range was great (4 - 18%), Following subsequent
treatments at weekly intervals the fall was
less,and following each treatment there was a
reticulocytosis of between 2 and 4% with a
partial recovery,(Figure 27). Initial values were
not attained during treatment. Osmotic
fragility studies showed no evidence of change
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FIGURE 27.
Following each hyperthermia treatment there was a fall
in haemoglobin concentration followed by a reticulo-
cytosis and recovery. This figure is representative
and is taken from one patient who was given six
treatments at weekly intervals.
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F. WHITE BLOOD COUNT AND THE IMMUNE
RESPONSE.
4.12 Figure 28 shows the average white count in
27 treatments on 21 patients. There is an initial
fall in the total white count maximal at one
hour followed by a rise which we treated as a
3
maximum averaging 15.8 x 10 cells at six hours.
The majority of the increase is due to immature
polymorphs with no increase in the absolute
lymphocyte count. The maximal response varies
from patient to patient with a range of 12 - 36 x
3
10 cells at six hours. Pre treatment values
were attained within seven days following treatment.
4.12 In all patients in whom immunoglobulin
and viral studies have been observed there have


















In 27 treatments on 21 patients there was an initial
fall in total white blood count followed by a rise.
The figure shows the average of all these treatments
though some individuals had a much higher rise post
treatment.
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G. INTRAVASCULAR COAGULATION; A LIMITING
FACTOR IN FRACTIONATION.
4.14 The most sensitive index of coagulation
defect was found to be the platelet count. Other
indices, such as prothrombin time, serum
fibrinogen, or the level of fibrin degradation
products remained stable unless there was a
marked thrombocytopenia with platelet counts
falling below 50,000/c.mm. following treatment.
The maximal thrombocytopenia occurred at
approximately 2 4 hours following treatment,
(Figure 29.).
4.15 There was an initial fall in the percentage
of platelets after the first treatment of less
than 300 C° min., 41°C. standard, this was less
in patients with non-responsive tumours,
averaging 75.7% (standard error 13.5%) as compared
with those in the responsive group who averaged
45.9% (standard error 9.4%). Both groups,
however, showed a degree of thrombocytopenia
(Figure 30.). This was clinically reflected in
the responsive group who felt unwell and were
usually sick for 48 hours following treatment.'
4.16 After an initial fraction of greater than
300 C° min., 41°C. standard, there was an
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CHANGES IN PLATELET COUNT DURING HYPERTHERMIA
TIME HRS DAYS
FIGURE 29.
Average platelet counts over 24 initial treatments.
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10" NR = NON RESPONSIVE GROUP
R = RESPONSIVE GROUP
PRE-TREATMENT TIME 24 Hr TREATMENT




Following an initial fraction of less than 300
Centigrade degree minutes, 41 C. standard,
there was a greater fall in the platelet count
of patients with sensitive tumours.
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there was an increased thrombocytopenia in both
the non-responsive group" averaging 54.5%
(standard error 17.9%)^and responsive patients
averaging 17.7%(standard error 11.7%) with
evidence of disseminated intravascular
coagulation in the most responsive tumours (
(Figure 31). Three such patients died with
platelet counts below 10,000 and fibrinogen
degradation product levels of 160 micrograms
per cent, 640 micrograms per cent and 161
micrograms per cent respectively.
4^.17 If a second fraction was given above
300 C.° min. but less than 500 C.° min. , 41°C.
standard, one week after the first fraction of
less than 300 C.° min., 41°C. standard, there
was a rise in the platelet count in those with
non-responsive tumours averaging 116% (standard
error 2 7 . 7%), whereas those responding again
showed a decrease following treatment averaging
58.6% (standard error 17.5%) (Figure 32.).
4.18 Two patients with non-sensitive tumours
were treated at above 500 C.° min., 41°C.
standard, following a previous fraction below
300 C.° min., 41°C. standard, there was a fall
in platelets to 31,000 and 70,000/c.mm.
respectively; the patient with greater thrombo¬
cytopenia required clotting factors. Neither




PLATELET COUNT CHANGES FOLLOWING 1st HYPERTHERMIC
FRACTION GREATER THAN 300°C Mins
FIGURE 31.
After an initial treatment fractign of greater than
300 Centigrade degree minutes, 41 C. standard,
there is a risk of inducing disseminated intra¬
vascular co-agulation in patients with disseminated
sensitive tumours.
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CHANGES IN PLATELET COUNT FOLLOWING SECOND HYPERTHERMIC
FRACTION GREATER THAN 300°C Mins
FIGURE 32.
A second fraction greater than the first given one
week later resulted in a fall in platelets in those
with responsive tumours, whereas those with non-
responsive tumours showed a rise in the post
treatment platelet count.
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CHANGES IN PLATELET COUNT FOLLOWING SECOND HYPERTHERMIC
FRACTION ^ FIRST FRACTION
TREATMENT
FIGURE 33.
A second fraction less than or equal to the previous
fraction caused no fall in platelet count in
responsive or non responsive patients.
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4.19 When patients were treated with the same
or a lesser fraction than previously within
one week of the previous treatment there was
an increase in the platelet count in the
responsive group averaging 138.7% (standard error
57.6%) (Figure 33). These four patients had no
nausea or sickness following this fraction.
One patient with a non-responsive tumour was
also treated in this manner and showed a similar
rise in platelet count.
H. CLINICAL RESULTS OF WHOLE BODY
HYPERTHERMIA.
4.20 .62 Patients in the terminal stages of
cancer, recurrent following conventional therapy
have been treated by whole body hyperthermia.
Each patient was considered unsuitable for
further treatment by conventional means. Patients
of all age groups 3-75 years have been treated
and in 232 treatment sessions a total of 560
hours over 40°C. have been given. Patients
tolerate hyperthermia well, the maximum number
of treatments in any one patient being 24. 21
patients were excluded from the series, 14 were
treated in developmental stages of the method
when temperatures above 40°C. were not used.
These patients did not respond and it is now
accepted that temperatures in excess of 40°C. are
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needed (Giovanella, Lohman and Heidelberger, 1970).
A further 7 patients, with no obviously measurable
tumour, were treated for symptomatic relief of
pain alone. This series therefore comprises 41
patients. Though the numbers were small, tumours
of gastro-intestinal origin and sarcomas appeared
to respond more favourably than genito-urinary
or breast neoplasms. Lung tumours and malignant
melanomas showed an intermediate response.
The cases are summarised in the following para¬




4.21 8 Cases: 6 being soft tissue sarcomas, of
which 4 responded favourably to treatment. In 1
patient a lung deposit disappeared, a second
showed healing of pathological fracture and a
third complete regression of a fibrosarcoma
recurrent in the operation scar. The fourth
patient, with an advanced liposarcoma, died 24
hours after treatment. Necropsy showed recent
massive necrosis throughout the tumour (Figure 34).
A child with a rhabdomyosarcoma showed no response
and one fibrosarcoma h^d subjective improvement
only. Two patients with osteogenic sarcomas were
treated; the first had a hindquarter amputation -
two months' after the end of an 18 month course




Liposajrcoma A. pre treatment. B. post treatment
necropsy specimen showing gross necrosis of the tumour.
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sensitive form. The second showed no response to
treatment.
Carcinoma of the Stomach
4.22 4 cases: 2 anorexic patients who had been
in great pain gained weight and were able to lead
a relatively normal life. The third had
extensive mediastinal and lung metastases and
died 48 hours after treatment. At necropsy there
was extensive necrosis of the tumour causing
compression of the bronchus. The fourth had
pain relief and weight gain but died suddenly
one month after treatment with a pulmonary
embolus. Necropsy was not performed.
Carcinoma of the Colon
4.23 7 cases: 1 patient had almost complete
regression of massive hepatomegaly. A second
had regression of skin nodules in the lower
abdominal wall. One further patient had
regression in tumour size. The fourth died
three weeks following hyperthermia. At necropsy
there was very extensive tumour necrosis. The
other three showed no response.
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Malignant Melanoma
4.24 8 Cases: In 4 there was a good initial
regression of secondary deposits and pain relief.
One patient had pain relief alone and three
showed no response.
Carcinoma of the Lung
4.25 4 cases of bronchogenic carcinoma. In 1
patient with an adenocarcinoma there was
regression of the primary lung tumour (confirmed
at necropsy) (Figure 35), though secondary
deposits remained active. The second patient,
with a squamous carcinoma, showed regression of
a secondary deposit in the lumbar spine. The
third had relief from pain but no tumour
regression. The fourth died within 24 hours of
hyperthermia, prior to death there was evidence
of disseminated intravascular coagulation and
at necropsy there was extensive haemorrhage into
the tumours.
Ovarian and Testicular Tumours
4.25 Two testicular teratomas and two ovarian




4.27 Two children with neuroblastomas were
treated. One showed a good initial response
with healing of ulcerated skin over the tumour
of his jaw. The second showed initial
improvement till he developed a respiratory
difficulty and died two days after treatment.
Necropsy showed multiple haemorrhagic areas and
necrosis in the tumour. One child with a
nephroblastoma showed initial improvement but
-—_ also died from a respiratory arrest. At necropsy
there was gross necrosis of the tumour.
Breast Cancer
4.28 Two patients with scirrhous carcinoma
were treated, one obtaining pain relief alone.
Miscellaneous Tumours
4.29 One case of mycosis fungoides showed
initial healing and there was pain relief alone
in a case of adenocarcinoma of the nasopharynx.
One case each of chronic myeloid leukaemia and






Primary Ca. bronchus. A. pre treatment. B. following
3 increasing fractions. Though the primary resolved
distant secondaries continued to grow. At necropsy
some months later there was only scar tissue at the
primary site.
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I. COMPLICATIONS OF WHOLE BODY
HYPERTHERMIA.
4.30 Complications may arise from the method,
from the physiological response to high
temperatures or from the toxic effects of tumour
breakdown and absorption. Considering that
patients had been maintained in an unconscious
state at temperatures over 40°C. for 560 hours,
complications of major nature have been
remarkably few.
4.31 In 1966, before the present method was in
use a patient developed ventricular
fibrillation and died. This was due to her
temperature reaching 43°C. as a result of
thermometer failure,and was the only fatality
directly attributable to induced hyperthermia.
The importance of several thermometers has been
stressed; these should be placed at different
levels in the rectum and oesophagus and read out
on at least two separate systems. The highest
reading thermometer is taken as the true reading.
4.32 50% of the patients developed circumoral
herpes simplex following the first treatment but
not after subsequent treatments (Figure 36). Sore
throats, pressure sores due to prolonged
immobilisation during treatments and superficial
burns in oedematous, hypoproteinaemic patients
111.
50% of patients developed circumoral Herpes simplex
after the first treatment but not after subsequent
treatments.
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may be minimised by adequate padding and air
mattresses. For grossly oedematous patients
the wax temperature was decreased to 45°C.
4.33 Five adult patients died within 48
hours of hyperthermia. Their deaths were
associated with evidence of disseminated
intravascular coagulation. In 3 necropsy
showed recent tumour necrosis. This is a
reported complication of agressive chemotherapy
in the presence of widespread sensitive
tumour and indicates the necessity of
fractionating hyperthermia in the presence of
disseminated sensitive tumour.
4.34 Two children with advanced neoplastic
disease died shortly after treatment. They
were given opiates for the relief of distress
and died of respiratory complications. In
both post mortem show gross tumour necrosis
and respiratory difficulties are a reported
complication of disseminated intravascular co¬
agulation (Hardaway, 1973). Another patient
died from fibrosing alveolitis, possibly due to
repeated exposure to the hot, moist ventilating
gases then in use (Henderson, 1971), or as a
result of treatment with bleomycin, 6 months
previously. Hot, dry gas is not used and this
complication has not recurred. No patient has
developed uric acid nephropathy due to increased
1-13.
cellular breakdown but patients developing raised












B. FACTORS EFFECTING HEAT SENSITIVITY
C. DOSAGE AND THE UNITS OF HYPERTHERMIC STRESS





PLASMA ELECTROLYTE AND ENZYME LEVELS
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F. CLINICAL RESULTS OF WHOLE BODY HYPERTHERMIA
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A. MECHANISM OF ACTION OF HEAT STRESS
Fever Therapy
5.1. The induction of fever by means of infection
or repeated injection of purified toxins has
resulted in some complete regressions of tumours,
(Nauts, 1953). The method of action may be divided
into the effects of hyperthermia, stimulation of
the immune response, and, possibly, a direct
toxic effect on the tumour cells by bacterial
—_ endotoxins and exotoxins. It is likely that
those patients who had the greatest pyrexia and
the highest regression rate also reacted more
vigorously to the exogenous antigen and were
immunologically more competant. It is not possible
to separate these factors but cancer treatment
by each of the three methods has its advocates.
5.2 The effects of immunotherapy with B.C.G.
or Corynebacterium parvum are poorly understood,
and the role of chemotherapy is constantly changing.
By understanding the mechanism of action of each
limb it may be possible to combine different modes
of treatment so that maximal potentiation of tumour
cell death recurs with the least possible damage
to the normal cell.
Cellular Respiration
5.3 Inhibition of oxygen uptake occurs in
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sensitive tumours at temperatures over 40°C.
(Dickson and Shah, 1972). Precht (1973)
suggested that this was due to a reversible
denaturation process which after prolonged
incubation becomes irreversible. Bowler (1973)
found a good correlation between the lethal
dose for heat stress and the loss of respiratory
control with a decrease in oxidative phosph-
ory 1 ation in the mitochondria. There are
considerable variations in the heat sensitivity
of the oxydative phosphorylation in the mito¬
chondria from different organs. Brain mito¬
chondria being the most heat resistant.
5.4 Christiansen and Kvamitie (1959) found that
electron transport in the succinate cytochrome
'C' region of the mitochondria is inhibited
by hyperthermia together with a loss of
respiratory control and uncoupling of phosphorylation.
They also demonstrated leakage of endogenous
cytochrome 'C during hyperthermia from the
mitochondria. Overgaard,- (19 75) showed that
mouse mammary carcinoma cells have a pronounced
decrease in cytochrome 'C' oxidase activity after
incubation at 42.5°C. for one hour. Mondovi
(1969) working with Novikhoff hepatoma cells was
able to show that the addition of cytochrome 1C'
enhanced oxygen consumption at 42°C. and reduced
the inhibitory effects of heat. Total disruption
of the cells abolished the differential heat
sensitivity of normal and tumour cells.
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5.5. The differential heat sensitivity of aerobic
respiration in different cell types is therefore
dependant on the integrity of the mitochondria and
the cytochromes maintained in ordinary sequence
on their cristae. Anaerobic respiration is
decreased but not completely inhibited by heat
(Muckle and Dickson, 1971). During hyperthermia
there is diminished aerobic glycolysis and
increased reliance on anaerobic glycolysis with
a subsequent decrease in intracellular pH.
(Overgaard, 1974). There is therefore a decrease
in production of adenosine triphosphate to power
the intracellular function such as synthesis
and transport across the cdllular membranes.
Nucleic Acid Synthesis
5.6. The effects on supranormal temperature on
nucleic acid synthesis was first studied in
viruses. Lwoff (1962) established a critical
thermosensitive event involving hydrogen bonds
in the viral cycle and advanced the idea that
the event was the polymerisation of a monomer
polymerase protein. A viral structural gene
carried the information for the synthesis of
this monomer which can be synthesised at supra-
ncrmal temperatures but cannot be polymerised
into an active polymerase.
118.
5.7. Gharpure (1965) showed that fifteen
minutes at 45°C. would inhibit the growth of
DNA viruses but not RNA viruses. The heat
sensitive step appeared to be DNA dependant
RNA synthesis necessary for the transcription
of DNA virus specific protein. This would agree
with Simard and Bernhard's (1967) findings who
suggested that the decreased rate of DNA
synthesis was due to heat damage of sensitive
hydrogen bonds responsible for the structural
integrity of the DNA double helix, this damage
blocking transcription. Depression of RNA
synthesis at 42°C. may add to the inhibition of
DNA synthesis as RNA. is necessary for the synthesis
of late replicating DNA and for the mitotic
process to take place (Warocquier, 1969).
5.8. It is not possible at present time to affect
to polyraerase enzyme and inhibit DNA transcription
in this way. Alkylating agents by reacting with
the sulphdryl groups of DNA, replacing the
hydrogen ion with an alkyl radical, block trans¬
cription in a similar way to that suggested for
hyperthermia. It is likely that such drugs would
cause an additive effect with hyperthermia.
5.9. Resistance to alkylating agents is in part
due an increased capacity for repair of damage to
the DNA (Crawthorn and Roberts, 1968). Inhibition
of repair enzymes may result in the continued
sensitivity of a tumour to alkylating agents and
thus has possible clinical significance in
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tumours which are initially very sensitive to
such agents.
5.10. RNA synthesis by transcription of DNA,.
takes place both in the nuclear cytoplasm
forming messenger RNA, and in the nucleolus
with the production of ribosomal transfer RNA,'
Nucleolar changes have been studied in depth.
The sensitivity of the nucleolus to heat is
reflected by a loss of granular ribonuclear
protein and nucleolar structure including the
vacuoles. Similar structural changes have been
found to occur with a number of antimetabolites
(Love, Studzinski, et al, 1965). Transcription
of the nucleolar RNA from the organiser
chromosome results in the synthesis of 45s
molecules which are the precursors of ribosomal
RNA. This transcription is blocked by actinomycin
D which causes a loss of granular and fibrillar
nucleoprotein, in the nucleolus (Stevens, 1964).
5.11. Warocquier and Scherrer, (1969) studied the
sedimentation analysis of labelled nucleoproteins
after incubation at 42°C. and were able to
show a build up of pre ribosomal RNA. This is
seen in the cell as an overaccumulation of
fibrillar ribonucleoprotein. No evidence of
granular ribonucleoprotein formation was found
suggesting a completely different mode of action
to Actinomycin D. Following heat stress,
ribosomal RNA was selectively inhibited with
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defective conversion of the 45s preriboxomal RNA
to the functional 28s and 18s species. The
primary lesion appeared to affect the processing
of preribosomal RNA to functional riboxomal RNA
which fails to appear in the cytoplasm.
5.12 This might be due to formation of altered
preribosomal RNA as a consequence of faulty
primary, secondary;or tertiary structure, or to
the thermo sensitivity of the enzymes responsible
for the conversion. Non ribosomal RNA appears
in the cytoplasm at the normal rate and there
- is only a slight decrease in synthesis of
messenger RNA in Hela cells at 42°C. At higher
temperatures cells show an overall 50% decrease
in the RNA production with an arrest of messenger
RNA transfer to the cytoplasm (Heine, Sverak et al).
5.13 Simard and Bernhard (1967) found that the
nucleolar loss of granular ribonuclear protein
was reversible and was probably due to uncoiling
of the ribonuclear protein to form a fibrillar
variety. Feldherr (1973) suggested that
irreversibility in the later stages may be due
to leakage of ribonuclear protein from the
nuclear envelope with the development of cyto¬
plasmic inclusion bodies, shown by Love et al in
1970 to consist of aggregations of ribosome
like granules. High levels of ribonuclear protein
in the nucleus during heat stress has a protective
effect (McCormick and Penman, 1969) .
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5.14 Chemotherapeutic drugs which act by
inhibiting RNA synthesis, therefore act in a
different manner to hyperthermia. Purine
antagonists, such as 6 mercapto purine, or
more specifically 5 fluorouracil, might be
expected to potentiate the effect of hyper¬
thermia, This effect has been shown to occur
in Hela cells (Palzer and Heilelberger, 1973) .
Protein Synthesis
5,15. Protein synthesis Is inhibited at
temperatures above 40°C. in heat sensitive
cells (Mondovi, Agro et al, 1969). The
disaggregation of polysomes with resultant
decrease in protein synthesis which occurs
may prevent synthesis of repair enzymes required
for replacement of enzymes naturally degraded.
This process may be of benefit in combating
viral infections of the cell by denying the
virus amino acids necessary for viral synthesis
(McCormack and Penman, 1969).
5.16 The importance of inhibition of protein
synthesis as a cause of cellular death following
heat stress is unclear. Palzer and Keidelberger
(1973), were able to show that the inhibition of
protein synthesis by cyclohexamide prior to
hyperthermia exerted a protective effect on the
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cells. If inhibition of protein synthesis is
protective, it would explain the resistant phase
shown by cells subjected to a second episode
of hyperthermic stress within a few hours of
the first.
5.17 Gerweck and Dewey (1975), have explained
this resistant phase in terms of cell cydle
effects. They suggested that cells progressed
to a more resistant phase of the cell cycle.
A third alternative is that as hyperthermia
recruits cells from the Gq phase into cycle
(Kal, 1975, Dickson and Calderwood, 1976),
there may be fewer cells left capable of
entering into the cycle.
Cell Cycle Effects
5.18 The most sensitive phase of the cell cycle
to hyperthermic killing is during DNA synthesis
of the 'S' phase. During this period the number
of chromosomal aberrations induced by hyperthermia
is similar to an equivelantly lethal dose of
X-rays (Dewey, Westra, et al, 1971). Cells
heated in either mitosis or had an aberration
frequency lower than that observed following a
correspondingly lethal dose of X irradiation.
This would suggest that cells die in 'S' phase
primarily because of an effect on DNA production
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resulting in chromosomal aberrations.
5.19 In mitosis and G^~this was not true as very
few chromosomal abnormalities were induced and
these were far too low to account for the
fraction killed. The primary effect on the
sensitive mitotic cell probably involves heat
denaturation of spindle protein (Sisken et al,
1955). This conclusion is based on the observation
that cells heated in metaphase are unable to
complete mitosis and appear in the next division
in the tetraploid state (Dewey et al, 1971). The
damage during results in less cell killing
than in 'S' phase because chromosomal aberrations
induced during 'S' phase tended to result in the
loss of large pieces of genetic material (Westra
and Dewey, 1971). This fragmentation of the DNA
has been studied mainly in bacteria and viruses.
5.20 Bacterial and viral DNA when heated in
vitro sustains both single and double strand
breakages (Bridges, Ashwood-Smith and Munson,
1969). The effect on the nucleic acid is by
disruption of the secondary structure, held
together by non-covalent bonds, such as hydrogen
bonds, and cleavage of the N - glycosidic end of
the phosphate-ester bonds.
5.21 Breakage of the non-convalent bonds leads
to a very abrupt change in the conformation in
the double helix and dissociation of the individual
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complementary strands. Within a narrow range of
temperature this reaction is rapidly reversible
(Szybalski, 1967). Cleavage of phosphate-ester
bonds causes single strand breaks which are
normally repairable.
5.22. A further effect which has been shown to
occur during slight temperature increases in the
cell in hydrolysis of N - glycosidic bonds of
purine deoxy nucleotides in DNA. This causes a
loss of biological activity as a sequel to
depurination (Eigner, Boedtker and Michaels, 1961).
Thermal inactivation of RNA is also in part
caused by cleavage of phosphate-ester bonds
(Szybalski, 1967).
5.23. Damage to covalent bonds causing strand
breaks can normally be repaired in the cell by
using the complementary DNA strand as a template
and replace the missing or modified bases. If
not repaired the free radical ends may react with
surrounding molecules making repair impossible.
5.24 Alvarez(1973), has shown that tumour DNA
is more sensitive to heat damage than normal DNA.
This may explain the difference in heat
sensitivity of some cancer cells. Deletions in
the X chromosome,which is the site of a
nucleolar organiser are very frequent,and may be
responsible for subsequent changes in nucleolus.
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Membrane Effects
5.25 Cellular membranes are formed of a lipo¬
protein complex and their precise integrity and
structure has to be maintained for the function
of their attached enzymes. In the crayfish,
Bowler, Duncan et al, (L9 7 3) were able to show
a correlation between the temperature for death
of the whole animal, the impairment of membrane
bound Mg++ ATPase, and the control of membrane
permiability. Oxydative phosphoryllation in
mitochondria is uncoupled at temperatures between
41 - 4 5°C., and the cytochrome C. content of the
medium increases due to damage of the mito¬
chondrial membrane and subsequent leakage.
Christiansen and Kvamme (1969), found that ascites
tumour cells were more sensitive than liver cells
in this respect.
5.26 Emmelot and Bos (1968), studied the
temperature sensitivity of both intact cells and
isolated membrane enzymes from normal rat liver
and from hepatomas. They found that the rat
hepatoma cells were more heat sensitive than
the normal rat liver cells. There wem clear
differences between the liver and the hepatoma
cells in the specific activities and the ATPase
enzyme systems. They concluded that as the Na+ -
K+ - Mg++ - ATPase systems are lipoprotein
complexes forming part of the cell membrane, the
differences between liver and hepatoma sensitivity
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were due to differences in chemical and morphological
composition of the membranes rather than to changes
in the proteinaceous enzymes themselves. Changes
in either the lipid or the enzymes attached has
been suggested by Miura, Kawashima et al, (1971)
as the reason for hyperthermic fragility of human
leukaemic cells. The heat energy of inactivation
of such proteins is within the capacity of
hyperthermic therapy (Westra and Dewey, 1971).
5.27 Of clinical interest is the observation that
some chemotherapeutic drugs are able to enter the
sensitive cells more easily at higher temperatures
due to these membrane changes (Hahn, 1975).
5.28 Damage to lysosomal membranes could cause
leakage of toxic enzymes and products into the
cytoplasm, however this does not appear to be a
primary method of cell killing by hyperthermia
(Turano, Ferrard, et al, 1970). There is a
decrease in intracellular pH which would activate
lysosomal enzymes once released. This together
with ease of diffusion of toxic products through
the damaged membrane might account for the rapid
absorption of toxic material which occurs during
hyperthermic therapy.
Repair
5.29. Inhibition of repair of sublethal damage
may be due to heat destruction of the enzymes
concerned, a block in their synthesis, their
inactivation by alteration in structure, or by
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lack of energy supply in the form of ATP required
for reactions. Damage to DNA during hyperthermia
has been shown to be due in part to loss of
repair of single strand breaks caused by heat
or alkylating agents. Rejoining of such induced
breaks in the DNA is inhibited above a critical
temperature which is about 41.5°C. for human
skin cells (Bronk, Wilkins and Regan, 1973).
5.30 Hochacka (1969), and Somero (1969), have
provided evidence that acclimatisation to a new
temperature involves changes in the kinetic
properties of enzymes, probably by the production
of different isoenzymes. Different thermo
sensitivities for cells of varying origin can be
explained on a differing thermal sensitivities
of contained enzymes.
B. FACTORS AFFECTING HBAT SENSITIVITY
5.31. In 1934 Crabtree amd Cramer noted that
"most neoplasms are badly vascularised and,
if they are large, unequally vascularised".
Different parts of a growth are therefore
supplied with oxygen in a varying degree so that
they will vary in their susceptability to a
given dose or radiation". This statement is also
true of hyperthermic therapy as nutritional
status, contact inhibition, and the number of
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cells in active cycle governs their sensitivity.
Like other forms of tumour therapy, cells can
become resistant to heat therapy.
5.32. Studies at a cellular level have shown
that in heat resistant cell lines there is a
decrease cellular permeability, reflected by
decreased leakage of materials such as uridine
following heat stress, combined with an
accelerated rate of repair of heat induced damage
(Reeves, 1971). A change in membrane permiability
would agree with the lipoid theory and fit with
the fact that the inhibition of thymidine uptake
by DMA is abolished in cell free preparations
(Modovi, Agro et al, 1969), Increased repair rates
due to a build up of reserves of ENA as suggested
by McCormick and Penman, (1969), or the production
of a specific RNA, would promote cellular function
under conditions of heat stress.
5.33. There appears to be two mechanisms of
resistance to heat stress, the first, acting
after acute heat shock in which the cells are
heat tolerant for 17 - 25 hours, and probably
represents cells arrested in a heat tolerant phase
of the cycle (Gerweck and Dewey, 1975), but may
represent protection endowed by inhibition of
protein synthesis as discussed earlier. The
second is reflected by an increased heat resistance
in daughter cells, and may be genetically controlled
though there are no obvious chromosomal changes
(Harris, 1967 b).
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C. DOSAGE AND THE UNITS OF HYPERTHERMIC
STRESS. ~ "
5.34 The treatment dosage given at any one time
has the objectives of causing maximal tumour
damage with the least possible damage to normal
tissue. Each fraction should be large enough to
prevent the induction of resistant clones of
tumour cells. The heat stress required to kill
a fixed percentage of cells, usually taken as
67% (°37 value), has been shown by Westra and
- Dewey, (19 71) to be directly related to
temperature and time above a critical temperature.
5.35 The critical temperature represents that
temperature above which cells are irreversibly
damaged and co-incides with the beginning of the
straight line portion of the survival curve.
Each system has its own characteristic survival
curve as shown by Adolf (1947) for the whole
animal, and by Orr (1955) for different tissues.
Each survival curve has its characteristic
critical temperature.
5.36 To state treatment dosage in terms of temp¬
erature and duration of treatment is therefore
insufficient to standardise the degree of heat
stress to which the system has been subjected.
In most cell systems, at temperatures above
the critical value, for each 1°C. rise in
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temperature the time taken to produce the same
degree of thermal damage is halved. If treat¬
ment is standardised to the time taken at 1°C.
above the critical temperature to produce the
same degree of thermal stress as the actual
treatment a clinically useful unit of heat
stress can be defined. The centigrade degree
minute is the time equivalent at 1°C. above
the critical temperature for a specified cell
system under specified conditions required to
produce the same degree of thermal stress in
that system.
.37 Unfortunately the heat sensitivity of
human tumours has not been charted though some
preliminary studies have been carried out by
Dickson and Suzanger, 1976 . The usage of the
degree minute would enable comparisons of tumour
and normal tissue sensitivites to be made. A
tumour which requires 800 C.° minutes at 41°C.
standard would also be cured by 400 minutes at
42°C. or 200 minutes at 43°C. If the normal
surrounding tissue requires 1000 C° minutes at
41°C. standard for cell death, there is a reasonable
differential of heat sensitivity. If the effect
of hyperthermia is potentiated x 2 by a given
dose of radiotherapy or a standardised drug
concentration then the centigrade degree minutes
required for cell death can be halved. In this
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way the hyperthermic fraction can be easily
calculated and any potentiating factors allowed
for. In the clinical situation the tumour
temperature is difficult to keep constant and
there are changes when the tissue is heating up
and cooling down. The dosage in degree minutes
can be calculated in terms of a single value
in spite of changing temperature, and has the
advantage of stating the critical temperature of
the system described.
38 In this thesis the degree minute 41°C.
standard was used for tumour therapy by whole
body hyperthermia and assumes a critical value
for all tumours treated of 40°C. This is
certainly inaccurate, some tumours may have a
lower critical value, some, such as ovarian
and testicular tumours must have a critical
value considerably above this level. 40°C.
was assumed as this was the temperature at which
inhibition of oxygen consumption began in
sensitive tumours in vitro (Dickson and Shah, 1972).
39 Whole body hyperthermia produced stress as
reflected by an increase in ACTH and Cortisol
levels at temperatures above a critical value of
38°C. Heat stress to the whole body was
therefore standardised in centigrade degree minutes
39°C. standard, and assumes a linear relationship
for heat stress between temperature and time above
38°C.
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D. ADVANTAGES OF THE METHOD
5.40 The advantages of using molten wax as a
source of heat are considerable. It is cheap
and easy to obtain, and as it does not come into
contact with the patient, is re-usable. Wax
is an insulator and there is no danger of short
circuiting electrorradiograph electrodes or
conducting should the need for defibrillation
arise.
5.41 Wax adjacent to the patient solidifies
—-forming an insulating barrier from the rest of
the molten wax at 50°C. There is a large
thermal resevoir of molten wax but a skin temp¬
erature of approximately 44°C. is achieved,
allowing a maximal permissible thermal gradient.
As the molten wax cools it gives out latent
heat of solidification so tending to keep the
average temperature of the liquid wax constant.
This method therefore gives the maximum possible
rate of increase in body core temperature.
5.42 Once the required increase in body
temperature is achieved the molten wax can be
syphoned off leaving an insulating pellicle
to conserve heat loss. The absence of water
vapour allows this pellicle to be opened to a
varying degree allowing the evaporation of sweat
with resultant cooling of the patient. In this
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way the body core temperature can be maintained
to within 0.1°C. The only disadvantage of
using wax is that it is difficult to clean up
spills.
5.43 The method is safe and only one patient
has died during hyperthermia. This was the
second patient treated in 1966,when only two
thermometers were usedfand the patients core
temperature reached 43°C. due to thermometer
failure. With 8 thermometers at different sites
registering onto 2 different recording systems
the possibility of thermometer failure is
very remote.
5.44 Patient care is easy using this method as
the patient is .easily seen and can be easily
exposed for clinical examination. If at any
time it is required to stop treatment the patient
can easily and quickly be lifted out of the
bath and left wholly exposed, resulting in a




5.45 Patients are closely monitored during treat¬
ment and the temperature of the body core taken
as the highest reading of the eight thermometers
used. During active heating the temperature in
the oesophagus is 1 - 2 centigrade degrees
higher than in the rectum (Figure 13). At
stable temperature the oesophageal and rectal
temperatures are the same and agree with the
value for the typanic recording. The elevation
of oesophageal temperature during active heating
probably reflects the local heating effect produced
by ventilating with heated gases.
5.46 During other forms of pyrexia in man
variations of temperature in different parts of
the body have been observed. The intra-cardiac
temperature may be as much as 0.8°C. below the
rectal temperature (Eichna, Berger, et al, 195]).
The temperature of blood draining from the liver
and brain indicate that these organs are at a
higher temperature than the intra-cardiac reading,
but the exact temperature difference is not
known (Aschoff and Wever, 1958). Some preliminary
work by Budinger (1976) in rats suggests that
in this species the liver may be as much as 1 - 2°C.
above the measured rectal temperature. In the
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present series the rectal, tympanic and oesophageal
temperatures were the same at stable temperature
and would suggest some average homogeneity of
temperature, but precise organ differences are not
known.
Anaesthesia During Hyperthermia
47. At temperatures over 40°C. patients
become restless and anxious (Wallace, 1943).
Increasing muscular activity makes external thermo¬
regulation more difficult and uses the patient's
reserves of energy and increases the rate of
lactic acid production. Patients were therefore
paralysed and ventilated during treatment, light
narcosis being mainatained by intermittent opiates
✓
and short acting barbiturates.
48. At temperatures over 40°C. there is a rapid
increase in the quantity of anaesthetic agents
required to maintain mild narcosis/and at the
end of the treatment session there was a large
quantity of drugs circulating resulting in prolonged
anaesthesia. The use of a high epidural
anaesthetic decreases the need fcr systemic
narcotics;and by causing peripheral vasodilation,
increases the rate of heat absorption from the
skin.
49 One patient following epidural anaesthesia
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with intermittent marcaine. developed motor weakness
in both legs. Marcaine is stated by the makers
to be stable at the temperatures involved,
however, it has not been used subsequently. 2%
plain Xylocaine was routinely used for the
epidural anaesthetic and there have been no
complications responding from it use. McKenzie
(1975) using the same method of inducing whole
body hyperthermia has used low dose Halothane
and reported no side effects.
Haemodynamic Response
5.50 Heat death in humans is usually caused
by failure of the heart and blood vessels
(Cloudsley-Thompson, 1963). In uncontrolled
hyperpyrexia both hypoglycaemia and dehydration
have adverse effects on the heart and circulation.
Dehydration results in an increased workload on
the cardiovascular system. The blood volume is
reduced and the viscosity of the blood increased.
In addition the peripheral blood pool space
expands in response to attempts by the body to
move core heat to the skin. Eventually, the
flow is reduced to the point that removal of heat
and waste products from the tissue and delivery
of energy substrates to the tissue is so impaired
that death ensues. Inducing controlled whole
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body hyperthermia necessitates careful monitoring
with accurate control of body core temperature as
well as fluid and electrolyte balance to ensure
maintenance of an adequate cardiac output and
tissue perfusion.
Changes in Heart Rate
5.51 Damato, Lau et al (1968) found that in
unacclimatised conscious volunteers heat stress
caused a decrease in arterial and central venous
pressures due to peripheral vasodilation
resulting in compensatory increase in heart
rate. During hyperthermia the increase in heart
rate was only 60% of that found in conscious
patients (Tanner, 1951). This can be explained
I
by anaesthetic depression of the sympathetic
cardiac stimulatory fibres as a reduction of the
depth of narcosis leads to a further rapid
increase in the heart rate. That the mechanism
is neurological, as suggested by Cooper and Kerslake,
(1955), is supported our finding of a decrease in
eventual rate at stable temperature under epidural
anaesthesia. The increase in heart rate per
centigrade degree rise in temperature is less
during active heating when the body core temperature
is rapidly raised/this implys a limit to the rate
at which the compensatory mechanisms can respond
to changing temperature. With epidural blockade
-138.
the increase in heart rate was less suggesting




5.52 At body core temperatures above 40°C.
there is a hyperdynamic circulation which is
dealt . with by different species in different
ways, and may account in part for the
differences in thermal tolerance between
species. Hales and Dampney (1975) showed that
in dogs there is a marked increase in cardiac
output with a large degree of arterio-venous
shunting of blood, whereas sheep, which are more
resistant to thermal stress, reacted largely
by redistribution of blood flow to central organs..
There is an increase in cardiac output of 30% at
40°C. in man (Demarto et al, 1968), which is
due to an increase in pulse rate as there is a
fall in stroke volume (Rowell and Murray, 1969).
5.53 In terms of hyperthermic stress the blood
flow to any particular organ is important, but
also the temperature of that organ, which may be
different to the core temperature, the degree of
arterio-venous shunting in the organ concerned;
and its metabolic rate, determine its heat
sensitivity. The pattern of blood flow distrib¬
ution in man during hyperthermia is not well known
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but some studies have been recorded. At normal
temperatures a decreased arterial blood carbon
dioxide tension (Pa C^) has been associated with
a decreased cerebral blood flow (Reivach, 1969).
Colton and Frankel, (1972) showed that in dogs this
was also true .during hyperthermia, but because of
the decrease in overall vascular resistance,
cerebral blood flow increased during hyperthermia.
Snodgrass and Lorenzo (1972), found between a
6 - 11% increase in cerebral blood flow per degree
rise in temperature up to 41°C. Nemoto (1370),
found that cerebral hypoxia did not develop in
hyperventilated dogs at 42°C. In man treated for
venereal disease by whole body hyperthermia to
41°C. cyanosis was a constant feature with
marked mental changes (Wallace and Gushby, 1945),
5.54 In 1968 Rowell, Brengelman et al, showed
that in heat-stressed man at 40.2°C. there was
a reduction in hepatic and splanchnic blood flow
with an increase in the hepatic lactate production
indicative of anoxia. In 1970 working with a
group of young univeristy students who were heated
to temperatures in the right atrium of 39°C.,
Rowell et al found a decrease in total peripheral
resistance but an increase in splanchnic
resistance. Hepatic and renal blood flow was
again decreased in spite of an increase in cardiac
output. In view of these findings our method was
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modified in that the patients were hyperventilated
with oxygen enriched air, thus ensuring that any
blood going to a hypoxic region such as the liver
would carry as much oxygen as possible. By
ventilation the muscular work of breathing is
reduced and it was hoped to reduce lactic
production in this way. Plasma is infused at
a body core temperature of 41.8°C. to compensate
for the increased blood pool volume, 40 mgs. of
Lasix is given towards the end of treatment session
to ensure that there was no circulatory overload
as venomotor tone is regained during cooling.
Plasma Electrolyte and Enzyme Levels
5.55 The lethal effects of hyperthermia by
inhibition of cellular metabolism together with
increased membrane permiability involved changes
which are intracellular. In dogs, Spurr and
Barlow, 1970 measured "tissue electrolytes and
found that after heating to a rectal temperature
of 42.5°C. for one hour there were significant
increases in the concentration of sodium in the
liver, jejunum, and brain, potassium in the
heart and skeletal muscle,and also an increased
water content in the jejunum. Some changes are
reflected by changes in the extra-cellular fluid
and show as changes in plasma electrolytes and
1.41.
enzymes, whose concentrations which can be measured
In the present series it was hoped that by maintain
ing the fluid and electrolyte balance and plasma
electrolyte concentrations within the physiological
range, that the normal cell would have the best
possible conditions to withstand heat stress. In
particular it was hoped that this would avoid
myocardial irregularities.
Fluid and Electrolyte Losses
.56 Without replacement, electrolyte changes
occur in hyperthermic animals (Spurr and Barlow,
1959), and in Dr. Pettigrew's earlier treatments
there were significant changes in these levels.
Fluid losses during hyperthermia were great,
averaging over 550 mis/hour of which 90% is
lost in sweat (Figure 37). However, this sweat
rate is similar to that reported in unacclimatised
subjects exercising in a hot climatic chamber,
and although the sweat sodium concentration of
84 m.mol/1 is higher than the reference range of
20 - 70 m.mol/1, similar increased sweat sodium
concentrations have been reported during
prolonged heavy sweating in unacclimatised
subjects (Furman and Beer, 1963). It was possible
to achieve a satisfactory overall salt and water
balance by monitoring the serum electrolyte
concentrations during hyperthermia therapy. Using
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FLUID AND ELECTROLYTE LOSSES AND REPLACEMENT
LOSS








Fluid and electrolyte losses are great during
hyperthermia but are adequately replaced by
the infusion regime now used.
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a standard replacement regime running at 500 mis.
per half hour and giving Lasix if necessary to
maintain a urinary output of over 100 mis. per
hour, the serum electrolytes are now maintained
within normal limits.
Liver Function, A Limiting Factor in
Maximal Therapeutic Temperature.
5.57 Following fever therapy for neurosyphilis
or gonorrhoea, jaundice was a frequent
occurrence, usually appearing after the second
day and being of brief duration. MacDonald (1944)
reported an incidence of 19% and transient
hyperbilirubinanaemia was detected in 75% of
King, Wallace and Nicol's (1943) series, and in
all of the cases studied by Wallace (1943). A
detailed account of the post mortem changes in
17 fatal cases was made by Gore and Isaacson,
(1949) who found that in the early post hyper¬
thermic period there was liver congestion with
cloudy swelling and glycogen depletion of paren¬
chymal cells. This was followed by nuclear and
cytoplasmic vacuolation and the accumulation of
fat droplets. Those patients who died more than
48 hours after hyperthermia had all developed
clinical jaundice and there was centralobular
necrosis of the liver which became increasingly
severe as the survival period lengthened.
144.
5.58 It appeared that the liver was the most
heat sensitive organ in the human body. These
findings could be due to the increased
temperature of the liver over the body core
temperature (Budinger, 1976), or due to anoxia
resulting from the decrease in hepatic blood flow.
In order to investigate this and. to establish
the maximum safe therapeutic temperature in man
a series of liver function tests and enzyme studies
were carried out.
5.59 In animals Burger (1970) has shown that
there is a critical core temperature of 42°C. above
which there is an increase in serum enzyme activity.
In Adolf's (1947) series studies the rate of
death of mammals became time related at body core
temperatures over 42°C. The serum enzyme activities
in man in our series also increases at temperatures
over 42°C., and, although isoenzyme studies were
not carried out to prove that the hepatic origin
of these enzymes, the relationship to liver function
in the form of decreased excretion of B.S.P. is
suggestive of liver origin. Perfusion of the
isolated cat's liver by Rawlinson and Kellaway,
(1944), indicated a critical level of 41°C. for
hepatic thermal injury, and it is therefore probable
that this is a direct thermal effect.
5.60 We were not able to protect against the
development of enzyme changes by the use of
glucagon or with hyperbaric oxygen at two
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atmosphere pressure. These changes in serum enzymes
were taken to indicate a maximum safe therapeutic
temperature of 41.8°C. giving a 0.2°C. margin of
safety. This was subsequently adopted for all later
treatments.
Plasma Cortisol Levels: Stress Response
5.61 Collins in 1969 subjected 12 fit young male
volunteers to environmental heating inducing a
gradual rise of oral temperature to 3S°C. over a
- period of two hours. During this there was a
rapid fall in the plasma Cortisol maximal at one
hour followed by a sharp rise. If the fall in
plasma Cortisol was temperature related, it might
be prolonged by the higher temperatures used in
hyperthermia therapy.
5.62 The second factor which prompted this
study was the possibility of either adrenal mal¬
function of the occurrence of adrenal metastases
in patients with disseminated cancer. It was
undertaken to evaluate adrenal function during
hyperthermic therapy and to see whether the. routine
replacement hydrocortisone therapy previously given
was necessary during treatment. Serial plasma
Cortisol levels were estimated in eight patients
during fifteen sessions, and serum adrenocortico-
trophic hormone (ACTH), in four of these patients
during five treatment sessions.
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5.63 The observed changes in plasma, ACTH and
subsequent Cortisol levels, of an initial fall at
temperatures above 33°C. followed by a sharp rise
occurred in all patients. This includes one
patient treated on three occasions in whom no
epidural anaesthetic was technically possible.
5.64 Pre-medication and muscle relaxants have
been shown to have no significant effect on plasma
Cortisol levels during surgery (Hammond and
Vandam, et al, 1958). This was also the case in
our series in which two of the patients had no
premedication and showed the same Cortisol response
as those premedicated. Opiates have been shown
to block the release of ACTH at the hypothalamic
level (Vandam, and Moore, 1960). However, as
opiates were given on several occasions during
treatment without apparent effect, it is probable
that this effect is not significant during stress.
5.65 Figure 25 showed the plasma ACTH and
Cortisol levels against temperature showing that
the lowest point for Cortisol at about 39.5
Q
40 C. The graph is very similar to that of Collins,
Few et al, (1969), who subjected volunteers to
a lower rise in body core temperature (39°C) and
found a similar fall in plasma Cortisol at above
38 °C. which lasted for one hour, followed by a
rise. The rate of disappearance of ACTH would be
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in keeping with inhibition of synthesis, and decay
of that already in circulation, as the half life
of ACTH is eight minutes (Gallagher, Yoshida,
et al, 1973). Similarly, the subsequent fall in
plasma Cortisol is also accounted for by decay
as it has a half life of 70 minutes (Gallacher
et al, 1973). The rise in ACTH to pretreatment
values takes nearly 45 minutes to occur and would
appear not to be entirely temperature dependent.
5.66 This conclusion is supported by Collins et
al (1969) previous studies, in which the time
taken for the Cortisol level to return to pre¬
treatment value was one hour. This would suggest
that the Cortisol response is dependant on hyper¬
thermic stress rather than an absolute temperature
level. The posterior hypothalamus mediates both
heat' retention and the discharge of ACTH from the
anterior pituitary (Hensel, 1973). There would
appear to be an inter-relationship between thermo¬
regulation and adreno-cortisol function mediated
by ACTH release, inhibition being followed by a
resetting event after a period of time. Increasing
fractions of treatment above 450 centigrade degree
minutes, 39°C. standard, causing a further reset¬
ting event with higher levels of ACTH and Cortisol.
This would suggest that with increasing fractions,
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even with adequate fluid and electrolyte replacement,
there is a increase in the total body stress and
that there must be a maximal treatment in terms of
temperature and time that can be tolerated.
5.67 Though these results are crude in that
ideally to measure ACTH levels samples should be
taken within the half life of ACTH in order not
to miss a secretory episode, and few patients
were monitored, the trend after an initial fall
is for a rise in plasma Cortisol levels to supra-
normal levels. There is therefore no need during
hyperthermic therapy for the replacement steroids,
but as there is a stress response induced by this
form of treatment, adrenal function requires to
be checked prior to treatment.
Haematological Changes
5.68 No treatment of cancer is wholly selective.
The toxic effects of the treatment limit the
maximum permissible dose. Figure 38 is an
extension of the Johnson's work (1940), and compares
the heat sensitivity of tumours and normal tissue
from in vivo and in vitro studies. The thermal
death times for each tissue lies within a band of
temperature and time. It is probable that at 42°C.
approximately 20 hours of treatment would be
required for total tumour destruction of a


































10 20 30 £0 50
FIGURE 38.
Temperature/Time for 100% necrosis of various
tumours in animals as compared with that for
normal human skin.
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of time at 41.8°C. could be tolerated in cancer
patients or what the limiting factor in hyper¬
thermia would be. Cohen and Warren, (1935)
treated patients for up to 20 hours at 41.5°C.
for venereal disease. Measurements of oxygen
consumption during treatment in our unit proved
too insensitive to limit treatment on this para¬
meter, and a more sensitive index was required.
For this reason the blood forming elements and
blood coagulation was studied in depth.
Marrow Studies and Changes in Haemoglobin
5.69 In cancer therapy the side effects are
caused by toxicity to normal tissue. Cells in
cycle are affected by all groups of drugs and by
X-raysfand one of the most frequently affected
regenerating cell systems in the body is the bone
marrow. As hyperthermia acts mainly on cells
in cycle,the effects on the bone marrow might
indicate the degree of"toxicity of hyperthermia.
5.70 The marrow histology, from biopsies taken
before and after hyperthermia,together with
the reticulocytosis which developed between treat¬
ment fractions;indicate an active marrow with no
depression. Another regenerating system in the
body is gut epithelium. We were not able to
study this although some patients did develop a
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form of diarrhoea following prolonged hyperthermia.
The results indicate that either the marrow is
not sensitive to the hyperthermia, or more likely,
that the degree of hyperthermic stress induced was
insufficient to produce a toxic effect.
5.71 There was a 10% fall in the haemoglobin
following each treatment, which was probably due
to the destruction of ageing red cells as
demonstrated following hyperthermic treatment in
rabbits (Karle, 1969). If the damaged ageing
red cells are rapidly removed by the reticulo¬
endothelial system during treatment it might
account for the unexpected absence of an increase
in osmotic fragility of the red blood corpuscles
during treatment.
White Blood Count
5.72 Most causes of fever are associated'with
a rise in peripheral white blood count and this
has always been considered as part of the body's
defence to infection. Most cancer therapy
causes leucopenia,; the white count was therefore
studied to assess the relative importance of these
two opposing parameters, and to see whether there
was any significant fall in the white blood count
following hyperthermia which might necessitate
antibacterial cover.
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5.73 The dramatic increase observed in the white
cell count during treatment temains unexplained.
Leucocytosis following artificial fever was
reported in 1935 by Cohen and Warren, following
treatment of venereal disease, and the pattern of
this response was the same as our own. Immature
polymorphonuclear leucocytes cause the rise in
overall white count, but the origin and fate of
these leucocytes is not known. The leucocytosis
is not maintained following treatment and
subsequent leucocytosis may be indicative of
infection and should be investigated as such.
At the present time Mr. A. P. Gee is studying the
immunocompetance of these leucocytes, the
preportion of lymphocytes, and whether they are
capable of attacking tumour cells.
Intravascular Coagulation, A Limiting Factor
in Fractionation.
5.74 Increased vascular coagulation has been a
reported complication of malignant hyperpyrexia
(Purkis, Horrolt et al, 196 7), and is a known
complication of aggressive chemotherapy in the
presence of wide spread sensitive tumours (Levy,
Benham-Kahn, et al, 1970). Peck and Reiquam (1973).
found that cancer patients have a delicately
balanced coagulation mechanism which might easily
153.
be tipped towards a low grade chronic disseminated
intravascular coagulation by any changes in this balance.
5.75 Three adult patients died within 2 4 hours of
hyperthermia with evidence of coagulation defect,
with low platelets and raised fibrin-fibrinoger.
degradation product levels. For this reason the
coagulation status of the subsequent patients treated
was studied and related to the amount of treatment
they had received. The degree minute, 41°C. standard,
was taken as the unit of therapeutic hyperthermia
and was defined as the time in minutes multiplied
by the temperature in degrees centigrade that the
body core is at a temperature above 40°C., and
represents an equivalent time in minutes spent at
41°C.
5.76 After a first hyperthermic fraction of less
than 300 C° min. there was a fall in platelets
in both responsive and non-responsive patients.
The non-responsive group had no further decrease
in platelets when treated by a second, larger
fraction. This would indicate some initial
destruction of normal tissue which may be due, in
part, to the destruction of ageing red cells, as
shown by Karle (1969). Subsequent greater fractions
can be tolerated following a first smaller fraction.
In the patients with non-responsive tumours treated
above 500 Cw min., 41°C. standard, there was a
marked thrombocytopenia which may represent too
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large an increment in fraction dosage (200 C.° min,
41°C. standard), or a maximum to the degree of
thermal stress tolerable by the whole body.
77 The shape of the survival curve of cells
during hyperthermia has been shown to be
similar to that following X-ray irradiation,
having a shoulder indicating repairable damage
before an exponential phase is reached (Westra
and Dewey, 1971). The action of hyperthermia
in destroying cells is largely by damage to
enzyme systems necessary for the repair of other¬
wise sub-lethal damage (Hahn, 1974). Cells are
either killed or return to their previous state
following each treatment. Each treatment at weekly
intervals, was not additive and a second, larger
fraction was required to produce the same fall in
platelet count. This may be due to the remaining
population being more resistant to further therapy.
Clinical results reflected the platelet count, in
that patients having a second fraction, similar to
the first do not have a large fall in platelet
count and feel well immediately following the
second treatment.
78 Cytotoxic chemotherapy and hyperthermia have
been shown to potentiate each other (Hahn, 1975).
The only death due to D.I.C. in a patient treated
with an initial fraction of less than 300 C° min . ,
41°C. standard, occurred following chemotherapy
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given at the same time as hyperthermia. In subsequent
cases this combination has been used after two
fractions giving the chemotherapy along with the
third hyperthermia fraction, of the same duration
as the second. Three patients were treated with
closely monitored low dose heparin to try and
avoid platelet consumption. Patients with
sensitive tumours however, bled into the tumours
during treatment,and this form of preventative
therapy was therefore discontinued. In two patients
with over 500 C° min, 41°C. standard, resulting
D.I.C. has been successfully treated by an infusion
of platelets and clotting factors.
5.79 The present result would agree wTith previous
work that the most obvious effect of acute D.I.C.
in patients with cancer may be thrombocytopenia
alone. This may be: explained by an increased
production of consumed factors in cancer patients
(Peck and Reiquam, 1973). During hyperthermia the
patients are in a hyperdynamic vasodilated state
and there is a consequent rapid absorption of any
toxic breakdown products resulting from cellular
death. There is some breakdown of normal, probably
ageing tissue during hyperthermia, and if the load
of toxic products is increased by a breakdown of
sensitive tumour then disseminated intravascular
coagulation may be precipitated.
5.80 The present results have been on too few patients
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to be significant and also represent a random
selection of tumour types, which may have differing
sensitivities to hyperthermia. The trend however,
is towards a consumption coagulopathy in patients
with sensitive tumours. There is therefore a need
for fractionation in hyperthermic therapy but the
frequency of treatment and the exact heat fractions
to be used in each individual tumour are still
to be assessed.
5.81 No patient, treated without cytotoxic chemotherapy,
with a first fraction of less than 300 C.° min.,
41°C. standard, has developed a serious degree of
thrombocytopenia (Figure 39). This fraction was
therefore taken as the maximum for a first fraction,
and there have been no deaths following hyperthermia
using this fractionated type of therapy. Treatment
is planned in degree minutes and a circle of thread
of known area is pinned to the temperature chart
during therapy. Using this technique the planned
number of degree minutes can be given.
157.
PLATELET CHANGES AT 2/,hrs AFTER 1st TREATMENT
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FIGURE 39.
No patient treated with a first fraction of less
than 300 C. min., 41°C. standard, developed a
serious degree of thrombocytopaenia. The one Q
patient with low platelets at 300 C. min., 41 C.
standard was also given chemotherapy and was
included for completeness.
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Immune Response and Viral Studies
5.82 In 1972 one patient, with disseminated melanoma,
developed a marked lymphadenopathy with associated
pyrexia ten days following hyperthermic therapy.
This continued for five days following which the
pyrexia settled and the lymphadenopathy completely
regressed as did the tumour. Further it was
noticed that 50% of patients developed Circumoral
Herpes simplex following the first treatment but
not following subsequent treatments (Figure 36).
The possibility that latent virus was being
activated or extruded from the cells during hyper¬
thermic stress, or that hyperthermia might be
stimulating an immune response to the tumour
was considered. As there is a possibility of a
viral aetiology to some tumours (Culliton, 19 72),
and Mondovi, Santoro et al (19 72), had shown an
increase in the immunogenicity of heat treated
cells, all subsequent patients were investigated
for changes in immunoglobulins and by viral
antibody titres.
5.83 The absence of an immune response in these
patients may reflect the large bulk of tumour
present and the poor clinical state of the patient.
There is a considerable difference of opinion
regarding the effect of hyperthermia on the
immune response. Crile (1963) found that tumours
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heated in foot pads of mice could be cured. However,
if the same tumour was minced up immediately after
heat exposure and injected into another animal it
grew almost as though it had not been heated.
Goldenberg and Lancer, (1971), found that local
heating of colonic human tumours implanted into
one cheek pouch of a hamster inhibited growth of
a similar tumour in the contro-lateral pouch,
suggesting some stimulation of the immune response.
Dickson (1975) on the other hand suggested that
even local hyperthermia may decrease the immune
response and prepare the ground for metastatic
spread. However he was not able to apply local
heat without inducing whole body hyperthermia
and there was a 90% death rate following local
treatment. He was unable to cure tumours over
3 cms. in diameter by heat alone. The activity
of the immune response following hyperthermia
requires further evaluation and no definite results
have as yet been published. These studies are
being carried out on Dr. Pettigrew's patients by
Mr. A. P. Gee and form the basis of his Ph.D.
thesis.
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F. CLINICAL RESULTS OF WHOLE BODY
HYPERTHERMIA.
5.85 In 1965 Dr. Pettigrew started to induce
whole body hyperthermia using a water bath. In
his initial series few patients were treated
at above 40°C., and these cases were therefore
excluded from the review. Those patients
treated before 1972 were assessed on reports in
the case notes. This was not satisfactory as
all the patients were terminally ill with -
disseminated disease and had no further therapy
planned. Notes were often scanty and measurement
of size of tumours and degree of regression
following hyperthermia rarely noted. Where no
comment of improvement was made it was assumed
that there was no response and the patient placed
in the non responsive group.
5.86 From 1972 to the end of the study, the
review sheet was completed at regular intervals,
however, it was still difficult to evaluate a
moderate response, or lack o:f progression of
disease. These groups were again classed as
non responsive. This method of documentation
was carried out in the hope of isolating one or two
tumour types which might be very sensitive to
hyperthermic therapy and to which this labour
intensive form of therapy might offer cure.
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5.87 There were no cures following hyperthermia
alone, poorly differentiated tumours such as
fibrosarcoma showed evidence of massive tumour
necrosis following therapy. Similarly two
children with neuroblastoma and one with a
nephroblastoma showed massive tumour necrosis,
These patients were treated at a time when the
importance of fractionation in whole body hyper¬
thermia was not realised,and these patients died
within one week of treatment. Similar tumours
have not been treated by fractionated therapy.
5.88 With the advent of gradually increasing
dosages of thermotherapy, the treatment became
safe and the effects easy to predict. At the
same time it was realised that the likelihood
of tumour cure by heat alone was small. Regression
was dependant on the core of a large tumour mass
being nutritionally deprived and therefore thermo-
sensitive. Decreasing blood pressure and thus
tumour blood flow during treatment accentuates
this effect, resulting in a central area of
necrosis surrounded by a cuff of viable cells, as
observed by Overgaard and Overgaard (1975).
5.89 At this time the degree minute was adopted
as our unit of hyperthermic therapy. From the
graph of tissue sensitivities approximately
20 hours at 42°C., equivalent to 2,400 centigrade
degree minutes, 41°C. standard, in a single
fraction, would be required for tumour cure in
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a sensitive tumour. From the Cortisol response
we did not consider it was feasibly possible
to carry out such a prolonged treatment. The
number of fractions required to build up to
this sort of dose would be large and the
treatment impractical. It was therefore
considered unethical to continue without the
addition of chemotherapy to the regime. All
patients treated since 1974 have received a
preliminary fractionated course of hyperthermia
alone, with a subsequent treatment giving
combined hyperthermia and cytotoxic drugs.
This sequence has produced greater remission
and, unlike hyperthermia alone, the tumours do
not recur in an insensitive form after three
months.
5.90 Hyperthermia alone produced a remarkable
sense of well being during periods of remission
with relief of tumour induced pain. This is
probably due to tumour shrinkage though,
hyperthermia has been shown to cause conduction
defects in nerves, the finer 'C" fibres trans¬
mitting pain impulses being the most responsive
(Young and Henneman, 1961). The great improvement
which was observed in the quality of life
possible after palliative treatment in a responsive
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A. PRINCIPLES OF LOCAL HYPERTHERMIA
6.1. Methods of temperature elevation in a part
of a body can be divided into those in which the
blood supply to the part is temporarily arrested
and those in which the blood supply remains
intact. The importance of the cooling effect of
blood flowing through vasodilated hyperaemic
tissue is reflected in the observation that the
temperature recorded by a thermometer situated
in tissue at a distance from a constant heat
source rises to a maximum and then falls off
to a steady reading. This fall in temperature
is due to the increase in blood flow caused by
reactive vasodilation (Rowel1, Brengelman et al,
1970). ,
6.2 Moritz (1947) found that with a skin
temperature of 45°C. for three hours the
temperature recorded at 2 mm. deep was 44°C.
There is therefore a large thermal gradient
(0.5°C. per mm.), with poor heat penetration.
Heat penetration may be improved by an increase
in the applied temperature. However, at
temperatures in excess of 44°C. there is little
difference between the effect on tumour and
normal tissues. 45°C. is the temperature at
which the sensation of heat is transfered to
that of pain in the human skin (Belehradek,
1957). This limits the maximum local
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temperature, temperatures above 45°C. cause
irreversible damage as a burn as oppossed to
heat stress and are painful. Such a limitation
gives a poor penetration from local external
heating extending over a few millimetres of
tissue before ineffective temperatures are
reached.
6.3 Heat penetration can be improved by
inhibiting the blood supply to the part, by
methods such as applying a tornequet to a
leg. The problem is then complicated by ischaemia
and time limitation. Technical aspects of
perfusion of the isolated limb brings its own
complications resulting from both the surgery
involved perfusion pressures used.
6.4 In this part of the thesis the methods
of inducing local hyperthermia are reviewed,
A trial of local hyperthermic perfusion of the
distended urinary bladder in the treatment of
transitional cell carcinoma was carried out.
It was hoped that by local pressure it would
be possible to reduce the blood flow to
the bladder sufficiently to allow heat penetration,
and by exposing the whole tumour, enable
curative therapy to be carried out.
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B. METHODS OF INDUCING LOCAL
HYPERTHERMIA'.
Short Wave Diathermy
6.5 In short wave diathermy, ultra high
frequency electrical currents are passed through
the body between two electrodes in contact
with tissue. Because the current has a
tendency to spread, its concentration per
square centimeter diminishes as the distance
from the electrode is increased (Schwan and
Piersol, 1954) . Heating is dependant on the
resistance of the tissue through which the
high frequency current passes. The resistance
of tissue depends on the relative amounts of
fat, water and electrolytes as well as cell
size and shape, which together make up the
dielectric properties of the tissue.
6.6 Fat and bone have very different dielectric
properties, and the heat which is developed per
volume unit of subcutaneous fat is greater than
that produced in deep tissues which have a
higher water content (Johnson and Guy, 1972).
This difference becomes less as the frequency is
increased but even at the highest practical
frequency of about 100 Mc.,fatty tissue is
heated more than muscle tissue (Schwan and Piersol,
1954) .
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6.7 Short wave diathermy was extensively used
in the treatment of gonorrhoea prior to the
advent of penicillin. Using a rectal, water
cooled, electrode and broad abdominal pads,
Herring (1953) reported achieving a prostatic
temperature of 46°C. Percy (1916) used local
diathermy at an open laparotomy to raise the
temperature of inoperable uterine carcinomas to
45°C. with good results. However, no
histological confirmation was given in his
reported series.
Heating by Probes Inserted into the Tumour
6.8 Heated probes suffer from an extreme
limitation of heat penetration. Single probes
have been used with limited success to
potentiate chemotherapy in the treatment of
gliomas of the brain (Sutton, 1971). Doss (1975),
implanted parallel needles at 1 cm. intervals
as a planar implant,and then produced eddy
currents by electromagnetic induction so heating
the tissue between the needles. Following eight
daily treatments of one hour at 45°C. he was
able to produce remarkable regressions,and a
cure rate in both animal and human squamous




6.9 Using circulatory high frequency currents
a changing magnetic field can be induced within
the tissue. The strength of the electromagnetic
field so induced is proportional to the current
passing. Heating is induced by eddy currents
formed by changing magnetic field, and is there¬
fore dependant on the frequency. Penetration
is influenced only by the magnetic properties
of the tissue and these do not vary within the
human body (Schwan and Piersol, 1954). Using
large circulatory currents at 27 megahertz
good penetration is possible but with the
available equipment the energy imparted would not
be sufficient to raise the thigh above 39°C.
(Guy, 1975). The equipment necessary to induce
greater heating is very expensive but is theoret¬
ically possible. Lower levels have been used in
the treatment of lymph nodes spread by injecting
a target material into the lymphatics (Gilchrist,1965).
Microwave Heating
6.10 Microwaves are produced in a magnetron by
accelerating electrons in a spiral orbit.
The frequency of rotation of the electrons is
related to the wave length of the electro¬
magnetic wave produced. The effects of electro-
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magnetic field produced as a wave passes through
the tissue are due to oscillation of the free
charges of ions and rotation of dipole molecules
at the frequency of the applied electromagnetic
energy (Johnson and Guy, 1972).
6.11 Microwaves are reflected at tissue inter¬
faces, such as fat/muscle or muscle/bone,
producing 'standing waves' by reflection.
Those 'hot' spots in the tissues with the
lower dielectric constants can be decreased by
using lower frequencies, than the standard 2450
megahertz, with a longer wave length. This
also gives an increased penetration (Johnson
and Guy, 1972). Even at 750 megahertz there
is scatter of microwaves by tissue and also
focusing of microwaves by round structures
producing hot spots.
6.12 Considerable use of microwaves has been
made in the treatment of human cancer, the most
recent of which is by Holt (1975). Some success
has been claimed for this method of treatment,
however, it has been used in conjunction with
other forms of therapy and no actual tumour
temperatures have been given. This is mainly
because of the difficulty of measuring
temperature in a microwave beam as any
metalic objects are heated. Recently crystal
thermometers have been invented which may be of
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use in this field. Effects of hyperthermia in
these cases are difficult to assess without
knowing the temperatures induced.
Heating by Ultrasound
13 Ultrasound is produced by very rapid
oscillation of a diaphragm. The sound waves
so produced are conducted through tissue and
generate heat by vibration of the tissue
through which they pass. There is preferential
heating of bone and bone marrow (Nelson,
Herrick and Krussen, 1950), and the temperature
of nerves rises to approximately twice that of
the surrounding tissue (Herrick 1953). Of
particular importance is reflection from
interfaces with hollow air-filled organs and
this severely limits the use of ultrasound.
14 It may have a particular use in the treat¬
ment of brain tumours' in that it can be well
localised,and there is an increased production
of heat in the tumour as compared with the
surrounding brain tissue (Lele, 1975). For this
procedure burr holes are required to remove the
bone prior to application of the ultrasound
beams. In other tissues distribution and
scatter appears too great to make it useful in
its present form.
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Vascular Perfusions with Heated Solutions
15 Hyperthermic perfusion of the hind limbs of
guinea pigs and cats had been carried out by
Kellaway and Rawlinson, 1944,who found that
damage occurred at temperatures above 45°C. and
43°C. respectively. Cavaliere, Ciocatto et al,
(1967), studied hyperthermic perfusion on the
dog's hind limb, and found that temperatures of
between 42 and 44°C. could be tolerated for two
hours without major damage. They then used the
same technique on human tumour bearing limbs.
In 22 patients with cancer of limbs,the
temperatures of the tumours was raised to between
41.5 and 43.5°C.,for several hours in 25
regional perfusions with pre-warmed blood
Cavaliere, Ciacatto, ;et al (1967). Nine further
patients were treated but severe complications
led to six deaths and three immediate amputations.
In ten of the surviving patients the tumours
completely disappeared,_however, three subsequently
recurred. Three patients failed to respond, four
could not be evaluated, and in five there was
evidence of tumour regression. Cavaliere's method
involved cannulating the main artery and vein but
did not isolate the limb from the general
circulation,and modifications had to take into
account toxic products absorbed during treatment.
16 In 1958 Creech, Krementz, et al reported
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their experience of perfusion of tumour bearing
limbs, isolated from the rest of the body by
tourniquet, with high doses of Phenylalanine
mustard. The rationale was to deliver a
high dose of the cytotoxic agent directly to
the tumour and its venous and lymphatic
drainage, in a dose which would be fatal if
administered systemically.
6.17 Stehlin, Giovalella et al (1975) combined
the two ideas, and,by isolating the limb were
able to perfuse it with a heated isotonic
_____ solution of melphalan. He has produced
remarkable regressions in melanoma treated in
this way. The advantages of this type of
perfusion are that as blood is not used
there is no need for systemic anti-coagulants.
The red blood cells are not broken down as
they could be using a combination of high dose
chemotherapy plus heatfand high dose chemotherapy
and hyperthermia can be used safely.
6.18 The disadvantages are in the complexity
of the method, requiring a skilled surgeon to
carry out the isolation of artery and vein. It
is necessary to have some pressure to drive the
circulation but at ordinary arterial pressure
there is congestion and development of a 'sick
limb' (Stehlin, 1975). The inflow pressure has
to be adjusted so the inflow and outflow rates
are exactly the same. The other problem which
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may be important is that, as with coronary bypass,
pulsatile flow is necessary for bypassing more
than two hours, Dalton, McCarty, et al, (1965).
It may be that pulsatile flow would decrease the
complication rate in local perfusion. Koops
(1972) has suggested that post perfusion oedema
induces ischaemia and recommends fasciotomy as a
routine decompression procedure prior to treatment.
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C. A NEW METHOD INVOLVING HYPERTHERMIC
PERFUSION OF THE DISTENDED URINARY
BLADDER UNDER EPIDURAL ANAESTHESIA.
Introduction
6.19 Previous methods of perfusion of the urinary
bladder did not involve distention. It was thought
that in the contracted state some of the tumour
would be shielded from the perfusate by folds of
normal bladder. This together with other factors
discussed later in the thesis prompted the present
study. The trial was carried out to assess the
effect of hyperthermic perfusion on the distended
urinary bladder and the tumour it contained.
6.20 All patients in this series had a biopsy
proven transitional cell carcinoma of the urinary
bladder, recurrent following radiotherapy, and
not controlled by cystodiathermy. Tumours were
Stage III, being palpable on bimanual examination
and had spread through the whole thickness of
the bladder wall into "the surrounding structures.
Most presented with gross haematuria, not
controlled by repeated cystodiathermy. One
patient was treated for gross haematuria due to
post radiotherapy telangiectasia.
6.21 Initially, single treatments of increasing
duration were given. Subsequently, fractionated
treatments were used and a comparison made
between the effects of perfusion with and without
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epidural anaesthesia. A total of 115 treatment
sessions in 28 patients have been carried out.
6.22 This section has not been divided into
material and methods followed by results as
each series was based on findings of the
previous study. The method used is basically
the same throughout but reasons for the
modifications and these modifications are
given at the beginning of each study.
Method
6.23 It was found that even slight bladder
distention proved uncomfortable, and, because
of the variation in flow rate, caused by inter¬
mittent bladder contraction the outflow temp¬
erature was difficult to control. Continuous
epidural anaesthesia allowed relaxation of the
bladder and a steady flow rate to be achieved
at a constant outflow temperature. Epidural
anaesthesia was achieved by introducing an
epidural catheter at the L4/5 level and feeding
it cranially for approximately two inches.
Anaesthesia was induced by intermittent
injections of 1.5% plain Xylocaine to achieve
anaesthesia up to the level of T10.
6.24 Under epidural anaesthesia the nature and
extent of the tumour was established by cyst-
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oscopy and bimanual examination. Biopsies were
taken from the tumour and from the normal
mucosa. The bladder capacity was measured, and
a 24F three-way Foley catheter introduced into
the bladder and inflated with 5 ccs. of warm
saline. The bladder was then washed out to
remove air bubbles or clots and perfused with
normal saline, heated by passage through a
heating coil which was inserted in the
water bath.
5.25 The outflow from the catheter ascended
over a gradient to an overflow tank (Figure 40).
The height of the overflow tank was adjusted
so that slightly less than the known bladder
capacity caused overflow. This was usually at
a height between 15 to 20 cms. above the
symphysis pubis. Patients were placed on an
X-ray table during treatment, and the degree
of bladder distention was monitored radio-
graphically by injecting a coloured solution
of radio-opaque medium into the perfusate and
taking check films (Figure 41).
6.26 • Thermocouples were used to measure inflow,
outflow and rectal temperatures. A further
probe was attached to the skin, one inch above
the symphysis pubis. In three patients a
further probe was inserted into the tumour
cystoscopically.
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6.27 Perfusion was at a constant rate of 3
litres per hour, the inflow temperature being
adjusted to give the required outflow temp¬
erature of 45°C. (Hall et al, 1974^ but
this caused lower abdominal discomfort and the
temperature was therefore reduced to 44°C.
which was well tolerated by all patients
(Figure 42). Three patients were treated at
an outflow temperature of 43°C. for four hours.
6.28 At the beginning of the perfusion there
was a rapid rise in outflow temperature
which remained stable providing the inflow
temperature was kept constant (Figure 4 3).
The rise in skin and rectal temperatures
depended to some extent on the size of the
tumour. It was greatest when the tumours were
infiltrating and extensive, rising to 40.5°C.
in such cases during the first two hours of
treatment.
6.29 At the end of the treatment session a Foley
catheter was inserted and left on free drainage
for 24 hours before removal. The effect of
treatment was assessed by cystoscopy, bimanual
examination and biopsies. These were initially
taken three days and two weeks after treatment,
and thereafter at six weekly intervals. In
later cases biopsies were also taken immediately










Method of hyperthermic perfusion of the distended
urinary bladder. The overflow height was
approximately 35 cms. above the table or 15 - 20
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Radiograph during hyperthermic perfusion showing
distention of the bladder and minimal reflux
in the left side.
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FIGURE 42.
A patient during hyperthermic perfusion of the
distended urinary bladder. The patient is
lying on an X-ray table to enable check films
of bladder distention to be taken.
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FIGURE 43.
Temperature graph during hyperthermic perfusion
showing a stable outflow temperature is maintained.
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a special assessment sheet was completed without
referral to previous assessment sheets, and a
drawing of the appearances of the bladder made
(Figure 44) .
Homgeneity of Heating
6.30 In three cases a probe was inserted into
the tumour cystoscopically. However, when the
bladder emptied as the cystoscope was withdrawn
the probe cable was forced down the urethra.
When the bladder was distended during treatment,
the probe pulled out of the tumour. The reading
on the probe was similar to that of the outflow
and at cystoscopy following treatment the probe
was found to be lying freely in the bladder.
It is therefore not-known when the outflow
temperature accurately reflects the tumour
temperature.
6.31 It was not possible to calculate this
treatment in terms of"centigrade degree minutes
as there was a temperature gradient across the
tumour. Treatment was therefore recorded in
terms of outflow temperature and duration of
perfusion.
6.32 As there is also a possibility of
incomplete circulation of the perfusate in that
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This sheet was completed at each cystoscopy. The
position of tumour was marked, if at the vault the
patient was treated on his side. Biopsy sites were
also marked.
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through the outflow hole of the Foley catheter
without circulating round the bladder, a plastic
bag was used to represent the bladder and dye
put into the infusate (Figure 45). Good
circulation of the infusate round the bladder
was found in repeated tests.
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FIGURE 45.
Serial photographs showing circulation of dye
during perfusion,under the same conditions as
used in the human bladder,showing good mixing
of infusate.
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SECTION 7. STUDIES CARRIED OUT TO
ASSESS THE SENSITIVITY
OF TUMOUR AND THE NORMAL
BLADDER TO HYPERTHERMIA.
A. SINGLE TREATMENTS OF INCREASING DURATION
UNDER EPIDURAL ANAESTHESIA.
B. FRACTIONATED PERFUSION UNDER EPIDURAL
ANAESTHESIA.
C. FRACTIONATED PERFUSION WITHOUT EPIDURAL
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D... - ELECTRON MICROSCOPIC AND THYMIDINE
UPTAKE STUDIES.
E. SINGLE TPEATMENTS UNDER EPIDURAL
ANAESTHESIA FOR THE ARREST OF GROSS
HAEMATURIA.
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A. SINGLE TREATMENTS OF INCREASING
DURATION UNDER EPIDURAL ANAESTHESIA
7.1 Using the method described,patients were
treated by gradually increasing durations of
treatment at an outflow temperature of 44°C.
Fifteen treatments were carried out in thirteen
patients, and the duration of perfusion varied
from 1 to 4 hours. In all of the initial
patients, gross haematuria was arrested but
slight haematuria persisted for up to one week
following treatment.
7.2 After treatment of one hours duration
there was no frequency. At cystoscopy the mucosa
appeared healthy and the bladder capacity was
not altered, there was however, residual
viable tumour present. These two patients had
recurrent haematuria in six weeks and required
further treatment (Figure 46).
7.3 After three hours at 44°C. there was
obvious tumour necrosis appearing at cystoscopy
as a grey-white slough which took up to two
months to separate from the mucosa. The normal
mucosa appeared red and inflamed and the bladder
capacity was reduced to between 150 - 200 mis.
There was no evidence of recurrent tumour
for three months, thereafter recurrent tumour
was found in all patients.
7.4 After four hours at 44°C. there was
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LOCAL BLADDER HYPERTHERMIA
COMPARISON OF CLINICAL RESULTS FOLLOWING DIFFERENT TEMPERATURE /
TIME COMB 1 NAT IONS
OUTFLOW TREATMENT DURATION OF
TEMP.°C TIME FREQUENCY EFFECT ON
HOURS WEEKS TUMOUR
44 1 NIL NIL
44 2 1 NIL
44 3 12 Clear 3/12
44 4 20 + Clear 5/12 +
43 4 6 SOME NECROSIS
FIGURE 46.
The effects of different durations of perfusion at
an outflow temperature of 44 C.
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prolonged and continuing frequency and at cysto-
oscopy the bladder capacity was reduced to
between 50 and 75 mis. The whole of the
bladder mucosa was covered with a grey-white
slough. Bimanual examination revealed an
indurated palpable bladder. Because of
continued frequency within this group urinary
diversions became necessary. Figure 47 shows
calcification in the fibrosed wall of the
bladder of one such patient. He remained fit
and well with no evidence of recurrent tumour
at 2 years post treatment.
7.5 Patients treated at an outflow temperature
of 43°C. for four hours had frequency and
cystoscopic findings equivalent to those treated
at 44°C. for two hours. The latter are recorded
along with those treated for gross haematuria by
0
treatment at 44 C. for two hours in a separate
section.
Hi s top atho1ogica1 Changes
7.6 The tumour biopsies taken before hyperthermia
were graded as described by Bergkvist (1965).
Six tumours were of Grade II, one of which was
invasive, six were Grade III, five of which were
invasive and one was Grade IV and invasive.
The effects of hyperthermia on the bladder vary
according to the interval after treatment.
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7.7 Changes seen in the transitional cell at
the end of treatment session consisted of
nuclear vacuolation, pyknosis, with vacuolation
of the cytoplasm and reduction of the
epithelial adhesion. These changes were
similar to those reported in the epidermis
after thermal injury (Moritz, 1947). Slight
changes were not easy to assess in a bladder
which was inflamed following hyperthermia and
had previously been subjected to radiotherapy
and repeated cystodiathermy. Severe effects were
easily recognised in both tumour and mucosal
epithelium and were often accompanied by
vascular connective tissue changes.
Effects of Hyperthermia on Bladder Tumour
7.3 No tissue necrosis was seen in tumour
biopsies taken after one houis perfusion at
44°C. The effects seen in biopsies taken
immediately at the end of the 3-4 hours
perfusion were often patchy. One part of the
tumour showing little change whilst another
showed complete necrosis.
7.9 Necrotic areas were accompanied by local
vascular changes such as necrosis and thrombosis
in the small vessels of the tumour and haemorrhage
into its stroma. These vascular changes may be
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FIGURE 47.
Plain radiograph of a patients pelvis six months
after hyperthermic perfusion at an outflow
temperature of 44°C. for four hours. The bladder
is outlined by phosphatic debris lining the
walls.
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responsible for some of the tumour destruction
since blood vessels are more susceptible to
thermal injury than is normal epithelium
(Moritz, 1947).
7.10 Necrosis manifested itself in two main
forms, either a ghost-like villi or in
distintegration of the tumour with disruption
of its cells (Figure 48). Three days after
perfusion for three to four hours, necrosis
was usually so advanced that it was difficult to
recognise tumour in the biopsy material.
7.11 Three of the tumours recurred after two
months or more and were of the same Bergkvist
(1965) grade as prior to treatment.
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Biopsy of transitional cell carcinoma immediately
after perfusion fgr three hours at an outflow
temperature of 44 C. Some villae in the lower
aspect of the illustration are ghost like whereas
some of the deeper layers appear normal.
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Effect of Hyperthermia on Bladder Mucosa
7.12 The normal mucosal epithelium initially was
considerably less affected than the tumour. Quite
marked changes however, occurred in the blood
vessels and connective tissue of the mucosa and
these led to additional changes in the epithelium.
The depth to which these vascular changes were
visible was related to the duration of the hyper¬
thermic perfusion.
7.13 Hyperthermia resulted in congestion and oedema
of the lamina propria with an inflammatory cell
infiltrate sometimes including numerous eosinophils,
Thermal effects upon blood vessels of the mucosa
led to exudation of plasma and occasionally to
interstitial haemorrhage. Some of the vessel walls
were frankly necrotic (Figure 4 9)(, and thrombi
tended to form (Figure 50).
7.14 These vascular changes exacerbated the direct
thermal injury of the lamina propria, sometimes
resulting in areas of necrosis with exfoliation of
epithelium and subsequent formation of hypervascular
inflamed granulation tissue, and a degree of fibrosis
usually followed (Figure 51). Regeneration of
epithelium was obvious in all biopsies taken two




Bladder wall three days after perfusion at 44°C.
for four hours showing vascular necrosis and




High power view of a stromal vessel showing
thrombosis in arteriole and venule three days
after perfusion at 44 C. for one hour.
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FIGURE 51.
Biopsy of the superficial muscle layer of the bladder
wall two months post perfusion at 44 C. for four
hours. This shows disorganisation and fibrosis of
the muscle coat with a diffuse inflammatory infiltrate
still present. The mucosa had entirely regenerated
but the patient had marked frequency with a bladder
capacity under anaesthesia of 50 cc.
19 9
B. FRACTIONATED PERFUSION UNDER EPIDURAL
ANAESTHESIA.'" '
7.15 From the previous studies it appeared that
under epidural anaesthesia that normal bladder
tolerance to hyperthermia at an outflow temperature
of 44°C. was one hour. However, from previous
studies on tumour and normal cell sensitivities,
assuming the whole tumour was at 44°C., the time for
total tumour destruction would be approximately
five hours. From Thymidine uptake studies it
appeared that 17 hours was required before the
mucosa cells fully recovered from a hyperthermic
episode. Fractionation was therefore done on a
daily basis. Initially, for five single treatments
each lasting one hour.
Method
7.16 The method used was as previously described,
the epidural catheter was left in situ over the
five days of treatment and local anaesthesia
induced by injection of 1.5% Lignocaine. After
four daily treatments the patients were cystoscoped
and the tumour and bladder assessed prior to giving
further hyperthermia. Three patients were managed
in this way, the first had a total of 5 , one
hour treatments, the second, 4 hours 40 minutes in
four fractions followed by a 2 hour fifth treatment.
The third had 5 hours in four fractions followed by
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a fifth single fraction of two hours.
Results
7.17 At cystoscopy on the fourth day following
four single fractions of at least one hour there
was a slight decrease in bladder capacity, the
normal mucosa appeared healthy and the tumour
obviously viable.
7.18 Following the fifth fraction of two hours
in the latter two cases there was seme tumour
---- necrosis appearing as white slough. Following
treatment the two patients who had a single
fraction of two hours at the end of their treat¬
ment had slight frequency lasting for one week.
Histology
7.19 There was extensive superficial necrosis of
the tumour, the tips of some of the villae were
totally necrotic and in other areas minute vessels
contained thrombi with haemorrhage into the stroma.
Most of the deeper portion of the tumour did not show
these changes and the basal portions appeared
relatively unaffected by hyperthermia.
7.20 The 'normal' bladder wall showed inflammatory
congestion, oedema and-infilltration by inflammatory
cells including eosinophils. No vascular necrosis
could be seen and the muscularis appeared normal.
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The charges were similar to those occurring after
a single fraction of two hours at an outflow
temperature of 44°C.
C. FRACTIONATED PERFUSION WITHOUT EPIDURAL
ANAESTHESIA.
7.21 Hyperthermic perfusion of the urinary bladder
without epidural anaesthesia is a simple procedure
which, after suitable instruction, can be carried
out by nursing staff. Five of the thirteen
cases treated in this way were managed mainly by
the nursing staff, under supervision.
7.22 Following the initial studies it was
thought that part of the problem of normal bladder
damage was due to the fact that patients had
previously had a radical course of X-ray therapy
(5,500 - 5,750 rads. to max in 20 fractions over
four weeks). Hall (1976) has shown by contrast
radiography that the bladder can be distended
and perfused without epidural blockade,and he had
been able to perfuse the bladder for periods in
excess of five hours as a single treatment without
subsequent side effects. The patients he perfused
had not received previous radiotherapy and in
order to assess this possibility a series of
patients were treated without epidural blockade.
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Method
7.22 The method used was the same as previously
described but the height of the overflow tank
had to be decreased to a maximum of five inches
suprapubically because of pain. All patients
were premedicated with Omnopon and Probanthine to
try and prevent bladder spasm. Initially,
patients were treated with- five daily one hour
fractions, at an outflow temperature of 44°C.
This was gradually increased to five daily fractions
of two hours at the same outflow temperature.
At the end of the treatment session the patient
was cystoscoped under general anaesthesia and
biopsies were taken of normal mucosa and tumour.
PesuluS
7.23 Patients tolerated this treatment extremely
well and were in little or no discomfort during
treatment as long as the overflow tank was not
raised. There was no frequency or side effects
following therapy. At cystscopy following treat¬
ment the bladder was only minimally inflamed and
of the same capacity as pre treatment. The tumour
did not appear to be affected and haematuria when
present was not arrested.
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Histology
7.24 There was little change in the pre or post
treatment biopsies. In post treatment biopsies
the muscularis appeared normal and the mucosa
was covered by transitional cell epithelium which
showed no sign of necrosis or even lesser thermal
damage. The collagen of the lamina propria appeared
swollen in some cases but this may have been due to
trauma of biopsy. There was no damage to the
larger blood vessels in any of the biopsies taken,
and no evidence of tumour necrosis was observed.
D. ELECTRON MICROSCOPIC AND THYMIDINE
UPTAKE STUDIES.
7.25 As a parallel study to the clinical findings
and to evaluate the importance of local ischaemia,
the normal epithelium and tumour were studied using
electron microscopic and thymidine uptake
techniques. Information on the ultra-structure and
histo-chemistry of the human bladder is very
limited (Brattifora, Eisenstein and McDonald, 1964).
The study was therefore limited to changes which
occurred in biopsies taken before and after treat¬




7.26 The bladder was filled with saline at body
temperature, rather than water at cystoscopy, and
immediately the biopsy was taken it was divided
in half. Half was sent for routine histology
the other half was transfered quickly into
Medium 199 (Gibco, Bio-cult). Sections were
then cut for fixation for electron microscopic
study, or thin tissue slices exposed for varying
o 14
time intervals at 44 C. then incubated with C
Thymidine for one hour. Excess Thymidine was then
washed off, and the tissues fixed. A layer of
photographic emulsion was poured over the section
and auto radiographs obtained.
Results
7.27 In vivo and in vitro incubation at 44°C. for
four hours caused tumour necrosis with loss of
intracellular constituents and lysis of lysosomes
(Figure 52,53). The normal mucosa both in vivo
and in vitro appeared resistant to this degree of
hyperthermia. To further study the effect on the
vascular epithelium thin tissue slices from the
deeper parts of the biopsies were incubated with
Thymidine. There was no inhibition of Thymidine
uptake by the vascular epithelium after four hours
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exposure at 44°C. (Figure 53).
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FIGURE 52.
Electron micrograph of part of a cell of a transitional
cell carcinoma from a biopsy taken immediately before
perfusion at 44 C. It shows a cell formed endoplasmic
reticulum and nuclear membrane. Similarly the mito¬




Biopsy of transitional cell carcinoma taken
immediately after perfusion at 44°C. for three
hours. There is a loss of definition of the endo¬
plasmic reticulum, the mitochondria are swollen
and disorganised and numerous large lysosomes have
appeared. The black specks are glycogen granules.
These changes were also found aftgr incubation of
transitional cell carcinoma at 44 C. but not in
the normal mucosal cells so treated.
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Thymidine uptake autoradiograph of a vascular
endothelial cel^ from a stromal arteriole
incubated at 37 C. for one hour.
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FIGURE 55.
Thymidine uptake autoradiograph of a vascular
endothelial cell from the same biopsy as Figure
54,bu^ a thin slice of this tissue was incubated
at 44 C. for four hours prior to incubation
with tritium labelled Thymidine at 37 C. for one
hour. There was no inhibition of Thymidine
uptake.
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E. SINGLE TREATMENTS UNDER EPIDURAL ANAESTHESIA
FOR THE ARREST OF GROSS HAEMATURIA.
7.28 Early in the initial series it was realised
that patients with gross haematuria stopped
bleeding following hyperthermia. This was due to
the heat induced vascular damage in the vessels
of the bladder wall. Following two hours at an
outflow temperature of 44°C. there was some
frequency which settled after two weeks. This
treatment fraction was therefore chosen for the
treatment of gross haematuria in that it was the
maximum dose which caused vascular damage but did
not cause significant bladder contraction.
Method
7.29 The method used was as in the original series.
Under epidural anaesthesia the bladder was perfused
at an outflow temperature of 44°C. for two hours
using a distention height of approximately 20 cms.
suprapubically.
7.30 Nineteen treatments were given to twelve
patients with gross haematuria, in eleven the
haematuria was due to recurrent tumour and in one
to post radiotherapy telangiectasia. Five patients
were treated twice as the first fraction was
unsuccessful, one patient was treated three times.
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.31 In three patients it was not possible to
arrest the haematuria. In eight patients the
haematuria was arrested for between six weeks
and six months, after which time all patients
with tumours had recurrent haematuria. The one
patient treated for post radiation telangiectasia
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A. METHODOLOGY OF LOCAL HYPERTHERMIA
8.1 Heat is an ubiquitous form of energy and many of
the problems in localised hyperthermic therapy arise
from the difficulty in keeping the heat energy in
one place. Short wave diathermy relies on the
electrical resistance of tissues through which the
current passes. Unfortunately tissue resistance
varies with water and fat content and make
uniform fields very difficult to achieve. Microwave
and ultrasonic therapy is also limited by reflection
and refraction in tissues of differing density. The
most uniform beam is produced by a very rapidly
changing magnetic field. This creates heat by
inducing eddy currents and can penetrate tissue
evenly because the magnetic properties of tissue
do not vary within the human body. .
8.2 If such a beam could be positioned at right
angles to the plane of a megavoltage X-ray therapy
beam a completely variable system could be
envisaged. The electrons liberated by photons in
the X-ray beam could be accelerated by the charging
magnetic field thus altering the effective linear
energy transfer in the tumour volume. By varying
the heat production, the degree of thermal stress
could be changed as could the radiation dose. There
is therefore a system which could be tailored to
any particular tumour sensitivity with an infinitely
variable degree of heat or X-ray damage,and control
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of the ability to repair sub-lethal damage.
8.3 Perfusion of a limb isolated from the rest
of the body is simple and relies on well known
surgical techniques. It has several disadvantages
in that is is difficult to give repetitive
treatments. A curative dosage has to be given
in a single treatment and the normal tissues are
therefore pushed to the limit with the
resulting 'sick limbs' (Stehlin, 1975).
8.4 Perfusion of hollow organs such as bladder
or bowel are simple and do not require major
invasive surgery, and the progress and results
of such therapy can be observed endoscopically.
These features are particularly applicable to
the urinary bladder as a considerable amount of
work and assessment is done endoscopically in
this organ.
B. HYPERTHERMIC PERFUSION OF THE HUMAN BLADDER
8.5 Transitional cell carcinoma of the urinary
bladder tends to remain localised and spread mainly
by local invasion. In view of the discouraging
results following total cystectomy for invasive
carcinoma (Whitmore and Marshall, 1962), and the
ease with which local hyperthermia can be induced
by perfusion it is not surprising that several
attempts of this form of treatment have been made.
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Local hyperthermic irrigation through a three-way
Foley catheter has been used either alone (Hall,
Schade and Swinney, 1974) or to enhance the
effects of radiotherapy (Cockett, Kazmin, et al,
1967), or chemotherapy (Lungl-mayr, Czech et al,
1973), all with some success but in general
disappointing results.
8.6 In each of these series the undistended
urinary bladder has been perfused. In the
contracted state the bladder form folds of mucosa
which might shield the tumour from the full
effects of hyperthermic perfusion. Distention
of the bladder causes full exposure of the
tumour and increases the area available for
heat exchange
8.7 Holden and Gurne (1931) using the Elliot
technique in the treatment of gonorrhoea, which
involved inserting a bag into the vagina which
was then distended and perfused with heated water,
reported achieving temperatures of 40°C. in the
urethra and 41°C. in the anterior rectal wall.
8.8 The present studies were undertaken to
assess the validity of hyperthermic perfusion as
a treatment in localised cancer of a hollow organ,
and to attempt to estimate the depth to which a
therapeutic temperature would penetrate.
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C. ADVANTAGES OF THE NEW METHOD
8.9 The method of hyperthermic perfusion of the
urinary bladder has several advantages over
normal perfusion techniques. The apparatus is
simple comprising of a drip giving set, a blood
warming coil, a paediatric suction trap with a
hole bored in the bottom as the overflow tank,
a three-way Foley catheter, and a water bath.
Distention of the bladder ensures all the mucosa
is exposed to the perfusing solution.
8.10 By distention the area exposed for
absorption of heat is increased and the thickness
of the bladder wall decreased. The pressures per
unit area of the bladder wall is related to the
height of the overflow tank, and to the bladder
capacity. The area exposed increases as a cube
power of the radius, as does the pressure per unit
area of bladder wall. At full distention this
pressure is balanced by -the inelastic fibrous
coverings of the bladder. Blood vessels are compressed
between these two forces and the resultant
resistance to blood flow is related to systemic
blood pressure and the pressure in the bladder
wall. As blood flow is decreased the rate of
heat dissappation by blood flow is decreased and
conduction through tissue increased. There is
therefore greater heat penetration using perfusion
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of the distended bladder.
8.11 Muscle tone is absent under high epidural
anaesthesia and, as there are no bladder
contractions, a steady state of flow is easily
achieved. Using a model bladder good and even
mixing of the inflowing heated saline was
observed.
8.12 The method suffers from any method in
which the treatment is applied to one surface
in that there is a heat gradient across the
tumour. It was hoped that as tumour blood
vessels do not vasodilate, the heat conduction
would be great enough through the tumour to
enable therapeutic temperatures throughout the
tumour to be achieved. As the deeper parts of
the tumour are intermingled with hormal blood
vessels which would dilate, we did not expect
complete cure, but hoped to.,be able to destroy
the tumour bulk leaving a viable rim which could
be treated by local diathermy.
Normal Bladder Sensitivity
i
8.13 By increasing single fractions of hyperthermic
perfusion using an epidural anaesthetic, repeatably
effects on tumour and'normal' mucosa were achieved.
The transitional epithelium did not appear markedly
heat sensitive, however, by decreasing the blood
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flow there were two additional factors which were
not expected. The xirst was local iscnaemia and
nutritional deprivation sensitising the vascular
endothelium to heat damage. The second was
physical trauma by compressing vessels and
stretching muscle fibres. These factors are
assumed to explain the sensitivity of the bladder
wall to hyperthermic perfusion during distention.
8.14 A sensitivity graph could be drawn
starting with little or no damage up to one
hour, then increasing damage with total destruction
and fibrous replacement of the bladder wall after
four hours treatment at an outflow temperature of
Q
44 C. From the graph of tumour sensitivities
(Figure 38 ), approximately twenty hours at 42°C.
or five hours at 44°C. would be required for
complete tumour destruction. This was not possible
in a single treatment at an outflow temperature of
44°C. without destroying the normal bladder.
8.15 In view of the limiting sensitivity of the
vascular endothelium, three patients were treated
at an outflow temperature of 43 G. This meant that
the heat penetration would be less and that 10
hours would be required for tumour cure. After
four hours at 43°C. there was frequency for two
weeks but little damage to tumour or normal
vasculature. It was therefore apparent that it
was not distention alone, but a combination of
hyperthermia and distention which caused the limiting
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vascular damage. Eventual regeneration of the
transitional epithelium "occurred in all cases.
E>. FRACTIONATED PERFUSION
8.16 A decrease in the inflow temperature had
the disadvantages of a poorer heat gradient
across the tumour, all of which were T3
extending outwith the bladder wall. After approx¬
imately four hours the quantities of Lignocaine
required to maintain the high epidural blockade
produced some toxicity due to systemic absorption.
It was considered that the possibility of treating
a patient for ten hours at 43°C. was not really
feasible. Fractionation of the treatment into
single hourly treatments at daily intervals would
enable time for tumour cells to regain sensitivity
and treatments might summate unlike the whole
body treatments at weekly intervals which did not.
8.17 A planned radical course of therapy of
five daily one hour treatments was therefore
started. After four such fractions, the patient's
symptoms of frequency were sl_ight but the
possibility of summation equivalent to four hours •
o
at 44 C. in a single treatment was present. The
patients were therefore cystoscoped at this
stage to assess the degree of bladder damage.
8.18 There uas no evidence of summation and the
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bladder mucosa appeared as following a single
fraction of one hours duration. Microscopical
sections taken from the patients at this stage
confirmed the clinical impression of no summation
during daily fractions. The overall quantity
of damage was equivalent to one hours perfusion
at an outflow temperature of 44°C.
8.19 Fractionation has been shown to summate to
some degree in tissue culture work (Robinson, 1976),
but the time between fractions has been of the
order of 1 - 2 hours. This is in contradiction to
the previous work which showed that following a
first exposure to heat, the cells remain resistant
to further therapy for a period of up to 17
hours. It may be explained on the basis that,
though cell killing is less on a percentage basis,
there is an increase in overall cell death which
does not occur if sufficient time is left between
fractions for complete cellular recovery.
8.20 Our results would indicate that, in vivo,
subsequent fractions have to be of a greater degree
than previous ones to cause any further tumour
necrosis. Multiple fractions within one or two
hours of heat other may cause summation but allow
some recovery of normal cells. This possibility
has still to be explored, but single fractions at
daily intervals did not summate.
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Fractionated Perfusion without Epidural
8.21 It was believed in this thesis, that hyperthermic
perfusion without epidural or general anaesthesia
could not be effective. This was because the
bladder left with its sensory and neuromuscular
reflexes intact, would react to the irritation of
local heat by contracting, so decreasing the area
for heat absorption, increasing the thickness of the
wall and the blood flow per unit area of mucosa.
Further, any locally heated area would cause a
local contraction of the wall pulling the irritated
area out of the heated saline. The mucosa exposed
would therefore be constantly changing. This
arrangement might explain the unpredictable
results which Dr. Hall (1376) was getting with his
method,and the fact that he was able to perfuse
bladders at an outflow temperature of 45°C. for up
to six hours with no residual frequency or side
effects.
8.22 It was possible, that by using our method of
distention, along with Probanthine to block the
neuromotor fibres to the bladder and opiates to
decrease pain, that sufficient mucosa should be
exposed to allow treatment to superficial lesions.
Without epidural anaesthesia the method becomes
very simple and easily managed by nursing staff.
A further reason for starting a trial of hyper¬
thermic perfusion without epidural anaesthesia,
was the possibility that the sensitivity that we
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had experienced with epidural anaesthesia was due to
bladder damage following the previous radiotherapy,
which all our patients had received. The results in
this series agree with those of Hall et al (1974) that
no frequency or bladder damage,as confirmed by
microscopical review of biopsies taken at the end
of treatment, is caused by even prolonged therapy
without epidural anaesthesia.
8.23 The degree of distention and tone of the
bladder, and an active autonomic system,was therefore
very significant in altering the effects of a seemingly
similar treatment. The possible explanation was
that either the thermal gradient was so slight in
perfusion without epidural as not to effect the
vascular endothelial cells, or that the damage to
the endothelium was due to pressure, heat and
ischaemia combined.
8.24 Thymidine uptake studies on the transitional
cell epithelial cells and vascular endothelial
cells were carried out to establish the mode of
sensitivity. In vitro studies by incubation of the
cells at 44°C. for four hours confirmed that the
tumour cells were more sensitive than the normal
transitional cell epithelium to hyperthermic
stress. There was no inhibition of Thymidine uptake
in the cells of the vascular endothelium after
incubation at 44°C. for four hours. The vascular
endothelium was therefore not greatly sensitive to
hyperthermia alone but was sensitised by the
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the ischaemia, pressure and trauma induced by the
method in association with hyperthermia.
E. HYPERTHERMIC IRRIGATION FOR THE
ARREST OF GROSS HAEMATURIA.
25 By limited application of hyperthermic
perfusion of the distended bladder under epidural
anaesthesia,it was possible to cause thrombosis
in the superficial vessels which were bleeding.
This principle has been used by surgeons for
many years in the form of a hot pack to arrest
bleeding. It was found that complete anaesthetic
was required to the umbilicus (T10), and a perfusion
for two hours with an outflow temperature of
44°Ceffectively arrested bleeding without
causing lasting frequency. Patients who failed to
stop bleeding all had markedly reduced bladder
capacities/ and in those patients the pressure
achieved in the bladder wall was presumably insufficient





9.1. Fever therapy has produced some cures in
advanced human cancer, but this form of therapy
is unpredictable and acts in at least three
different ways:-
a. By direct effect of heat suggested by
the finding that the group with the
highest degree of fever had the greatest
remission rate.
b. By stimulating the immune response to
act effectively against the cancer cells.
c. By direct toxic effect of the bacterial
endo and exotoxins on the cancer cells.
Which of these possible mechanisms is the most
important is not known but chemotherapy, immunotherapy
and, more recently, heat stress, have all been used
individually in the treatment of cancer.
9.2 The effects of hyperthermic stress have been
studied by animal and in vitro work which shows
that some tumours are markedly more sensitive to
hyperthermic killing than their normal counterparts,
other tumours are more resistant. Most cellular
functions were affected by heat stress to an amount
related to the heat sensitivity of the process
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studied and the degree of heat stress to which it
was subjected.
9.3 Inhibition of oxygen uptake occurred at
temperatures above 40°C. in some sensitive tumours
and was due to uncoupling of the cytochrome chain
with leakage of cytochrome 'C' from the mitochondria.
DNA synthesis was inhibited and fragmentation of
existing DNA occurred after prolonged heat stress.
The nucleolus and RNA synthesis were shown to be
particularly sensitive, with failure of formation
of active messenger or transfer RNA, and lack of
subsequent transport to the ribosomes. Disaggregation
of existing ribosomes further decreased protein and
enzyme synthesis in the cytoplasm.
9.4 Observations on the cell cycle showed that
there was recruitment of quiescent Go cells into the
cycle, those remaining in the Go phase were the
most resistant to hyperthermia. Cell killing was
greatest in the sS' phase but cells were also
arrested and killed in metaphase. Drugs which
blocked DNA synthesis were either protective, or
at best, additive to heat therapy, whereas those
affecting RNA synthesis potentiated the lethal
effects of hyperthermia.
9.5 Membrane permeability increased and was due to
a change in the crystalline state of the lipo¬
protein complexes forming the cellular reticulum.
This allowed passive leakage of labelled material
across the membrane. Such leakage of lysosomal
enzymes, already activated by the decreased pH of
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the anaerobically respiring cells, might explain
the rapid destruction and absorption of cellular
breakdown products reflected in our study. These
products would cause fibrin deposition, and, in
large amounts could precipitate the disseminated
intravascular coagulation state that occurred in
some patients. The passive transfer of cytotoxic
drugs across these damagedmembranes has been
shown to occur and may have an important part to
play in future chemotherapy of heat sensitive
tumours.
9.6 Inhibition of cellular repair systems
following hyperthermia might be due to:-
a. Enzyme usage without replacement.
b. An increased rate of degradation of
existing enzymes.
c. Lack of energy in the form of ATP
to 'drive' the repair system.
d. Alteration in the quaternary structure
of the enzyme, so rendering the 'active
site' impotent.
9.7 It was concluded that cellular death
following hyperthermia was due to a combination of
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damage to nucleic acids, degradation of existing
protein with alterations in lipo-protein complexes
forming in the cell wall. These changes together
with a decreased rate of energy production and
inhibition of repair combined cause cellular
death. It is probably that different factors are
relatively more important in different cell lines.
9.8 Thermal 'tolerance' can be induced in cell
cultures by repeated exposure to sublethal doses
of hyperthermia. This also occurred following
whole body hyperthermia, recurrent tumours proved
resistant to further hyperthermia. Fractionati.on
of heat stress was dependant on the survival curve
of the tumour as compared with that of the most
sensitive normal tissue subjected to heat stress.
Above a critical temperature, which was individual
for a particular cell "dine under specific conditions,
there was a linear relationship for heat stress
between temperature and time. In this range for
each 1°C. rise in temperature the time required to
produce the same effect was halved. The Centigrade
degree minute was adopted in this thesis as the unit
of heat stress and was defined as the time
equivalent at 1°C. above the critical temperature
for a specified cell system under specified
conditions required to produce the same degree of
thermal stress in that system.
9.9 For whole body hyperthermia a critical
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temperature of 40°C. was assumed for all tumours
and heat stress worked out in terms of centigrade
degree minutes, 41°C. standard. It was concluded
that other suggested units such as the 'Thermal
Enhancement Ratio' (Robinson and Wizenberg, 1974)
were insufficient to characterise the degree of
heat stress to which a system is subjected as it
does not state temperature, time and critical
value of the system. The centigrade degree
minute could be modified by potentiation factors
and allowed for variations in temperature during
treatment.
9.10 Animal studies confirmed the in vitro
findings that there was a selective lethal effect
of heat on some tumours. These animal studies
were carried out using superficially transplanted
tumour which could be,heated by local methods,
such, as by immersing a tumour bearing limb in a
heated solution. It was found that with the
exception of a few very sensitive tumours it was
not possible to cause 100% tumour necrosis
without loss of the limb. At temperatures above
44°C there was no difference in the rate of
cell death between tumour and normal tissue and a
temperature of 44°C. therefore represents an
absolute maximum for any form of hyperthermic
therapy. An animal model for whole body hyper¬
thermia was difficult to achieve as most animals
are very sensitive, the normal laboratory animal
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the mouse, having a 90% mortality atter one hour at
Q
a rectal temperature of 41 C. Man was shown to be
tolerant to thermal stress when used in the
treatment of venereal disease in the 1940's.
9.11 Controlled whole body hyperthermia in man
by means of immersion in a bath of molten wax
proved an effective, cheap and reliable method
of rapidly elevating the body core temperature.
Introduction of an epidural anaesthetic had the
advantages of an early vasodilatation, so
increasing the initial rate of heat absorption,
a decreased need for systemic opiates and
sedatives so -that patient's woke up quickly after
treatment, and control of heart rate by blockade
of the sympathetic outflow to the heart. By
leaving the. epidural in situ for 2 4 hours it was
possible to use it for post treatment sedation.
Ventilation conserved the energy of already weak
patients, and by heating the inspiratory gases . it
was possible to compensate for some of the heat
lost by the latent heat of evaporation of water in
moisturising the ventilating gasses in the lungs.
The method allows for ease of control of body
core temperature by varying the area of skin
exposed for the evaporation of sweat. Safety is
ensured by ease of access to the patient and
continuous monitoring of vital functions.
9.12 Without epidural anaesthesia there were some-
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times alarming rises in the heart rate to over
150 beats per minute. With epidural anaesthesia
there was rarely a count greater than 130 beats
per minute. It was concluded that the use of
epidural anaesthesia was a significant factor in
the safety of the method.
9.13 Fluid and electrolyte losses and
replacements were great during hyperthermia but
by using a standard regime it was possible to
keep plasma electrolyte concentrations within
normal limits. Besides the electrolyte and sugar
infusions it was found necessary to infuse plasma
at 41.8°C. to avoid a fall in blood pressure due to
expansion of the vascular bed. As the regime is
standard it was concluded that renal and sweat
functions may be able to balance minor degrees
of fluid and electrolyte changes during, hyperthermia.
9.14 Liver function was the factor limiting the
maximum treatment temperature for whole body
hyperthermia. Above 42°C. there were changes in liver
function tests with an_ increase in bilirubin
concentration and changes in liver biopsies
suggestive of damage (Wills, Findlay and McManus,
1976). At temperatures below 42°C. these changes
did not occur and a temperature of 41.8°C. was
therefore adopted as the maximum safe therapeutic
temperature, leaving a 0.2°C. safety margin.
9.15 Plasma Cortisol and ACTH levels showed an
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fall due to inhibition of production. Subsequently
there was a rise in the plasma ACTH level followed
by a steep rise in plasma Cortisol. Prolonged
treatment resulted in a further rise in both
plasma ACTH and Cortisol levels suggesting increasing
stress to the body.
9.16 The white blood count was found to rise
during hyperthermic therapy. This has been shown
to occur in other forms of pyrexia and appears to
be a non specific response of immature polymorphs.
No significant depression of the bone marrow was
found following hyperthermia, and there was a
reticulocytosis between treatments suggestive of
an active marrow. It was concluded that the treat¬
ment fractions given were not large enough to
affect this system.
9.17 - t Treatment fractions were limited by the
induction of disseminated intravascular coagulation
due to the breakdown and rapid absorption of
sensitive cells. This was reflected by platelet
consumption, and in morf serious cases, by a rise
in fibrin-fibrinogen degradation products. Division
of treatment into increasing fractions was
necessary to prevent- the occurrence of intravascular
coagulation, especially in patients with sensitive
tumours. A first fraction of less than 300 C.° mins.
(250 for very extensive tumours) with an increment
of 200 C° mins. for each subsequent treatment was
given. Intravascular coagulation was only treatable
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by infusing clotting factors and platelets as
heparin caused bleeding into the hyperdynamic raw
tumour beds.
9.18 Viral studies using antibody titres
before and ten days post treatment showed no
change. Similarly there was no significant changes
in immunoglobin levels following hyperthermia.
It was concluded that these tests were not
sufficiently sensitive and further studies on the
immune status following treatment have been
•under taken by Mr. A. ?. Gee.
9.-19 The clinical results of whole body hyper¬
thermia were difficult to assess with regression
of disseminated disease being the main criteria
%
Previous case notes were often inadequately
documented, and there were too few cases in any
one group to assess the true palliative
potential of the treatment-. Patients were
divided into broad groups with a view to selecting
sensitive groups for further therapy. Tumours of
gastro-intestinal origin- especially colon, and
sarcomas appeared to show" the greatest response.
Lung tumours, and malignant melanomas showed an
intermediate response and there was no response
in the genito-urinary tumours treated. Testicular
and ovarian neoplasms showed no response whatever
to hyperthermic therapy. Palliation in the form
of tumour regression, relief from tumour induced
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pain and general increase in the quality of life
was achieved in a number of patients.
9.20 Tumours showing a favourable response to
hyperthermia recurred after approximately three
months in a heat resistant form and little or
no tumour regression was achieved by treating
those recurrences. It was concluded that hyper¬
thermia alone offered a good palliative treatment
for some sensitive tumours but that this remission
was short lived.
9.21 Therapy with increased fractions for 20
hours as a single treatment would be required for
tumour cure and this was not feasible. The
possibility of decreasing this time by using
whole body hyperthermia to potentiate systemic
chemotherapy is an exciting possibility. In our
limited experience there have been some very good
regressions using this combination and the tumours
do not become resistant to the combined therapy.
9.22 The complications following treatment were
few, and only one death occurred during hyperthermic
therapy. Fractionated treatment has removed the
chance of disseminated intravascular coagulation
occurring and v/ith the present fluid replacement
regime the method is safe. Minor complications
include sore throat, pressure sores on heels and
head, and circumoral herpes simplex in 50% of
cases.
9.23 Local hyperthermic perfusions have the
disadvantage of a heat gradient across the tumour.
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This gradient can be minimised by decreasing the
effect of blood flow cooling by inhibiting blood
flow. Blood flow can be limited in limb
perfusion by use of a torniquet, or in the
method described for hyperthermic perfusion of
the bladder, by pressure in the bladder wall.
Inhibition of blood flow causes deficiencies
of oxygen and nutrients to the cells and
increases their sensitivity to hyperthermia.
9.24 The method used for hyperthermic perfusion
of the distended urinary bladder under epidural
anaesthesia has the advantages of exposing the
whole epithelium to the perfusing liquid. It
was cheap and easy to set up,and by using a
contrast flow rate, it was easy to maintain a
steady state with a stable outflow temperature.
The results showed that a predictable degree of
damage to tumour.and normal mucosa followed each
increasing fraction of hyperthermia. Because
there was a thermal gradient across the tumour
and bladder wall it was"-not possible to express
the results in terms of thermal stress (centigrade
degree minutes).
9.25 The thermal gradient was less across
extensive tumours indicating a limited capacity
for increased blood flow through tumours. In
extensive tumours the skin or rectal temperatures
rose as high as 40°C. In tumours not invading
the tissue adjacent to the thermometer, skin and
rectal temperatures were nearly normal.
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9.26 Side effects of treatment were preportional
to the duration of perfusion and were due to the
damage caused to the bladder wall by ischaemic
necrosis of the superficial layers of the muscle
coat. The limiting factor was not the epithelium,
which in vitro proved remarkably resistant to
hyperthermia, but the sensitivity of endothelial
cells lining the blood vessels. Damage to the
blood vessels was caused by a combination of heat,
pressure, and ischaemia and resulted in vascular
thrombosis and ischaemic necrosis of the muscle
layer supplied by affected vessels. This was
minimal after one hours perfusion at an outflow
of 44°C., but after four hours perfusion the
subsequent ischaemia resulted in contracted,
fibrosed bladder with a 50 cc. capacity.
9.27 Tumour necrosis following hyperthermic
perfusion was related to the duration of treatment.
All cases treated were T3 tumours extending to
the pelvic wall. The conduction was not
sufficient to cause complete tumour necrosis,
residual tumour presenting later as recurrent
tumour. The period of relief from symptoms varied
with the degree of treatment. All tumours
treated eventually recurred except for two treated
at 44°C. for four hours. Both of these men have
had urinary diversions and no further symptoms.
9.28 Fractionated therapy was tried in an effort
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to over come the normal tissue sensitivity to
hyperthermic perfusion. Daily fractions did not
suxnmate and the tumour and tissue damage was
equivalent to the longest single fraction to
which they had been exposed. For summation of
fractionated therapy the gap between fractions
would have to be considerably reduced.
9.29 Fractionated therapy without epidural
anaesthesia produced no effect in either tumour
or the normal mucosa. This was thought to be
due to self protection from noxious stimulae
by the bladder epithelium which contracted out
of the perfusate, so constantly exposing a
different part of the epithelium. It was
concluded that only by paralysing the normal
reflex controls of the bladder could a predict¬
able effect be achieved by hyperthermia alone.
Perfusion without epidural anaesthesia is
unlikely to penetrate more than a few millimetres
of tissue.
9.30 To check the sensitivity of the three
major tissues of interest, that is the normal
mucosa, transitional cell carcinoma, and vascular
endothelial cells, to hyperthermia alone Thymidine
uptake studies were carried out following incubation
in vitro at 44°C. This showed that neither the
normal epithelium nor the vascular endothelial
cells were killed after incubation at 44°C. for
four hours whereas there was considerable necrosis
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in the transitional cell carcinoma. This study
confirmed that the vascular damage was not due
to heat alone and that the tumour was intrinsically
sensitive.
9.31 It had been noticed that during treatment
under epidural anaesthesia there was arrest of
gross haeraaturia. After two hours perfusion at
44^C. there was no lasting frequency though
there was some degree of vascular thrombosis in
the deeper layers of the bladder. Two hours at
44CC. was therefore chosen as a treatment for
gross haematuria and was successful if the
bladder was not contracted and the epidural
produced satisfactory anaesthesia.
9.32 The present method of hyperthermic perfusion
of the distended urinary bladder under epidural
anaesthesia produced reproduceable damage to both
tumour and normal mucosa. Single fractions
capable of causing tumour necrosis to any useful
depth also caused ischaemic fibrosis of the
bladder wall. Fractions of treatment at daily
intervals did not summate, and it may be possible
to allow recovery of the normal epithelium by
fractionating at shorter time intervals^ which
may cause an increasing effect on the tumour.
Local perfusion can only be curative in
superficial tumours as the heat gradient does not
penetrate more than a few millimetres. In this
239.
it may be of use in potentiating existing local
chemotherapy such as epodyl instillations.
9.33 The future of local hyperthermia is its
use to potentiate either local chemotherapy or to
localise systemic chemotherapy to the tumour
volume but may also be used to potentiate the
effects of localised radiotherapy. Other methods
of inducing local hyperthermia, in particular
a rapidly changing magnetic field, have great
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Patients Treated by Whole Body Hyperthermia
This table is a summary of the patients treated
by whole body hyperthermia and lists their disease,
previous treatment, the quantity of heat stress that
they were given and the clinical results of therapy.
It is added to the text to illustrate the difficulty
in assessing the results in a totally new form of
treatment.
In this series patients were treated in-
differing stages of terminal cancer with varying
heat fractions judged on clinical state alone. Only
late in the series was fractionation employed.
Patients with sensitive tumours treated for
prolonged periods tended to develop complications.
Only be establishing the maximum safe therapeutic
temperature together with the use of the centigrade
degree minute (4i°C. standard), to fractionate
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NAME AGE DIAGNOSIS SURG XRT CHEMO
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Yes Yes No 300 No Yes Yes No Lung met
disappeared
R 21
L.M. 35 Lymphosarcoma Yes Yes Yes 330 Yes Yes Yes No Healing of
Path fracture
R 20
L.W. 24 Lymphosarcoma Yes Yes Yes 100 No Yes Yes
- - R 1 week
K.C. 54 Liposarcoma Yes No No 420 No - D.I.C. Extensive Tumour
Necrosis
" R 1 day
F.D. 3 Rhabdomyosarcoma Yes Yes Yes 350 No " " " " NR 2 days
J.M. 41 Osteogenic
sarcoma
Yes No No 450 Yes Yes No No No NR 21
T.K. 37 Osteogenic
sarcoma
Yes Yes No 830 Yes Yes No No No NR 24
W.K. 54 Fibrosarcoma Yes No No 150 No Yes No No No NR 1
A.B. 56 Stomach Inoperable No No 120 No Yes Yes No No R 3
A.H. 61 Stomach Yes No No 260 No Yes Yes No No R 4
A.M. 52 Stomach Yes No No 520 No - D.I.C. " Extensive Tumour
Necrosis
R 1
T.M. 69 Stomach Inoperable No No 240 No " Yes No No R 1.5
J.S. 65 Colon Inoperable No No 250 No Yes Yes No No R 5
E.S. 51 Colon Yes No No 180 No Yes Yes No No R 5 days
R.P. 67 Colon Yes No No 100 No Yes Yes No No R 3
A.P. 51 Rectum Yes No No 280 No Yes Yes No No R 3 weeks
W.C. 61 Colon Yes No Yes 135 No No No No No NR 2
E.M. 62 Colon Yes No No 425 No Yes Jaundice No No No NR 3
A.S. 55 Rectum Yes No No 570 No No No No No NR 1
J.L. 40 Melanoma Yes No No 103 No Yes Yes No No R 2
J.M. 52 Melanoma Yes No No 480 Yes Yes Yes No No R 9
A.M. 27 Melanoma Yes No No 240 No Yes Yes No No R 0.75
N.S. 60 Melanoma Yes No No 260 No Yes Yes No No R 3
M.M. 52 Melanoma Yes No No 135 No Yes No No No NR 1
A.D. 50 Melanoma Yes Yes Yes 210 No Yes No No No NR 1
M.G. 65 Melanoma Yes No No 720 No No Jaundice
? CVA
No No No NR 2
J.H. 53 Melanoma Yes No No 255 No No No No No NR 3
M.W. 49 Adeno Ca
Bronchus
Biopsy Yes No 180 No Yes Yes No No R 4
A.H. 56 Squamous
Bronchus
Biopsy Yes No 320 'No' Yes Yes No No R 6
A.P. 47 Undiffn.
Bronchus
Biopsy Yes No 120 No Yes No No No NR 1
Y.G. 48 Undiffn.
Bronchus
Bioposy No No 410 No " 7 D.I.C. " Extensive Tunur
Necrosis
- ?R 1 day
i.e. 36 Teratoma
Testis
Yes Yes Yes 420 No " ? D.I.C. No No No NR 1
P.C. 34 Teratoma
Testis
Yes Yes Yes 360 Yes Yes No No No NR 2
C.H. 39 Anaplastic
Ovarian
Yes No Yes 250 No Yes No No No NR 6
B.P. 52 Adeno Ca
Ovary
Yes No No 120 No No No No No NR 4
D.C. 10 Neuroblastoma Yes Yes Yes 240 No Yes Yes No No R 6
N.H. 5 Neuroblastoma Yes Yes Yes 110 No No No Haemorrhagic
Ti«our necrosis
R 6 days
D.F. 6 Neuroblastoma Yes Yes Yes 95 No - " " Gross necrosis
or Tunour
R 2 days
M.E. 48 Breast Yes Yes No 450 'Yes' Yes No No No NR 3
C.T. 50 Breast Yes Yes Yes 400 Yes Yes No No No NR 3
R.N. 44 Mycosis
Fungoides
Biopsy Yes Yes 320 Yes - Yes " " R 8
V.Y. 47 Nasopharynx Yes Yes Yes 493 Yes Yes Yes No No R 6
M.K. 53 Acute
Myeloid
Biopsy Yes Yes 220 No No No No No NR 4 days
H.M. 38 Squamous
Bladder
Biopsy Yes No 130 No No No No No NR
R « Responsive
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Summary
Fifty-one patients in the terminal stages of cancer have
been treated with whole-body hyperthermia either alone
(38 cases) or in combination with chemotherapy (i3
cases). Altogether 227 treatment sessions were held
averaging four hours each. The most sensitive tumours
were those of the gastrointestinal tract and sarcomas.
Breast and genitourinary tumours did not respond, and
lung tumours and melanomas were only partially
responsive. Major complications were remarkably few.
Introduction
Temperatures in the range of 41 to 42°C have been shown to be
lethal to tumour cells but not damaging to normal cells
(Cavaliere et al., 1967; Vermel and Kuznetsova, 1970;
Obcrgaard and Overgaard, 1972). Hyperthermia has been
applied to human tumours in vivo by isolated limb perfusion,
either alone or in combination with cytotoxic drugs (Cavaliere
et al., 1967; Stehlin, 1969), by whole-body hyperthermia
(Warren, 1935; Henderson and Pettigrew, 1971), and by local
irrigation (Hall et al., 1974). This paper records the clinical
responses of a series of patients to whole-body hyperthermia
either alone (38 patients) or in combination with cytotoxic
therapy (13 patients). All the patients were in the terminal
stages of their disease and unsuited to further treatment by
conventional methods.
Method
The method used was that described previously (Pettigrew
et al., 1974), in which the narcotized patient is covered with
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molten wax at 50CC to prevent evaporation of sweat and insulate
the body. The overall effect is to raise the body temperature
by 3 to 6° an hour depending on body weight. Previous work
has shown that the method is safe for treatment periods up to
eight hours provided that the temperature does not exceed
41-8 C and so long as there is adequate replacement of the
water and salt lost in the sweat (Pettigrew ct al., 1974).
Thirty-eight patients have been treated with hyperthermia
alone in 188 treatment sessions and a further 13 with hyper¬
thermia in combination with cytotoxic drugs. In the first group
the average length of each treatment above 41C was four hours,
and treatments were given at weekly intervals. In the second
group treatment was given in three sessions each separated by
three days. The first lasted 90 minutes and the other two
four hours. Cytotoxic drugs were given by intravenous bolus
injection during the last treatment. Patients with malignant
melanoma were given Melphalan 1 mg/kg; the others were
given cyclophosphamide 200 mg during the period of tempera¬
ture rise and fluorouracil 15 mg/kg and vincristine 1 mg at a
temperature of 41°C.
The response to treatment was judged favourable if there was
weight gain or pain relief plus either regression in tumour size
on direct measurement or pathological evidence of necrosis in
serial biopsy specimens or radiological evidence of regression.
Further evidence of heat-induced tumour necrosis was obtained
at necropsy in five of the six patients who died soon after hyper¬
thermia.
Nineteen patients were excluded from the series. Fourteen
were treated in the developmental stages of the method when
temperatures above 40 C were not routinely used. These
patients did not respond, and it is now accepted that temperatures
in excess of 41CC are needed (Giovanella et al.', 1970). A further
five patients with no obviously measurable tumours were
treated for symptomatic relief of pain only.
Results
hyperthermia ai.one
Though the numbers were small tumours of gastrointestinal
origin and sarcomas appeared to respond more than genito¬
urinary or breast neoplasms; lung tumours and malignant
melanomas showed an intermediate response (tabic I).
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fig. 1—Photomicrographs of liposarcoma. A and C, appearances of primary
tumour after resection. (Haematoxylin and cosin. A x 110. C x 270). B and
D, appearances of recurrent tumour four months later after treatment with
hyperthermia showing total necrosis to right side and degenerate cells at
left margin. (Haematoxylin and eosin. B x 110. D x 270).
Case Reports
Sarcoma.—Eight cases. In one patient a lung deposit disappeared,
a second showed healing of pathological fractures, and a third
showed complete regression of a fibrosarcoma recurrent in the
operation scar. A fourth had a hindquarter amputation for osteo¬
genic sarcoma; two months after the end of an 18-month course
of treatments tlie tumour recurred in a heat-resistant form. A fifth
patient, with an alvanced liposarcoma, died 24 hours after treat¬
ment. Necropsy showed recent massive necrosis throughout the
tumour (fig. 1). Two had subjective improvement with pain relief,
and a child with rhabdomyosarcoma showed no response.
Carcinoma of Stomach.—Three cases. Two anorexic patients
who had been in great pain gained weight and were able to lead
a relatively normal life. The third had extensive mediastinal and
lung metastases and died 48 hours after treatment. At necropsy
table i—Results of Treatment with Hyperthermia Alone
Previous Treatment
-
No. of Patients Objective Subjective No Survival from Start
Tumour Type Treated Surgery Radiotherapy Chemotherapy Responses Response Response of Thermotherapy (Weeks)
Sarcoma 8 6 4 2 3 + 1* 6 1 84, 52, 20, 8, 4, 2, 1, 0 14
Gastric Carcinoma 3 3 0 1 2 + 1* 2 0 16, 16, 0 28
Carcinoma colon .. 4 4 0 1 2 2 2 20, 8, 4, 0-71
Melanoma 7 7 2 2 3 4 3 12, 12, 8, 8, 4, 4, 3
Carcinoma lung 3 0 3 0 2 3 0 24, 20, 4
Carcinoma breast .. 2 2 2 1 0 1 1 12, 12
Ovarian carcinoma, 4 4 2 3 0 0 4 24, 16, 8, 4
teratoma testes
Neuroblastoma, 3 3 3 3 1+2* 1 0 24, 0-85, 0-28
nephroblastoma
Miscellaneous 4 2 4 4 1 1 2 32, 24, 12, 0-57












fig. 2—Chest x-ray pictures from patient with bronchogenic carcinoma. A,
appearances before treatment with hyperthermia. B, appearances six weeks
later after six treatment sessions.
there was extensive necrosis of the tumour causing compression
of the bronchus.
Carcinoma of Colon.—Four cases. One patient had almost com¬
plete regression of massive hepatomegaly; a second had regression
of skin nodules on the lower abdomen. The other two cases
showed no response.
Malignant Melanoma.—Seven cases. In three cases there was
good initial regression of secondary deposits and pain relief. One
patient had pain relief alone and three showed no response.
Carcinoma of Lung.—Three cases of bronchogenic carcinoma.
In one patient with adenocarcinoma there was regression of the
primary lung tumour (confirmed at necropsy) (fig. 2) though the
secondary deposits remained active. The second patient, with a
squamous carcinoma, showed regression of a secondary deposit
in the lumbar spine, and the third had relief from pain but showed
no tumour regression.
Breast Cancer.—Two patients with scirrhous carcinomas were
treated, one obtaining pain relief alone.
Ovarian and Testicular Tumours.—Two testicular teratomas and
two ovarian papillary tumours showed no response to treatment.
Neuroblastoma and Nephroblastoma.—Two children with
neuroblastomas were treated. One showed a good initial response,
with healing of ulcerated skin over the tumour in his jaw. The
second showed initial improvement till he developed respiratory
difficulties and died two days after treatment. Necropsy showed
multiple haemorrhagic areas of necrosis in the tumour. One child
with a nephroblastoma showed initial improvement but also died
from a respiratory arrest. At necropsy there was gross necrosis of
the tumour.
Miscellaneous Tumours.—One case of mycosis fungoides showed
initial healing and there was pain relief alone in a case of adeno¬
carcinoma of the nasopharynx. One case each of chronic myeloid
leukaemia and transitional cell carcinoma of the bladder showed
no response.
HYPERTHERMIA IN COMBINATION WITH CYTOTOXIC THERAPY
The results in the 13 patients given cytotoxic drugs during hyper¬
thermia are shown in table II.
Case Reports
Gastrointestinal Tumours.—Six cases. One patient Had an adeno¬
carcinoma of the colon with large hepatic metastases enlarging the
liver to 12 cm below the costal margin. After treatment the liver
mass regressed to a lump 5 by 6 cm and the patient was alive
and well at six months. The second patient, with a choLangio
carcinoma of the liver, showed regression of hepatomegaly with
complete clearance of jaundice (initial bilirubin 7-2 mg/100 ml)
and resolution of gross ascites. The third patient had an un¬
differentiated carcinoma and was admitted to hospital as an
emergency case with large-bowel obstruction. There was a mass
20 cm in diameter in his left iliac fossa and he had renal failure
due to ureteric involvement. After treatment he had complete
regression of the mass with a return of normal renal and bowel
function. A fourth patient had some regression of hepatomegaly
and the fifth showed necrosis on serial biopsy. There was sympto¬
matic improvement in one patient with adenocarcinoma of the
gall bladder.
Malignant Melanoma.—Three metastatic cases. Two patients
showed regression of involved axillary nodes and the third showed
regression of hepatomegaly though her secondary nodules did not
change in size.
Breast Cancer.—Three cases. These patienrs had cancer en
cuirasse and were in severe pain. In the first two there was relief
of pain with discontinuance of opiates and regrowth of skin over
the tumours. One of these patients died within 12 hours of a
further treatment given for recurrence three months later. There
appeared to be no pathological evidence of tumour necrosis and
death was attributed to disseminated intravascular coagulation.
The third patient died 48 hours after treatment with disseminated
intravascular coagulation. In this case necropsy showed evidence
of recent cell death in the tumour metastases, which involved liver,
adrenal, both kidneys, skull, uterus, pancreas, vertebrae, and dura.
Miscellaneous.—One case of osteoblastoma was treated. Though
the patient had pain relief there was no regression of the tumour.













Gastrointestinal 6 4 1 1 5 5 0 32, 20, 20, 16, 12, 8
tumours
Carcinoma breast . . 3 3 3 2 2 + 1* 2 0 20, 12, 0 28
Melanoma 3 3 0 0 3 1 0 52, 44, 24
Osteoblastoma 1 1 0 0 0 1 0 12
* Necropsy evidence of recent tumour necrosis.
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Complications
Complications may arise from the method, from the physio¬
logical response to high temperatures, or from the toxic effects
of tumour breakdown. When one considers that these patients
were maintained in an unconscious state at temperatures of
over 41°C for a total of about 1,000 hours complications of a
Hiajor character were remarkably few. The second patient treated,
in 1966, before the present controlled method was evolved,
developed ventricular fibrillation. This was due to her tempera¬
ture reaching 43°C as a result of thermometer failure and was
the only fatality directly attributable to induced hyperthermia.
Half of the patients developed a circumoral herpes simplex
during the first session but not on subsequent treatments. Sore
throats, pressure sores due to prolonged immobilization during
treatments, and superficial burns in oedematous, hypoprotein-
aemic patients occurred.
Four adult patients died within 48 hours of hyperthermia;
their deaths were associated with evidence of disseminated
intravascular coagulation. In three necropsy showed recent
tumour necrosis. Two children with an advanced form of
neoplastic disease also died shortly after treatment. They were
given opiates for relief of distress and died of respiratory com¬
plications. Another patient died of fibrosing alveolitis, possibly
due to repeated exposure to the hot, moist, ventilating gases
then in use (Henderson and Pettigrew, 1971) or as a result of
treatment with bleomycin six months previously.
RECOVERY AFTER TREATMENT
Narcosis is maintained during treatment with short-acting
barbiturates and the patient is awake before leaving the theatre.
Patients with sensitive tumours show evidence of a systemic
reaction after the first treatment, especially if it is prolonged.
They develop a persistent tachycardia with a low blood pressure
and may remain pyrcxial for up to 48 hours. Recovery takes
place more rapidly after a subsequent treatment if given within
a week. After the first treatment patients may be managed on a
day-stay basis, coming into hospital on the morning of treatment
and being discharged the next day. Patients with unresponsive
tumours show no toxic effects and are fully recovered within
eight hours. If treatment is extended beyond four or five hours
post-treatment jaundice may develop.
Discussion
There have been no deaths during hyperthermia in over 200
treatment sessions. Of the four adult deaths occurring within
48 hours of treatment all but one were associated with extensive
tumour necrosis. In the series of patients treated there were no
cures and few complete clinical remissions; however, the
advanced nature of the disease in all the patients is emphasized.
In general patients responding to treatment experienced a
remarkable sense of well-being during the period of remission,
with relief of tumour-evoked pain. The quality of life possible
after even incomplete treatment of a responsive tumour has
been our justification for treating such advanced cases. In doing
this it has been established that the selective thermal killing of
tumour cells can be extended to human tumours in vivo. Most
patients treated with hyperthermia alone who showed initial
tumour regression had recurrence of the tumour at about three
months in a heat-resistant form.
Animal experiments indicate that at temperatures above'
42°C normal cells start to undergo irreversible damage (Burger,
1970; Burger et al., 1970). In this series it was found that at
42°C there was a rise in serum enzymes along with a post-
treatment jaundice (Pettigrew et al., 1974). This did not occur
after treatment at 41-8°C, which was therefore taken as the
maximum permissible therapeutic temperature. There are
indications that a treatment period in excess of 20 hours would
be needed at 41-8°C to produce total tumour necrosis (Johnson,
1940). This treatment period may become possible with a
greater understanding of the physiological processes which occur
at 41-8°C. Several workers have claimed that a synergism exists
between hyperthermia and certain cytotoxic drugs (Stehlin,
1969; Giovanella et al., 1970). By combining the two treatments
it may be possible to produce total tumour necrosis in a shorter
time. The rationale behind this, however, has recently been
questioned (Palzer and Heidelberger, 1973 a). Though the
numbers in this series were small it appeared that there was an
enhanced effect when hyperthermia and chemotherapy were
combined.
With any treatment regimen aiming at total tumour necrosis
in one session the possibility of toxic products causing dele¬
terious effects such as diffuse intravascular coagulation cannot
be ignored (Leavy et al., 1970; Peck and Reiquam, 1973). Yet
with therapy given in multiple sessions other problems may be
encountered. Work with transplanted animal tumours indicates
that heating to a degree insufficient to produce a cure has a
stimulatory effect on the spread and growth of metastases
(Brett and Schloerb, 1962; Dickson and Ellis, 1974) and may
allow repair of sublethal damage to the tumour cells to take
place (Palzer and Hcidelberger, 1973 b). Heat-resistant strains
of cultured human tumours have been produced by exposure to
sublethal hyperthermic damage (Selawry et al., 1957). In this
series some of the patients with responsive tumours who were
treated with multiple sessions of hearing without chemotherapy
seemed to develop Jess sensitive tumours. Patients who responded
to chemotherapy plus hyperthermia continued to respond to
further combined treatments given when there was tumour
recurrence.
This work was supported by a grant from the Melville Trust
for Cancer Research, Edinburgh.
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Circulatory and biochemical effects of
whole body hyperthermia
R. T. PETTIGREW, JEAN M. GALT, C. M. LUDGATE,
D. B. HORN AND A. N. SMITH*
summary
The physiological effects of whole body hyperthermia to
42 C° have been studied in 12 subjects. There was a
sustained increase in the heart rate and an initial
increase in the arterial and centra! venous pressures.
Sweat and electrolyte losses were high. The serum
bilirubin remained normal if the temperature did not
exceed 4T8 C°. Above this temperature the serum
enzymes lactate dehydrogenase, alanine amino¬
transferase and aspartate aminotransferase rose, as did
the serum bilirubin. While the latter effect might be due
to liver damage, it could also he related to thermal
destruction of red ceils. A leucocytosis develops during
the hyperthermic state.
The selective lethal effect of heat on cancer cells is
well known (Mondovi et al., 1969a, b; Mtickle and
Dickson, 1971); a review of the literature has been
published by Vermel and Kusnetsova (1970). Localized
human tumours have been treated by isolated hyper¬
thermic perfusion (Cavaliere et al., 1967; Stehlin,
1969). To extend this to the treatment of disseminated
malignancy a method of inducing whole body
hyperthermia has been developed. This paper details
the physiological response of 12 patients to extreme
hyperthermia during 70 sessions and is an attempt to
establish the safety, or otherwise, of the method.
Method
The method is a modification of that described by
Henderson and Pettigrew (1971). The patient is
premedicated with promethazine hydrochloride,
narcotized with intravenous barbiturates and then
curarized. He is sealed in a large polythene bag and
placed in a specially constructed bath. Paraffin wax
(melting point, 43-46 °C) heated to 50 "C is pumped
into the bath around the sealed bag. The wax solidifies
around the .patient, forming an insulating layer.
Ventilation is maintained through an insulated
endotracheal tube with an enriched oxygen mixture
heated to 80 °C. This is the temperature at the top of
the tube, where the closed-circuit adapter meets the
endotracheal tube fitting. It falls to 45-55 °C at the
lower end, i.e. near the carina. Moritz et a!. (1945)
have shown that dry gas at this temperature does not
damage the lungs. The body temperature is raised by
between 3 and 6 Centrigrade degrees/hour, depending
on body weight. During the first hour of temperature
rise, the temperature in the oesophagus is 1-2 Centi¬
grade degrees higher than in the rectum (Fig. 1).
When the oesophageal temperature reaches 41 °C,
usually after 1 hour, the liquid wax is removed,
leaving the wax which has solidified around the body
as an insulating layer. Following this, there is a slow¬
ing in the rate of temperature rise to 41-8 °C, during
which time the rectal temperature reaches that of the
oesophagus (about 90 min., Fig. 1). The wax is
removed earlier from thin patients in whom the
temperature rise is very rapid. By varying the area of
skin exposed for evaporation of sweat or the thickness
of the insulating layer, the temperature of the patient









Fig. 1. Haemodynamic response to hyperthermia.
There is continuous monitoring of the rectal and
oesophageal temperatures and the electrocardiogram,
with periodic monitoring of the blood pressure, central
venous pressure, heart rate and serum electrolytes.
The patient has a continuous, heated intravenous
* Departments of Anaesthetics, Clinical Chemistry and
Clinical Surgery, Western Genera! Hospital and University of
Edinburgh.
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infusion and is given intravenous barbiturates as
required. A urinary catheter and nasogastric tube
maintain continuous drainage during treatment. When
the patient is removed from the bath at the end of the
hyperthermic period (at 5-6 hours, Fig. I), cooling is
rapid (2-3 Centigrade degrees/hour) and normal body
temperature is reached within 2 hours.
Results
Haemodynamic response
A typical haemodynamic response is shown in Fig. 1.
During heating, the heart rate increases rapidly with
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Fig. 2. Variation of temperature-dependent tachycardia with
rate of heating.
8-5 beats/min Centigrade degree-1 rise in oesophageal
temperature, with a range 5-15 beats/min Centigrade
degree-1. In the same patient heated on different
occasions the rate of increase of heart rate depends on
the rate of heating (Fig. 2). Fast heating initially
increases the heart rate less per degree rise in tempera¬
ture. However, at the end of active heating the heart
rate continues to rise for some time, reaching a
typical maximum for each patient and independent of
the rate of heating. The final heart rate at stable
temperature corresponds to a rise of 1! beats/min
Centigrade degree-1 (range 8-18 beais/min Centigrade
degree-1). Stable narcosis is required to maintain this
constant heart rate.
Drugs used in the induction of anaesthesia may
induce the initial mild degree of hypotension (Fig. 1).
Thereafter, during heating, the systolic blood pressure
rises by 20-50 mm Hg, with little change in the
diastolic pressure. At the same time the centra! venous
pressure rises by 5-10 cm H«0. When the temperature
is stabilized, both arterial and venous pressures return
to the initial values which are then usually maintained
throughout treatment.
Biochemical and haematological changes
As large fluid and salt losses were expected in the sweat,
serum electrolyte concentrations were monitored at
half-hourly intervals throughout treatment. Results
were obtained within 20 minutes of sampling. Initially,
fluids and electrolytes were infused according 'to the
level of the central venous pressure and to the serum
electrolyte concentration in the most recent sample.
From this, the intravenous regime recorded in Fig. 3
was developed and was used throughout the 70 treat¬
ment sessions of this study. With it, there is no
significant change in the serum sodium or chloride
concentration during hyperthermia (Fig. 3), although
there is a slight early decrease in the serum sodium
concentration, averaging 4 mEq/'l which coincides
with, and has been attributed to, premedication and
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chloride concentrations measured 24 hours after
treatment show no. significant change from the
pretreatment values. However, the serum potassium
rises by a mean value of 0-5 mEq/1 during the first
90 minutes of treatment. This increase is not main¬
tained beyond 3 hours, when a slow fall in potassium
concentration starts, and 24 hours after treatment
the serum potassium concentration is, on average,
0-5 mEq/1 lower than the pretreatment value.
As a check on the accuracy of fluid and salt re¬
placement, losses during treatment were estimated
from urinary loss and sweat collection data (Table I).
Sweat loss was assessed by enclosing one iimb of each
patient in a polythene bag and multiplying the volume
of sweat collected in the hag during treatment on the
assumption that sweat losses from the limbs and trunk
are proportionai to their relative surface areas. Data
given by Aden et a'. (1973) indicate that 60 per cent of
the sweat is from the arms and legs, including hands
and feet, which together represent 59 per cent of the
body surface area. Half-hourly sweat samples were
also collected from the trunk on weighed pads of
filter paper to measure sweat electrolyte concentration
and variation in sweat rate. Sweating is profuse during
hyperthermia, averaging over 500 ml/hour. The sweat
rate increases rapidly with temperature. At stable
temperature, fluctuations of up to 10 per cent occur in
the sweat rate; no further increase with continued
exposure to high temperature has been determined.
The serum activities of lactate dehydrogenase,
aspartate aminotransferase and alanine amino¬
transferase, all of which have been shown to be stabie
at the temperatures involved (Burger, 1970), were
monitored regularly. In 47 treatments conducted in
10 patients, during which neither the rectal nor the
oesophageal temperature rose above 41-8 °C, there
was no significant increase in the serum enzyme
activities, and the serum bilirubin concentration rose
from an average of 0-47 mg/100 ml to an average of
0-62 mg/100 ml, no value lying outside the reference
range (Table II). However, during 17 treatments
within the same group when the temperature was held
between 41-8 and 42-2 °C for periods of 10-49
minutes, the average serum activity of aspartate
aminotransferase increased by a factor of 25, that of
alanine aminotransferase by a factor of 8 and the
serum bilirubin concentration rose to 1-56 mg/100 ml.
During the hyperthermic period the haemoglobin
concentration varies about the mean value by up to
0-5 g/100 ml. The haemoglobin concentration falls by
an average of 0-8 g/100 ml within 36 hours of each
treatment, following which there is a reticulocytosis of
3-4 per cent, leading to partial recovery, but initial
values are not attained until the treatment ends.
During heating there is a ieucocytosis, the average
leucocyte count rising from 8-2 x 103/mm3 at 37 °C to
13-7 x 103/mm3 after 4 hours at 41-8 °C. It returns to
normal, within 24 hours.
Complications
During the developmental stage of the method there
were 2 deaths. One was due to ventricular fibrillation
Tabic I: CONCENTRATION OF ELECTROLYTES IN
SWEAT AND URINE I.OST DURING HYPERTHERMIA
mEq/hr mEq/1
ml/hr Na+ K4 C!~ Na+ K4 Cl~ Na : K
Urine* 52 3-3 2-1 3-7 67 51 83 1-3 :1
Sweatf 514 43 2 0 41 84 3-6 80 23 : 1
Infusion 570 52 1-0 43 — — — —
* Mean of 40 measurements,
f Mean of 60 measurements.
Tabic II: SERUM ENZYME ACTIVITIES AND





Reference Before above above
range heating 41-8 ;C 41-8 °C
Lactate dehydrogenase 48-265 181 178 546
(iu/1)
Aspartate amino¬ 4-20 12 13 278
transferase (iu/1)
Alanine amino¬ 2-17 10 12 78
transferase (iu/1)
Bilirubin (mg/100 ml) 0-2-0-8 0-47 0-62 1-56
when thermometer failure resulted in a temperature of
43 °C. The other was due to fibrosing alveolitis
following repeated exposure to hot moist gases
generated by a soda-lime canister (Henderson and
Pettigrew. 1971). Dry heated gases have since been
used with no harm. These have been the only 2 deaths
attributable to the method in a series which now
amounts to over 250 treatments, the results of which
will shortly be reported. Minor complications
experienced were herpes simplex, sore throat with
hoarseness, lassitude, nausea and occasional super¬
ficial burns under ECG electrodes. There have been no
neurological defects or apparent depression of the
mental faculties.
Discussion
The hyperthermic state is rapidly and safely induced
by this method which effectively reverses the physio¬
logical processes allowing heat loss from the body.
The solid layer of wax both insulates the body and
prevents evaporation of sw;eat from the skin, while
respiratory heat loss is minimized by heating the
inspired gases. Knowing the approximate rate of
metabolism (1250cal/min at 37 °Q and the rate of
increase of body temperature, it can be deduced that
1000-2000 cal/min are supplied to the body by the
change of state of the wax.
The cardiovascular response to increased body
temperature found in anaesthetized subjects is
different from that found in conscious ones, who
respond by a decrease in arterial and central venous
pressures due to peripheral dilatation and by a
compensatory tachycardia (Damato et al., 1968). A
degree of hypotension already exists in the anaes¬
thetized subject before the heating process begins. The
rise in arterial and centra! pressures at the onset of
heating may follow a further diminution of afferent
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impulses from the baroreceptors in the carotid sinus
and aortic arch. This is known to lead to an increase in
the activity of the sympathetic vasomotor control of
the precapillary resistance vessels which raise the
arterial blood pressure and produce increased venous
tone and cardio-acceleration. The eventual return of
arterial and central venous pressures to their initial
values before cessation of hyperthermia is similar to
the normal thermoregulatory response to heat stress.
The final heart rate at stable temperature represents
an increase of only 60 per cent of that found in
conscious heat-stressed subjects (Tanner, 1951). This
may be attributable to anaesthesia, as a reduction in
the depth of narcosis will lead to a further rapid
increase of heart rate. The increase in heart rate lags
behind the increase in body temperature when the
latter is rapidly raised. This may imply that there is a
limit to the rate at which the compensatorymechanisms
can respond to stimuli.
Fluid losses during hyperthermia are great, averag¬
ing over 550 ml/hour, of which 90 per cent is lost as
sweat. However, this sweat rate is similar to that
reported for unacclimatized subjects exercising in a
hot climatic chamber, and although the sweat sodium
concentration of 84 mEq/1 is higher than the reference
range of 20-70 mEq/1, similar increased sweat sodium
concentrations have been reported during prolonged
heavy sweating in unacclimatized subjects (Furman
and Beer, 1963). In spite of the losses it was possible
to achieve a satisfactory fluid and salt balance
by monitoring the serum electrolyte concentra¬
tions.
Raised serum enzyme activities have been found in
animals heated above 42 °C (Burger, 1970). This only
occurred during this series at temperatures above
4T8 °C, which therefore sets a limit to therapeutic
applications. The fail in haemoglobin which occurs
following hyperthermia may be due to the thermal
destruction of ageing red cells. Reticulocytosis with
partial recovery between treatments indicates an
active marrow. Similar results were found by Karle
(1969) in induced fever in rabbits. The slight post-
treatment rise in bilirubin when the temperature has
not exceeded 41-8 C'C may be due to haemolysis, but
alternatively it may be due to liver damage. The
development of a leucocytosis during treatment is
similar to that seen under stress and may reflect the
discharge of additional white cells into the circulation.
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Coagulation defects following whole body
hyperthermia in the treatment of
disseminated cancer: a limiting
factor in treatment
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Experimental studies have shown that some tumour cells may be more
sensitive to heat than normal cells. The use of whole body hyperthermia
in the treatment of disseminated sensitive human cancer may result: in a
consumption coagulopathy. Subdivision of treatment into increasing
fractions is required to prevent excessive disseminated intravascular
coagulation. The consumptive coagulopathy is reflected in a fall in the
platelet count. Patients with non-responsive tumours had a fall in platelet
count after the first treatment, but not after subsequent treatments.
Patients with responsive tumours showed a fail in platelet count after
each increasing fraction.
Introduction
Animal and in vitro studies have shown that some tumours may be selectively des¬
troyed by heat (Vermel & Kuznetsova, 1970). In man, hyperthermic treatment has
either taken the form of localized perfusion for isolated disease (Stehlin, 1969) or of
whole body hyperthermia for disseminated disease (Pettigrew, Gait, Ludgate &
Smith, 19745). A method of inducing whole body hyperthermia along with the
physiological changes which occurred during treatment has previously been des¬
cribed (Pettigrew, Gait, Ludgate, & Smith 1974a). Single extended treatments
carried some mortality, but the method appeared safe for shorter treatments.
Increased intravascular coagulation has been a reported complication of aggressive
chemotherapy in the presence of wide spread sensitive tumours (Leavy, Benham,
Kahn & Brodsky, 1970). Peck & Reiquam (1973) found that cancer patients have a
delicately balanced coagulation mechanism which might easily be tipped towards a
low grade chronic disseminated intravascular coagulation by any change in the
*Requests for reprints to: C. M. Ludgate, Department of Clinical Surgery,
Western General Hospital, Edinburgh.
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balance. This paper is a summary of the effect of hyperthermia on the coagulation
status of 43 patients undergoing whole body hyperthermia for disseminated cancer.
Method
The method used to induce whole body hyperthermia is as described previously
(Pettigrew ei ah, The curarized, narcotized patient was placed in a heat
sealed polythene bag in a specially constructed bath. Low melting point wax (melting
point 35°C) was heated to 5o°C and pumped into the bath, immersing the patient.
Ventilation was|maintained through an insulated endotracheal tube using an oxygen
enriched air mixture, heated to 8ocC by passage through a heat exchanger. The
patients body core temperature was raised through 5°C over approximately' i h
and was maintained at a temperature of 4i-8°C during the treatment period. At the
end of the treatment session, the patient was removed from the bath and cooling was
rapid. Prior to treatment an intravenous cannula was inserted into the median
cubital vein and threaded into the superior vena cava. Blood was taken at regular
intervals from this cannula before, during and after treatment and the following
estimations were carried out.
Haemoglobin, using the Coulter Counter—Model S, Platelet count (Brecher &
Cronkite, 1950), using phase contrast microscopy, Quick's one stage prothrombin
time using standardized reagents (Poller, 1970), plasma fibrinogen (Ellis & Stransky,
1961) and serum fibrin—fibrinogen degradation products using the Tanned Red Cell
Haemagglutination Immunoassay (Merskey, Kleiner & Johnson, 1966). Sternal
marrow punctures were performed before, immediately after treatment and at 1 week
post-treatment. Three patients received controlled low dose heparin throughout the
hyperthermic period. In order to standardize the treatment fractions for different
temperature time equivalents, the centigrade degree minute (CC min) was taken as
the unit of hyperthermic therapy. This was defined as the temperature in centigrade
degrees ihat the body core temperature was above 40°C multiplied by the time in
minutes. Most patients were treated by serially increasing fractions at weekly inter¬
vals, though some early cases were not managed in this way. The response to treat¬
ment was judged favourable if there was a weight gain, or pain relief, plus either
regression in tumour size on direct measurement, or pathological evidence of necrosis
in serial biopsy specimens, or radiological evidence of regression (Pettigrew et ai.,
1974b). The patients form part of a larger series of 64 patients. The results of part
of this series have already been published (Pettigrew et al., 19740); sarcomas (4 out
of 8) and tumours of gastrointestinal origin (8 out of 13) were the most sensitive.
Melanoma and lung tumours occupied an intermediate group, and there was no
response in the ovarian or testicular tumours treated. There was no selection of
patients for the present study. They were mainly patients who presented in the latter
part of the series.
Results
The most sensitive index of coagulation defect was found to be the platelet count.
Other indices, such as prothrombin time, plasma fibrinogen, and the level of fibrin-
fibrinogen degradation products, remained stable unless there was a marked thrombo¬
cytopenia with platelet counts falling below 50Xio9/L following treatment. The
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maximal fall in platelets occurred at approximately 24 h after treatment (Figure 1).
Sternal marrow histology, before, immediately after treatment and at 7 days post-
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Figure 1. Typical pattern of platelet count changes following a treatment session
lasting 4 h (approx. 3oo°C min).
There was a fall in haemoglobin with a subsequent reticulocytosis following each
treatment, as previously recorded (Pettigrew ei ah, 1974a). There was an initial fail
in the percentage of platelets after the first treatment of less than 30or'C min, this
was less in patients with non-responsive tumour, averaging 75-7% °* the pre-treatment
value (standard error 13*5%), as compared with those in the responsive group who
averaged 45-9% (standard error 9-4%). Both groups showed some decrease in the
platelet count following treatment (Figure 2). This was clinically reflected in the






Pre - treatment 24 Post-
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Figure 2. Average results for 15 treatment sessions in responsive (R) and non-
responsive (NR) patients, showing a significant difference (P<o-oi).
After an initial fraction of greater than 300°C min, there was a greater fall in the
platelet count in both the non-responsive and responsive groups. In the
non-responsive group the platelet count fell to 74-5% (standard error 17-9%) of the
pre-treatment value and in responsive patients, to 17-7% (standard error 11*7%)
(Figure 3). There was evidence of disseminated intravascular coagulation (DIC)
in the most responsive tumours. Three such patients died with platelet counts below
iox io9/L and fibrin—fibrinogen degradation product levels of 160, 640 and 160 mg/L,
respectively, and at post-mortem there was evidence of gross tumour necrosis.
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Pre-treatment 24 Post-
Time (h) treatment
Figure 3. Average results for 11 treatment sessions in responsive (R) and non-
responsive (NR) patients, showing a significant difference (P<o*oi).
Subsequently, the policy was changed to a first treatment dose of less than 3oo°C min
and no further case of severe DIC occurred.
If a separate second fraction was given above 300°C min, but less than 5oo°C min,
after a first fraction of less than 30o°C min, there was a rise in the platelet count in
those with non-responsive tumours, averaging n6% of the pre-treatmeiii count
(standard error 27-7%); whereas those responding again showed a decrease following
treatment, averaging 58-6% (standard error 17-5%) (Figure 4). Two patients with
non-sensitive tumours were treated at above 500°C min, following a previous frac¬
tion below 300°C min, There was again a fall in platelets to 31 X io9/L and 70 X io9/'L,
respectively; the patient with the greater thrombocytopenia required clotting factors.
Figure 4. Average results for 11 treatment sessions in responsive (R) and non-




Figure 5. Average results for 4 patients with responsive tumours.
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The platelet counts of neither of these two patients returned to their pre-treatment
values within 7 days. When patients were treated with the same or a lesser fraction
than previously, at an interval of 1 week following the previous treatment, there was
an increase in the platelet count in the responsive group, averaging 138-7% (standard
errors 57-6%) (Figure 5). These four patients had no nausea or sickness following
this fraction. One patient with a non-responsive tumour was also treated in this
manner and showed a similar rise in platelet count. In the patients with non-responsive
tumours treated at above 500°C min, there was a marked thrombocytopenia and
this may represent too large an increment in fraction dosage (200°C min) or a
ceiling for maximal treatment.
Discussion
The lethal effects of hyperthermia occur at above 40°C with a decrease in oxygen
consumption of the cell (Johnson, Margottini, Mondovi, Moricca & Rossi-Funelli,
1967). Animal studies would indicate that a i°C rise in temperature results in a
twofold increase in the rate of destruction of cells (Westra & Dewey, 1971). The
degree minute was taken as the unit of therapeutic hyperthermia and this was defined
as the time in minutes multiplied by the temperature in centigrade degrees that the
body core is at a temperature above 40°C and represents an equivalent time in
minutes spent at qffC. At a hyperthermia fraction of less than 3QO°C min, there was
a fall in platelets in both responsive and non-responsive patients. There was, however,
no subsequent fall in the non-responsive group to a second, larger fraction, 1 week
later (Figure 4). This would indicate some initial destruction of normal tissue and
may be in part due to the destruction of ageing red cells, as shown in the animal
(Karle, 1969). Subsequent greater fractions can be tolerated following a first smaller
fraction. The shape of the survival curve of tumour cells during hyperthermia has
been shown to be similar to that following X-ray irradiation, having a shoulder
indicating repairable damage before an exponential phase of cell death is reached
(Westra & Dewey, 1971). The action of hyperthermia in destroying cells is largely
by damage to enzyme systems necessary for the repair of otherwise sub-lethal damage
(Hahn, 1974). Ceils are either killed or return to their previous state following each
treatment. Clinical results reflected the platelet count, in that patients having a
second fraction, similar to the first do not have a large fall in platelet count and feel
well immediately following the second treatment. Each treatment, at weekly intervals,
was not additive and a second longer fraction was required to produce the same fall
in platelet count. Assuming that the fall reflects effective therapy. This may be due to
the remaining population being more resistant.
Cytotoxic chemotherapy and hyperthermia have been shown to potentiate each
other (Hahn, Braun & Har-Kedar, 1973). The only death associated with DIC in a
patient treated with an initial fraction of less than 30o°C min, occurred following
chemotherapy given at the same time as hyperthermia. In subsequent cases this
combination has been used after two fractions giving the chemotherapy along with
the third hyperthermia fraction, of the same dose as the second. Three such patients
were treated with closely monitored low dose heparin, during each of the three
treatment sessions to try to avoid platelet consumption. One patient with a sensitive
tumour bled into her tumours during treatment and this form of preventive therapy
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was therefore discontinued. In two patients treated with over 5oo°C min, in whom
BIC was suspected because of rapidly developing thrombocytopenia, treatment by
infusion of platelets and clotting factors was successful.
The present results would agree with previous work, that the most useful indicator
of acute DIC in patients with cancer may be thrombocytopenia alone. The fact that
this may not be associated with reduced clotting factor levels may be explained by
an increased production of consumable factors in cancer patients (Peck Sc Reiquam,
I973)-
During hyperthermia the patients are in a hyperdynamic vasodilated state and
there is a consequent rapid absorption of any toxic breakdown products resulting
from cellular death. This may result in rapid removal of fibrin-nbrinogen degradation
products and explain why higher levels were not more frequently found in association
with a drop in platelet count. There is some breakdown of normal, probably ageing
tissue during hyperthermia but if the load of toxic products is increased by the
additional breakdown of sensitive tumour, then disseminated intravascular coagula¬
tion may be precipitated. The present results represent a random selection of tumour
types which may have differing sensitivities to hyperthermia. All tumours were
disseminated and some of the results may relate in part to the bulk of tumour within
the body. It is therefore difficult to make a definite clinical evaluation but the trend
is towards a consumption coagulopathy in patients with sensitive tumours. There is
therefore a need for fractionation in hyperthermic therapy, but the frequency of
treatment and the exact heat fractions to be used for each individual tumour are still
to be assessed. It would seem that the piateiet count may provide a useful measure
of tumour response to whole body hyperthermia.
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Hyperthermic Perfusion of the Distended Urinary
Bladder in the Management of Recurrent
Transitional Cell Carcinoma
C. M. LUDGATE, N. McLEAN, G. F. CARSWELL, J. E. NEWSAM, R. T. PETT1GREW and W. SELBY TULLOCH
Department of Clinical Surgery, University of Edinburgh and the Departments of Urology, Pathology and Anaes¬
thetics, Western General Hospital, Edinburgh
Temperatures above 40CC have been shown by in vitro and animal studies to be selectively lethal
to cancer cells (Cavaliere et al., 1967; Dickson and Shaw, 1972). Hyperthermic therapy in man
has either taken the form of isolated limb perfusion for localised disease (Stehlin et al., 1975) or
whole body hyperthermia for disseminated disease (Pettigrew et a!., 1974). Local hyperthermia
may have a role in treatment of transitional cell carcinoma of the urinary bladder since the disease
tends to remain localised and spreads mainly by local invasion. In view of the discouraging results
following total cystectomy for invasive carcinoma (Whitmore and Marshall, 1962) and the ease
with which local hyperthermia can be induced by perfusion, it is not surprising that several
attempts of this form of treatment have been made. Local hyperthermic irrigation through a 3-way
Foley catheter has been used either alone (Hall, Schade and Swinney, 1974) or to enhance the
effects of radiotherapy (Cockett et al., 1967), or chemotherapy (Lunglmayr et al., 1973). In each
of these studies the undistended urinary bladder has been perfused. In the contracted state the
bladder forms folds ofmucosa which might shield the tumour from the full effects of hyperthermic
perfusion. This is a report of 13 patients with transitional cell carcinoma of the bladder, recurrent
following radical radiotherapy, treated by hyperthermic perfusion of the distended urinary
bladder. Most presented with cross haematuria not controlled by repeated local cysto-diathermy.
Method
15 treatments were carried out in 13 patients. It was found that even slight bladder distension
proved uncomfortable and because of the variation in flow rate due to bladder contraction the
temperature was difficult to control. Continuous epidural anaesthesia allowed relaxation of the
bladder and a steady flow rate to be achieved at a constant temperature.
Under epidural anaesthesia the nature and extent of the tumour was established by cystoscopy
and bimanual examination. Biopsies were taken from the tumour and from the normal bladder
mucosa. The bladder capacity was measured and a 24 F 3-way Foley catheter introduced into the
bladder and inflated with 5 cc of warm saline. The bladder was then washed out to remove air
bubbles and perfused with normal saline which was heated by passing through a heating coil
inserted in the water bath. The outflow ascended a gradient to an overflow tank (Fig. 1), the
height ofwhich was adjusted so that slightly less than the known bladder capacity caused overflow.
This was usually at a height between 15 to 20 cm above the symphysis pubis. The patient was
placed on an X-ray table during treatment and the degree of distension was monitored radio-
graphically by injecting a coloured solution or radio-opaque medium into the perfusate and taking
check films. Thermo-couples were used to measure the inflow, outflow and rectal temperatures.
A further probe was attached to the skin 1 inch above the symphysis pubis (Fig. 1). It is hoped
that a further probe, when it is available, will be introduced into the tumour itself to determine
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Fig. 1. Method of hyperthermic perfusion of the distended bladder. The overhow height
was approximately 35 cm above the table or 15 to 20 cm above the symphysis pubis.
whether the outflow temperature truly reflects the temperature of the tumour. Perfusion was at a
constant rate of 3 litres per hour, the inflow temperature being adjusted to give the required
outflow temperature. It was initially intended to use an outflow temperature of 45CC (Hall el a!.,
1974) but this caused lower abdominal discomfort and the temperature was therefore reduced
to 44°C, which was well tolerated by all patients. 3 patients were treated at an outflow temperature
of 43GC for 4 hours. At the beginning of the perfusion there was a rapid rise in the outflow
temperature which remained stable provided that the inflow temperature was kept constant
(Fig. 2). The rise in skin and rectal temperatures depended to some extent on the size of the tumour.
It was greatest when the tumours were infiltrating and extensive, rising to 40-5cC in such cases,
during the first 2 hours of treatment.
At the end of the treatment session a Foley catheter was inserted and left on free drainage for 24
hours before removal. The effect of the treatment was assessed by cystoscopy, bimanual exami¬
nation and biopsies. These were initially taken 3 days and 2 weeks after treatment and thereafter
at 6-weekly intervals. In later cases biopsies were also taken immediately at the end of treatment.
Results
The duration of perfusion varied from 1 to 4 hours. In all cases gross haematuria was arrested
but slight haematuria persisted for up to 1 week following treatment. After treatment of 1 hour's
duration there was no frequency. At cystoscopy the mucosa appeared healthy and the bladder
capacity was not altered but there was residual viable tumour present. These 2 patients had
recurrent haematuria at 6 weeks and required further treatment (Table).
After 3 hours at 44"C there was obvious tumour necrosis appearing at cystoscopy as a grey-
white slough which took up to 2 months to separate from the mucosa. The normal mucosa
appeared red and inflamed and the bladder capacity was reduced to between 150 to 200 ml.
There was no evidence of recurrent tumour for 3 months. Thereafter, recurrence was found in 3
of the 6 patients (Table).
After 4 hours at 44°C there was prolonged and continuing frequency and at cystoscopy the
bladder capacity was reduced to between 50 to 75 ml. The whole of the bladder mucosa was
covered by a grey-white slough. Bimanual examination revealed an indurated palpable bladder.
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Time (minutes) Fig. 2. Temperature graph during treatment.
No recurrent tumour has been found in this group at 6months but, because ofcontinued frequency,
urinary diversions became necessary. They remain well at present with no tumour recurrence
(Table).
Histopathology
The tumour biopsies taken before hyperthermia were graded as described by Bergkvist, Ljung-
quist and Moberger (1965). 6 tumours were Grade II, one of which was invasive; 6 were Grade
III, 5 of which were invasive and 1 was Grade IV and invasive.
The effects of hyperthermia on the bladder vary according to the interval after treatment.
Changes seen in the transitional cell at the end of the treatment session consisted of nuclear
vacuolation, pyknosis, with vacuolation of the cytoplasm, and reduction of epithelial adhesion.
These early changes were similar to those reported in the epidermis after thermal injury (Moritz,
Table
Local BladderHyperthermia: Comparison ofClinical
Results following Different Temperature/Time
Combinations
Outflow Treatment Duration of effect
temp. time frequency on
(°C) (hours) (weeks) tumour
44 1 Nil Nil
44 2 1 Nil
44 3 12 Clear 3/12
44 4 20+ Clear 5/12+
43 4 6 Some necrosis
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Fig. 3. Necrosis in bladder tumour immediately after treatment for 3 hours at
44°C. Some villi are ghost-like (bottom left). In the central villi, stomal
haemorrhage is accompanied by partial necrosis. The remaining villus and
its stroma are relatively normal. H.E. x 180.
1947). Slight changes, however, were not easy to assess in a bladder which was inflamed following
hyperthermia and had previously been subjected to radiotherapy and repeated cyclodiathermy.
Severe effects were easily recognised in both tumour and mucosal epithelium and were often
accompanied by vascular and connective tissue changes.
Effect ofHyperthermia on Bladder Tumour
No tissue necrosis was seen in tumour biopsies taken after 1 hour's perfusion at 44CC. The
effects seen in biopsies taken at the end of 3 to 4 hours' perfusion were often patchy, one part of
the tumour showing little change whilst another showed complete necrosis. Necrotic areas were
accompanied by local vascular changes such as necrosis and thrombosis in the small vessels of
the tumour and haemorrhage into its stroma. These vascular changes may be responsible for
some of the tumour destruction since blood vessels are more susceptible to thermal injury than
is normal epithelium (Moritz, 1947). Necrosis manifested itself in 2 main forms, either as ghost¬
like villi or in disintegration of the tumour with disruption of its cells (Fig. 3). 3 days after per¬
fusion. for 3 to 4 hours, necrosis was usually so advanced that it was difficult to recognise tumour
in the biopsy material.
3 of the tumours recurred 2 months or more after hyperthermia. 1 was a Grade II tumour
(Bergkvist et a!., 1965) and 2 were Grade 11! tumours. Both of the Grade III tumours appeared
invasive before and after treatment.
Effect of Hyperthermia on Bladder Mucosa
The normal mucosal epithelium initially was considerably less affected than the tumour.
Quite marked changes, however, occurred in the blood vessels and connective tissue of the mucosa
and these led to additional changes in the epithelium.




Fig. 4. Bladder mucosa 3 days after 44°C for 4 hours showing vascular necrosis and
haemorrhage with devitalisation of stroma and disintegration of transitional cell eoitheiium.
H.E. x 250.
Hyperthermia resulted in congestion and oedema of the lamina propria with inflammatory
cell infiltrate sometimes including numerous eosinophils. Thermal effects upon blood vessels of
the mucosa led to exudation of plasma and sometimes to interstitial haemorrhage. Some of the
vessel walls were frankly necrotic (Fig. 4) and thrombi tended to form (Fig. 5). These vascular
changes exacerbated the direct thermal injury of the lamina propria, sometimes resulting in areas
of necrosis with exfoliation of epithelium and subsequent formation of hypervascular inflamed
granulation tissue. A degree of fibrosis usually followed (Fig. 6). Regeneration of epithelium was
obvious in the biopsies taken 2 months after hyperthermia but may have been established sooner.
Discussion
The aim of local hyperthermic treatment of transitional cell carcinoma of the bladder is to cause
maximal tumour damage with minimal injury to normal tissue. In this, the method was only
partly successful. Distension of the urinary bladder during hyperthermic perfusion ensured that
all the papillary tumour was exposed to the perfusing fluid. Continuous epidural anaesthesia
prevented intermittent bladder contraction which had previously caused fluctuation in flow rate
and difficulty in maintaining a constant temperature. The procedure is simple and was well
tolerated by all patients.
Perfusion at 44°C for 3 or 4 hours or at 43CC for 4 hours resulted in tumour necrosis but pro¬
longed perfusion at the higher temperature was followed by frequency of micturition and bladder
contraction. This has been found in previous reports (Hall el ah, 1974) and may be due to
exposure of the whole epithelium or sensitization by previous radiotherapy. There have been no
urinary symptoms following whole body hyperthermia at 41-8°C for up to 11 hours. At tempera¬
tures above 42CC there was some damage to normal cells (Pettigrew et al., 1974). In tissue culture
experiments some He La cells survive 25 hours' exposure at 42CC; exposure at 43CC produced
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considerably more cell destruction, few cells surviving 2 hours at this temperature (Paizer and
Heidelberger, 1973). The effect of hyperthermia on human and animal tissues is doubled for
each 1°C rise in temperature (Moritz, 1947). In the present investigation hyperthermic perfusion
for 1 hour at 44°C was not followed either by bladder irritability or by appreciable tumour necrosis.
The effect of longer perfusions resulting in tumour necrosis appeared to be brought about not
only from a direct action on the tumour cells but also from injury to its blood vessels. This latter
mechanism was probably responsible for damage to the bladder mucosa. In the skin, Moritz
(1947) has shown that dermal vessels are far more responsive to temperature changes than are
normal epithelial cells, and that severe and persistent vascular reactions were often elicited by
protracted episodes of hyperthermia of low intensity that fail to harm the epidermis. If this
pertains to the bladder it will be a factor limiting the prolonged treatment of tumours deeply
infiltrating the bladder wall or surrounding tissue. To achieve a therapeutic effect it is necessary
to raise the temperature of an infiltrating tumour to a minimum of 40°C. Prolonged perfusion
at 44JC has been shown to produce this temperature in the rectum in the case of extensive
tumours infiltrating the bladder base.
Hyperthermic perfusion of the bladder at relatively low temperatures results in necrosis of
transitional cell carcinomas and freedom from tumour which may persist for several months.
Our results and those of previous workers (Hall et a!., 1974) suggest that invasive tumours tend
to recur early. Much work needs to be done in terms of sensitivities, fractionation and temperature
gradients to assess the role of this method in the treatment of bladder cancer. This preliminary
investigation has, however, shown that themethod is of value in arresting intractable haemorrhage.
Fractionated therapy, at a lower temperature, may cause a selective lethal effect upon the tumour
ceils without damage to the deeper vasculature of the bladder. It is this possibility which requires
further evaluation.
Summary
The clinical and histological changes following hyperthermic perfusion of the distended urinary
bladder have been studied in 13 patients with transitional ceil carcinoma, persistent after radical
hyperthermic perfusion of the distended urinary bladder 847
Fig. 6. Fibrosis 2 months after 44cC for 24 hours. The bladder surface is seen bottom right and the mus-
cularis bottom left. H.E. x 150.
radiotherapy. Continuous epidural anaesthesia was necessary to achieve a constant state of
bladder relaxation during irrigation of the distended bladder.
This form of hyperthermic perfusion of the bladder was effective in arresting uncontrollable
haemorrhage from bladder tumours and may be of value in the treatment of this complication.
Perfusion at an outflow temperature of 44°C for 4 hours caused tumour necrosis. It was,
however, associated with damage to the vasculature of the bladder and frequency of micturition
which persisted after mucosal recovery. Perfusion at 43°C also caused tumour necrosis and the
after effects were less severe.
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